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Abstract
The true pattern of bone mineral density changes during childhood and adolescence is
unclear owing to a lack of longitudinal investigations, a lack of adequate control for maturational
differences, and size-mediated errors in the measurement of areal bone mineral density (aBMD).
This investigation incorporated mixed-longitudinal (distance data) and longitudinal (velocity data)
designs to describe pediatric changes in bone density at the total body (TB), femoral neck (FN)
and lumbar spine (LS). Maturational differences were controlled by aligning participants on their
age at peak height velocity (PHV). Changes in areal BMD (aBMD) were compared with
densities obtained from two methods of size correction: bone mineral apparent density (BMAD)
based on geometric assumptions, and statistically-corrected BMD (sBMD), which utilizes linear
regression. Correlations between bone projected area (PA) and density were strongest with
aBMD, intermediate with BMAD, and generally insignificant with sBMD, supporting sBMD's size
independence. With the distance data aBMD increased over the entire growth period at all sites.
Contrastingly, TB BMAD declined initially and then stabilized after PHV, and FN and LS BMAD
were generally stable until PHV, increasing afterward. Similarly, TB and LS sBMD decreased
until PHV, increasing afterward, and FN sBMD was stable until PHV, increasing thereafter.
aBMD velocity was positive at all sites and all ages. In contrast, TB and FN BMAD had a
negative velocity until after PHV, and LS BMAD velocity was generally stable until near PHV,
with a positive velocity afterwards. sBMD velocity was negative at the TB and LS until PHV and
there was a stabilization (males) or decrease in velocity (females) in FN sBMD until PHV.
Velocity curves for PA and bone mineral content displayed a consistent dissociation at all sites
with bones increasing in area first and later consolidating when rapid growth ceased or slowed.
The point of minimal density suggested from the corrected data coincided with PHV and is
supported by epidemiological data that reports the highest rates of fracture in adolescents during
this time. These results highlight the size-dependence of aBMD and cautions against its use in
the pediatric population. Physiologically, sBMD appeared the more appropriate size-correction
technique.
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1 Introduction
1.1 Bone, more than a framework for locomotion
The skeleton is a series of interconnecting levers, articulated by muscles, which aid in the
movement of an organism around its environment and provide scaffolding for the body's tissues.
However, bone, a specialized connective tissue, plays additional crucial roles in haemostases
(most significantly calcium and phosphate concentration), erythropoesis, vital organ protection (Le.
brain, heart, lungs), sound wave conduction (inner ear), and immune function.
Despite the integral roles bone plays in the body, there is a paucity of information regarding its
normal physiology and response to stimuli at the tissue and cellular levels, especially when
compared to other more metabolically active tissues such as muscle. There are numerous
arguments as to why bone research has comparatively lagged behind in scientific understanding.
Firstly, bone was previously erroneously believed to be a relatively static tissue with limited ability
to adapt; in reality, bone is a dynamic tissue that is responsive to both mechanical and hormonal
stimuli via pathways still incompletely understood. Secondly, bone's comparatively slow rate of
turnover, and adaptation, make its investigation time-consuming and expensive. Lastly, the
relatively central position of bone within the body makes its study difficult, often necessitating
undesirable invasive or radiographic techniques. Invasive techniques commonly elicit an acute
reparative response which overshadows any chronic adaption to the introduced stimulus, and
accurate and valid radiographic techniques often emit unsafe levels of radiation to make their use
widespread except in those instances where trauma or pathology necessitates it.
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1.2 Osteoporosis
Osteoporosis is a debilitating disease defined by pathologically low bone mass and
microarchitectural deterioration resulting in skeletal fragility and an associated increased risk of
fracture (1).
In 1992, a 50 year-old Caucasian woman had an approximate 40% risk of at least a hip, spine
or wrist fracture occurring during her remaining lifespan (2) and it was estimated that in North
American Caucasians one-third of women and one-sixth of men over the age of 65 yrs
experienced osteoporosis-attributable hip fractures (3). World-wide projections predict that by the
year 2050 there will be a 310% increase in men and a 240% increase in women who experience
hip fractures (4). In Canada, the prevalence of osteoporosis-related fractures is expected to
increase by 73% between the years 1987 and 2006; at least partially a consequence of an aging
population (5). Similarly, it is predicted that the rate of hip fracture over the next 40 years in
Canada will increase exponentially, further taxing an already overburdened medical system and
resulting in tragic losses of personal independence (6).
The economic and personal implications of osteoporosis and its associated fractures are
staggering. In 1993 the annual hospitalization, treatment and rehabilitation costs of osteoporosis
in Canada was estimated to be $1.3 billion (7). More importantly, osteoporotic fracture is
associated with a decrease in personal independence and quality of life for the effected individual,
particularly in the case of hip fracture (8). Following a fracture of the hip, individuals experience
significant morbidity and loss of independence, and approximately a quarter face mortality in the
year following the fracture due to fracture-related complications (8). Vertebral fractures also
significantly impact quality of life (9-11), whether diagnosed or undiagnosed (12), and mortality
after five years is approximately the same as that experienced with hip fracture (8;13;14). These
statistics illustrate the importance of increased investigation of methods to treat, and more
importantly, prevent osteoporosis.
Preventative strategies to avoid the premature onset of osteoporosis include the
maximization of bone mass accrual during growth, the maintenance of skeletal mass through
adulthood, and the reduction of loss associated with old age and menopause (in females).
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Genetics account for approximately 50-80% of the variability in bone mass, with the remaining
being attributable to modifiable environmental factors (15;16-24); consequently, 20-50% of the
variability in bone mass can be modified through choices in health behaviour or through the
administration of bone active pharmaceuticals. In light"of the relative plasticity of bone mass levels
with regards to modifiable factors, numerous investigators have studied the effects of interventions
to maximize, maintain, or slow the losses of bone during different phases of life. The most
commonly investigated interventions include dietary modification, physical activity, and bone-active
pharmaceuticals.
1.2.1 Treatment of osteoporosis - geriatric
The bulk of bone research has focused on interventions that maintain or increase bone mass
through adulthood and arrest or slow bone loss in the elderly. Outside of pharmaceutical
interventions, the preponderance of research suggests that after peak bone mass (PBM) has been
realized the most that can be expected is maintenance (25).
The treatment of osteoporosis is difficult due to the pathogenesis of the disease, particularly
at the histomorphometric level. While many pharmaceutical therapies are efficacious in slowing
accelerated levels of bone resorptive activity (Le. hormone replacement therapy, bisphosphonates,
selective estrogen receptor modulators) (26), there is no proven effective anabolic therapy. hPTH
(1-34) therapy is promising for the future, displaying anabolic action in a preliminary trial in
humans, but requires further investigation (27). The absolute losses in bone mass alone do not
adequately account for the decrease in mechanical integrity that result from the disintegration of
cancellous bone structure in severe osteoporosis (28-35). In advanced osteoporosis, elevated
bone turnover and imbalance between osteoblast and osteoclast activity cause trabecular struts
within the medullary cavity to become irreparably disjointed from extensive osteoclastic resorption
and no longer contribute to mechanical integrity of the bone as a whole (35-37). Following
trabecular malunion even radical treatment is largely ineffective and fragility fractures almost
invariably result (38). Even the anabolic activity of PTH cannot repair disjointed trabeculae.
Considering the relative irreversibility of osteoporosis, prevention is of paramount significance (39).
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1.2.2 Prevention of osteoporosis- paediatric
Osteoporosis has prominent pediatric antecedents (40-44). Attainment of an optimal PBM is
crucial for lifelong skeletal adequacy, and has been suggested to be the best indicator of
susceptibility to osteoporosis in later life (45-51). Approximately half of the variability in elderly
bone mass is a product of the bone mass that was acquired during childhood and adolescence
(52), and many investigations have demonstrated that at least 90% of the total adult bone mineral
has been deposited by the end of adolescence (48;53-59). Puberty is an especially critical period
of bone growth considering that in the four years surrounding peak height velocity (PHV) there is
as much bone mineral laid down as is lost during the whole of adult life (59). The adolescent years
may be the optimal time for gains in bone mass and also the most sensitive time to any
perturbations that decelerate or reverse accrual (40;48;54). To prevent osteoporosis it is essential
to delineate and encourage those interventions that maximize bone accrual during adolescence
and to avoid those that slow or reverse normal accrual (60).
1.3 Development of normative bone density values in pediatrics
When investigating bone mass during growth prudence must be taken to ensure that the
effects ascribed to interventions are not those that would be observed from normal growth and
maturation alone; that is, during periods of rapid growth positive accrual rates could be wrongly
attributed to the intervention. Before the impact of interventions, or perturbations, on pediatric
bone can be established it is imperative to first describe bone accrual and density in normal
children and adolescents through the development of normative growth curves. The development
of normative bone mineral values are further necessary to identify children and adolescents who
may have bone mass low enough to be deemed clinically relevant (56;61).
While a moderate number of investigations have attempted to describe the changes in bone
density through childhood and adolescence, few to date have done so in a methodologically sound
manner. Problems in study design, the methods for grouping of individuals, and the tools used to
estimate bone density are the foremost sources of error leading to the creation of misleading
standards.
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The preponderance of normative research in pediatric bone mineral accrual has been cross-
sectional in design. Growth data derived from cross-sectional investigations tend to be smoothed
and mask the individual variation between individuals, leading to the development of incorrect or
imprecise standards (62). Longitudinal data must be used to develop the shape of the growth
curve around the time of pUberty, otherwise serious error can result (63). Further, longitudinal
standards are required when a child is observed on more than one occasion, particularly during
adolescence (63). Longitudinal investigations are rare owing to the tremendous financial and
personnel commitment, as well as problems with attrition (64). Once normal growth curves are
developed, effective interventions can be identified and utilized to promote appropriate behaviour
to augment PBM.
Secondly, the bulk of normative bone research in children and adolescents has grouped
individuals by chronological age. By organizing growth data based on chronological age and not
maturational age the true magnitude and shape of the group growth curve is attenuated and not
representative of individual growth (the dashed line in the upper panel of Figure 1. demonstrates
the average growth curve that would be produced if subjects were aligned on chronological age,
and the bottom panel displays the same data but grouped on maturational age). This attenuation
occurs as a consequence of the tremendous variability in the timing of puberty in both males and
females. As is obvious from Figure 1., any attempt to describe growth through puberty based on
chronological groupings is flawed. Individuals should be grouped on a maturationally-based
benchmark to properly compare changes with growth and development, particularly during
adolescence.
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Figure 1.1. Methodological problems with using chronologically-based data for
normative growth curve development during adolescence. From Tanner et al. 1966 (65).
Lastly, almost all of the pediatric normative bone research in the past decade has utilized
dual-energy x-ray absorptiometry (DXA) to estimate areal bone mineral density (aBMD).
Confounding the already limited understanding of bone growth in children, DXA-derived aBMD
provides only an estimate of volumetric bone density. Measurement of aBMD by DXA is flawed as
it inadequately corrects for bone size, leading to consistent overestimation of density with larger
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and underestimation with smaller bones (56;66-69). This error in the estimation of aBMD is
particularly misleading in longitudinal study of the pediatric population where rapid growth is
punctuated with dramatic changes in bone size, and in cross-sectional investigations where
children of similar chronological age can have vastly different bone sizes. Observed longitudinal
changes in aBMD as measured by DXA in pediatric investigations can be ascribed to either
increases in density, bone size, or a combination of both. With current DXA technology it is
impossible to discern which combination of these factors account for the change in estimated bone
density observed.
To conclUde, longitudinal normative bone density values, independent of bone size and
based on a maturationally-grouped cohort, need to be generated before the affects of interventions
on pediatric BMD can be determined and to allow for the identification of children and adolescents
who have clinically low levels of bone mass.
This investigation compared DXA-derived aBMD with two hypothetical size-corrected BMD
values over adolescence in an investigation of longitudinal (and mixed-longitudinal) design with
maturationally-controlled comparisons.
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2 Review of Literature
The following reviews the general trends in bone growth through childhood and adolescence
and discusses how these trends may be erroneous as a consequence of the dependence of DXA-
derived aBMD on bone size. First, the different measurement techniques and tools utilized to
establish bone mineral mass and/or density will be introduced and their strengths and weaknesses
will be briefly discussed. Second, the use of DXA for the measurement of aBMD, and its inherent
strengths and problems, will be addressed. Third, the scaling of biological entities for differences
in body size is discussed, with a particular emphasis on skeletal structure. Fourth, changes in
bone size, mass and density with growth and maturation are presented at the three most
frequently assessed areas: the total body (TB), femoral neck (FN), and lumbar spine (LS). Fifth,
techniques that have been utilized for the correction of DXA-derived aBMD for bone size will be
examined, along with a comparison of corrected and uncorrected BMD trends during growth.
Lastly, the underlying physiological mechanisms that may be responsible for the oft-reported
phenomenon of an increased period of skeletal fragility during adolescence are discussed.
2.1 Measurement of bone mass
The measurement of bone mineral by radiographic techniques is based on the principle that a
direct correlation exists between the amount of bone present and the absorption of ionizing
radiation. Conventional radiography is inadequate to evaluate bone objectively as bone mass may
decrease 30-40% before changes in bone density are optically apparent as osteopenia (70).
Bone densitometry is founded on the supposition that the amount of bone mass present at a
given skeletal site is directly correlated with the strength of that site (71). While this relationship is
well established in osteoporotic bone, it is not as well defined in non-osteoporotic bone. Bone
density as assessed by densitometric methods has been consistently demonstrated to have
significant correlations with bone strength and therefore, fracture risk (72-78). While BMD is an
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important determinant of skeletal integrity, other factors, such as bone geometry and architecture,
also impact bone strength (28;71 ;79-82).
In the contemporary measurement of bone mass the mostly commonly reported variable is
bone mineral density (BMD). However, the method of determining BMD is inconsistent between
instruments making it difficult to ascertain what each respective measurement of BMD is portraying
without a working knowledge of the instrument and its limitations and assumptions. For example,
aBMD by DXA provides an areal density, single photon absorptiometry (SPA) estimates a density
derived from the length of the region of interest, and a true volumetric density is provided by
quantitative computerized tomography (QCT), however they are all often reported simply as BMD.
QCT is the only instrument available that is able to provide a true, volumetric measure of
BMD in vivo (83). Volumetric bone density refers to the amount of mineralized tissue per unit
volume of tissue (osseus and non-osseus). Volumetric bone density must be distinguished from
the intrinsic material density of bone, which is expressed as the ash weight per unit volume of bone
(osseus only). The material density reflects the degree with which the bone matrix is mineralized
and is variable over any particular bone, although the variability is typically small (84). BMD
measures from SPA, dual photon absorptiometry (DPA) and DXA are not true measures of
density, but often a poor estimate based on the most available linear or areal measures of the
region of interest. aBMD does not take into consideration the nonmineralized spaces within bone,
such as the medullary cavity, or intracortical remodeling sites or for channels to allow for the
passage of extracellular fluids or vasculation, when determining bone volume. These assumptions
lead to a density that is assumed to be homogeneous across the bone's volume (84).
Table 1. presents the precision, accuracy, scanning time and radiation dose for the most
commonly used densitometric techniques (71 ;85). Errors in the noninvasive measurement of bone
include both technical and biologic factors including source variability, radiation scatter, differing
marrow composition, fat content both within and surrounding (overlying/underlying) the bone,
fractures, osteophyte formation, extraosseus calcification, and subject positioning (85).
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Table 2.1. Comparison of precision error, accuracy error, and radiation dose of
techniques for bone mineral measurement.
Distal third radius
Ultradistal radius
Os calcis
ius
SOS calcaneus/tibia
I SUA calcaneus
I
95/5
60/40
5/95
?
?
1-2
1-2
1-2
0.3-1.2
1.3-3.8
4-6
4-6
4-6
?
?
10
10
15
<1
<1
<1
o
o
Adapted from Genant, 1996 (85) and Faulkner, 1991 (71).
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2.1.1 Single photon absorptiometry (SPA) and single x-ray absorptiometry (SXA)
SPA and SXA measure appendicular sites (usually the radius) where variations in soft tissue
are minimal (86). SXA has improved precision and spatial resolution and has a reduced exposure
time as compared to SPA (85). A highly collimated photon beam from a radioactive source (SPA),
or an x-ray tube (SXA), is directed towards the region of interest to measure radiation attenuation,
and from that the estimation of bone mineral content (BMC, in g) (85). BMD is calculated by BMC
divided by the length (cm) of the region of interest (g/cm). Since neither the shape nor the depth of
the radius can be assessed and the size and shape of the medullary cavity is unknown, precise
volumetric or intrinsic bone mineral density cannot be established from SPA (87). Further, since
SXA and SPA are based on an areal measure they are unable to ascertain measurements of
density for the different bone envelopes. However, evidence has suggested that SPA and SXA
can predict fracture risk, particularly in non-spinal sites with predominant cortical bone composition
(45;88-90).
2.1.2 Dual photon absorptiometry (DPA)
Single-energy measurements, such as SPA, cannot assess BMO at sites with variable tissue
thickness and composition (ie. axial skeleton, hip, whole body, lumbar spine) (85). OPA, a
predecessor of OXA, is primarily used to evaluate axial sites where there is both bone and
substantial soft tissues present. The low radiation associated with this technique and the ability to
non-invasively assess axial sites made it a popular choice in the 1980's (86). With OPA, BMC (g)
is measured by the attenuation of two differing energies of photons, which is then divided by the
region of interest surface area (cm2) to estimate aBMD (g/cm2). DPA uses a radioactive isotope
C53Gd) which decays over time necessitating constant adjustments in the attenuation values and
making measurements of mass and density variable. This variability introduces error that is often
larger than the effect of the intervention making its use for research limited.
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2.1.3 Dual-energy x-ray absorptiometry (DXA)
DXAs are the tool most widely utilized for the assessment of appendicular and axial bone
mineral density (91) owing to their high speed, low radiation density, accuracy, reliability and
relatively inexpensive capital costs (86;92). DXA measures bone mass by posteriorly emitting two
energies of x-rays that pass though the body's hard and soft tissues and are collected by a
collimator after passing out the anterior surface of the subject. The differential absorption of these
two energies of x-rays within the body allow for DXA, after comparing the absorption to a
calibration phantom, to estimate bone mass (as well as lean and fat mass). The use of an x-ray
tube instead of an isotopic source decreases radiation exposure, reduces scanning times,
improves both short and long term precision, and enhances image resolution (71 ;85). DXA
provides an areal density (g/cm2), based on the same calculation as the DPA. Unfortunately, areal
BMD is unable to distinguish between osseus and non-osseus areas within the bone envelope,
rather, assuming it to be a homogenous substance.
Recent modifications to DXA have included the ability to perform lateral lumbar spine scans.
Lateral DXA may have increased sensitivity in the diagnosis of osteoporosis since it eliminates the
posterior elements of the vertebrae, which are primarily of cortical bone (losses in cortical bone are
typically observed following dramatic losses in trabecular bone). By the removal of the posterior
elements from the LS measurement, a greater proportion of the vertebral body, and it's primarily
trabecular bone, is measured (85). However, the. precision of lateral DXA is lower (6.4%) and
often L2 or L4 cannot be measured due to the presence of an overlying rib or the iliac crest,
respectively (93). Some DXAs are able to estimate volumetric density by taking both lateral and
PA scans of the LS region and calculating volumetric density (g/cm3). While these lateral DXA-
derived vertebral volumetric densities theoretically are robust, they combine the errors from both
the posterior-anterior and lateral scans, making them highly variable and questionable for scientific
investigation.
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2.1.4 Ultrasound
Ultrasound is an attractive option for the measurement of bone mass due to its low relative
cost, portability, ease of use and lack of ionizing radiation (85). Two forms of ultrasound have
been developed: speed of sound and broadband ultrasound attenuation. The speed of sound
ultrasound is postulated to produce a signal influenced by the elastic properties of bone, while the
broadband ultrasound attenuation is believed to provide an estimate of physical density (94). Most
ultrasounds now provide both of these measurements within their protocol. Common
measurement sites include the patella and the os calcis. While ultrasound is a promising research
tool, the technology is still in its infancy and needs further validation (94), and to date no
commercial ultrasound has the capability to measure the elastic modulus of a bone.
2.1.5 Quantitative computerized tomography (QCT)
2.1.5.1 Axial quantitative computerized tomography
The only way to assess true volumetric density (g/cm3 ) in vivo is through aCT, since it is
capable of obtaining an accurate and valid measure of both bone volume and mass (85). Further,
it is able to discern between trabecular and cortical bone mass. Accordingly, the best sensitivity
and specificity for diagnosing patients with spinal osteoporosis is provided by aCT, followed by
DXA, DPA and then SPA (71). However, even with aCT there are sources of error: error in the
measurement of vertebral cortical bone owing to the thinness of the cortical shell and differing
levels of intravertebral marrow fat lead to errors in the estimation of trabecular density (85;95).
Unfortunately, regardless of the diagnostic accuracy of aCT, the high doses of radiation
associated with aCT make it restricted to only those individuals that have undergone some form of
traumatic accident or require clinical investigation for pathology, and is not justifiable for serial
scientific research into children's bone density.
2.1.5.2 Peripheral quantitative computerized tomography (pQCT)
Recent advancements in aCT design have allowed for the development of peripheral aCT
(paCT). The paCT is used to evaluate bone density at appendicular sites, primarily the distal
radius and ulna. paCT has an advantage over the SPA as it allows for separate measurements of
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the cortical and trabecular bone compartments and provides a true volumetric density. Radiation
doses associated with the pQCT are far below that of the QCT since the diameter of tissue to be
scanned is diminished (85), allowing its use in descriptive and interventional research. The CV
associated with pQCT is high (-5%), which may limit its use except in those cases where dramatic
changes (>5%) are observed (85).
2.2 Measurement of bone mineral density by DXA
For the calculation of areal bone mineral density, DXA estimates both the surface area and
the bone mineral found in the region of interest. The bone projected area is assumed to be a valid
estimate of bone volume, but since it is not an actual volume measure, but rather a measure of
area, the BMD supplied by the DXA is not a true volumetric density and should be designated as
an areal BMD (aBMD).
2.2.1 Assessment of bone projected area by DXA
The measure of bone projected area (BA), the denominator in the areal bone density
equation, by DXA is quite accurate, with little measurement error associated with its estimate; the
algorithm which determines bone edge detection leads to limited error in the estimation of PA (96).
Pencil beam versions of DXA (typically the older versions) allow for slightly better estimates of
bone projected area, whereas the fan-beam models (typically the newer versions) are more
variable with error introduced as a function of the distance of the subject from the scan aperture.
2.2.2 Assessment of bone mass by DXA
The determination of bone mineral content (BMC) with DXA has been repeatedly found to be
highly valid, accurate, and reliable (96). However, BMC is highly dependent on bone size (69),
limiting its use for comparison of bone mass between individuals of differing sizes. Similar to the
measurement of bone projected area, errors associated with bone edge detection in the software
of DXA can lead to variability in the measurement of BMC (96). However, this error introduced by
systematic magnification error affects bone projected area and BMC in the same direction, thereby
decreasing the absolute error in aBMD assessment as compared to either measure alone (67).
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2.2.3 Estimation of areal bone mineral density (aBMD)
To estimate aBMD, DXA divides BMC by the respective BA. The estimation of aBMD is
advantageous when compared to BMC for several reasons: it reduces the influence of skeletal
size (by dividing for area) and decreases accuracy error (since errors in BMC and PA are in the
same direction and somewhat cancel out one another). Utilizing aBMD has been demonstrated to
halve the affect of size as compared to uncorrected measures of BMC (92). In fact, the use of
aBMD partially removes some of the 20-30% sex difference witnessed with BMC in adolescents
and young adults, allowing for better direct comparison between the two (92;96).
2.2.3.1 Positive implications of bone mineral assessment by DXA
There are a number of situations where the measurement of aBMD by DXA is valuable. In
investigations where repeat testing (i.e. longitudinal investigations) is performed over a period of
time without a change in bone size, aBMD may be beneficial since differences due to slight
movements or differences in bone edge detection tend to affect PA and BMC in the same
direction, making aBMD more reproducible, and therefore clinically accurate, as compared to BMC
(67). However, there are few instances, if ever, over the lifespan when bones are unchanging in
terms of size.
Foremost, measurement of aBMD by DXA is a useful clinical tool for the management of
osteoporosis and the prediction of future fracture risk in adults (72;73;92;93). With no change in
bone size over the period of interest, aBMD can be considered a good clinical measure for
assessing change in an individual's density. Similarly, the comparison of aBMD in individuals of
the same bone size is a valid procedure for comparing bone mass and density among individuals
(97); however, it is exceedingly difficult to match individuals on PA prospectively.
Because aBMD possesses a strong dependence on bone size, it may be a sensitive predictor
of osteoporotic fracture. Bone size itself, particularly cross-sectional area of bone, correlates
strongly with architectural strength just as increasing the radius of a pipe increases its strength by
increasing the moment of inertia (see Figure 2.1).
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Figure 2.1. Moment of inertia and bone strength
The cross-sectional area of these three cylinders are identical (AA = As = Ac). The elastic
modulus of the material that makes up these cylinders is also identical (EA= Es = Ec). Therefore
for an axial force (ie. Pushing or pulling at the ends of the bar), the stress is identical (OA = Os =
oc). However, because the geometry of the cross sections is different, the ability of each of
these cylinders to resist bending and or torsion is strongly dependent on the distance of the
material relative to the centre of the cylinder. The relative resistance to bending of these
cylinders is IA = 100%, Is = 400% and Ie = 700%. Subtle changes in a bone's cross-sectional
geometry will contribute heavily to the bone's structural properties. From Rubin and Rubin, 1999
(98).
Since aBMD combines both a rough measure of density and a gross measure of skeletal
size, correction for size may actually decrease the predictive value of aBMD on future fracture risk
(99). In the Study of Osteoporotic Fractures, an extensive investigation of hip fracture risk in
Caucasian postmenopausal women (n=7963), it was concluded that at the femoral neck aBMD
and aBMD adjusted for bone size had a similarly strong predictive value for future hip fracture and
that despite the theoretical appeal, size correction had no advantage over standard aBMD for
prediction of hip fracture (99). In a similar investigation (93), geometric information from PA and
lateral DXA scans were combined to estimate the volume of L3 in 26 postmenopausal women with
osteoporotic vertebral fractures and in 114 control women with no fractures; no improvement in
diagnostic accuracy for fracture risk was found. Jergas et al (100) concluded that the best
diagnostic sensitivity for vertebral fracture is from aCT, followed by a volumetric estimate of LS
BMD based on paired PA and lateral LS scans; less diagnostic sensitivity was achieved with DXA
aBMD or estimates of volumetric density from only PA DXA LS scans. Therefore, assuming there
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is no change in the size of site during the trial, the use of aBMD is probably merited for use in
clinical fracture studies and for assessment of osteoporotic fracture risk (101).
2.2.3.2 Limitations of bone mineral assessment by DXA
Areal BMD is highly dependent on bone size, as well as on overall mass and body height (67-
69). While DXA supplies reliable and accurate estimates of aBMD, these measures are not valid
measures of true volumetric density and are subject to error introduced by differences in bone size
serially. In the comparison of individuals of different sizes or of a given individual through a period
of rapid growth, areal density may be misleading and lead to incorrect measures as changes in
bone thickness confound the estimate of areal density (69; 102). Prentice et al. (67) concluded that
the use of aBMD in research should be discontinued in epidemiologic investigations as it often
leads to spurious associations between factors that are themselves related to body size, such as
calcium intake.
Density is defined as the mass of an object divided by its respective volume. DXA is unable
to measure volume since its scan path travels in a posterior-anterior manner, precluding a
measurement of depth, and without a depth, volume ascertainment is impossible (height x width x
depth). DXA software makes the assumption that surface area and volume increase in a linear
fashion, which is a highly erroneous assumption as there is a disproportionately greater increase in
volume as compared to surface area (67). If the theory of a linear relationship between volume
and surface area were true, a 1% change in volume will lead to a concomitant 1% change in BA.
When scaling based on the laws of geometric similarity, it is a basic tenet that surface area varies
to volume by a factor of 0.67, not the 1:1 ratio that the DXA software assumes. In biological tissue
this assumed relationship is rarely, if ever, realized and is used in the estimation of DXA-based
measurement for lack of better-developed methodologies. The result of the volume:surface area
discrepancy with DXA is that larger people will have an overestimate of their true volumetric bone
density and smaller people an underestimate.
A definitive test of the supposed linear relationship between surface area and volume of bone
is the regression of the natural logs of BMC and BA. The reSUlting power coefficient should not be
significantly different from unity if this theory utilized by DXA is true. If it is significantly different
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then the assumption of the 1:1 relationship between BMC and PA is not met and the calculation of
aBMDis an inaccurate adjustment for size. Consequently, any variation in aBMD may be due to
differences in size rather than differences in true mineralization (67).
The effect of bone size on aBMD is diagrammatically illustrated in Figure 3. In this example
both bones are assumed to be of an identical true volumetric density (1g/cm3). For the ease of
calculation the two bones are assumed to be isometric and exactly cubic (as in the assumption by
Katzman et al. of the LS (69). The lumbar vertebra of the older boy is assumed to be exactly twice
the physical size of the younger boy's lumbar vertebra. After a DXA scan the PA and BMC are
estimated and the aBMD calculated. When the aBMDs are compared between the two individuals
it becomes apparent that for two individuals with identical volumetric densities, but different
physical sizes, there are vast differences in the aBMD, a supposed adequate estimate of
volumetric density. This example illustrates the effect of changing bone size on the measure of
aBMD by DXA. It comes as no surprise that the dependency of areal BMD values on bone size is
seen most dramatically in growing children (101).
t~.
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True volumetric density =
DXA BMC =
DXA PA =
DXAaBMD
31 g.lcm.
1 g.
1 cm.2
1 g.lcm.2
31 g.lcm.
8 g.
4cm.2
22 g.lcm.
Figure 2.2. Size dependence of DXA-derived areal bone mineral density. Adapted from
Katzman et al. 1991 (69).
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2.2.4 Implications of areal BMD measures in studies of growth and maturation
One of the problems with monitoring aBMD over a period of years, such as in a longitudinal
investigation over adolescence, is whether the changes in aBMD are a function of volumetric
density, bone size, or a combination of the two. In the study of children over a period of growth,
changes in bone size may mask the biological phenomenon occurring in terms of bone density. In
the recognition that the estimation of aBMD is most likely flawed by bone size, many growth and
maturation investigations through adolescence have simply relied on DXA-attained measures of
BMC. BMC measures are highly correlated to body and bone size and are not adequate for
comparing individuals of different sizes or for comparing an individual through a period of rapid
growth, such as adolescence (67;101). Perhaps more alarming is the widespread use of
uncorrected DXA aBMD measures in the pediatric literature, despite the widespread knowledge of
its inappropriateness during this period.
It is assumed, based on data from largely cross-sectional investigations of aBMD, that during
growth and maturation bone density increases, but during this period there are also concomitant
increases in bone size. Schonau et at. (103) concluded that BMC and aBMD determined by DXA
were closely related to age, height, and mass and that in growing children the observed increase
may be simply an artifact of increased bone size. Schonau et at. further postulated that if aBMD
values were corrected for bone size, the values would become stable across childhood and
adolescence. Until adequate controls for the confounding effect of bone size on aBMD have been
developed and proven valid it is difficult to ascertain the true changes in bone density that are
associated with growth and maturation apart from those solely attributable to measurement artifact.
Only after the changes in bone density over growth are fully understood longitudinally can the true
effect of interventions on bone mass during the pediatric years be established.
To date, the true pattern of bone formation over childhood and adolescence is largely
unknown owing to several methodological constraints including primarily cross-sectional designs
(very few longitudinal), frequent grouping based on chronological age (few maturationally-based),
and DXA-based, size-dependent, measures of aBMD (very few size-corrected). No study before
this one has eliminated these three constraints simultaneously.
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2.3 Scaling in biological tissues
2.3.1 Basic scaling theory
From the most pragmatic point of view, the skeleton can be thought of as the body's
scaffolding, and hence should obey the laws of engineering physics. In engineering when
increasing the size, and therefore the mass, of a structure, three different parameters of the
supporting structure may be altered to adapt to the increased forces:
1.) By increasing the physical dimensions of a supporting structure, larger applied loads can
be supported;
2.) By altering the material composition of a structure to include materials that are of greater
material strength larger loads can be tolerated (i.e. from pine to oak), and;
3.) By altering the design of a structure to better resist the applied loads upon it, either
through more functional distribution of materials (i.e. buttressing stress points), or through a
change in the type of forces resisted (i.e. changing from compression to tension elements, such as
is seen with bridges), a more judicious use of materials and architecture results in an increased
ability to bear loads.
In humans there is evidence that all three of these adaptations are used by the body to
provide a skeleton that possesses greater mechanical integrity. As body mass increases the size
of a number of long bones increase, thereby increasing their moment of inertia and ultimately their
resistance to the greater bending moments brought about through a greater diameter (98).
Further, it has been demonstrated that the vertebrae in elderly men combat the aged-associated
persistent decreases in bone mass and trabecular thinning by increasing the CSA of the vertebral
cortices in an attempt to preserve mechanical integrity (79; 104); this phenomenon of increasing the
second moment of area has also been described in the midshaft of long bones (105;106). A
recent investigation concluded that fracture risk was significantly associated with bone size in a
cohort of men (107). In essence, the further that the building material is from the neutral axis, the
better placed it will be to resist bending; this strategy is an economical way to rapidly increase
flexural stability for a small investment in material (98; 108).
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Functional strength is constantly augmented in bone by qualitative material changes. As
primary osteons are turned over into secondary osteons there is an increase in the actual material
density of the bone and, as a consequence, the compressive strength (109). As bone ages within
the body the material density increases, barring newly formed remodeling spaces.
Lastly, numerous investigations have elegantly displayed the ability of bone architecture to
adapt to applied strains in order to better match the strains engendered (110;111); for example, in
the greater trochanter region of the femur the trabecular architecture matches the strain patterns
applied to it (81).
Surprisingly, when bone material strength and internal architectural patterns are surveyed
across species, these parameters remain relatively constant, despite vast differences in body
mass (112). The major dissimilarity observed among species is differences in bone size; different
species and sizes of animals adapt to changes in their respective mass primarily by altering the
dimensions of their bone to better match the loads placed upon them (for an example see Figure
2.3.).
11.1,\
Figure 2.3. Two extinct mammals. Neohipparion (right) and Mastodon (left).
Drawn to the same scale, yet in reality the Neohipparion is the size of a deer and the Mastodon
an elephant. Intuitively, it seems natural to assume that the Mastodon is a larger animal based
on the underlying premise that skeletons must be scaled to support the weight of the body as its
bulk increases with the third power of the linear dimensions. Adapted from Gregory, 1912.
2.3.1.1 Geometric Similarity
Geometric similarity assumes that any two geometrically similar bodies will have their
corresponding linear dimensions related to one another in the same constant proportion. Any two
bodies or objects that share geometric similarity are called isometric. The following equation
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demonstrates the relationship between corresponding linear measurements in two isometric
structures:
Formula 1: L2=kL L1 or L2IL1=kL
where L1 is the length of one linear dimension on object 1 and L2 is the corresponding linear
dimension on object 2. Solving for kL provides the similarity ratio. This similarity ratio allows for the
proportional relation of all other linear measures between the two objects (113).
The surface areas of one side of isometric structures vary to the square of the similarity ratio,
as shown in the following equation:
Formula 2: (L2)2 =(kd2 X (L1)2
Further, the volume of two isometric objects changes in proportion to the cube of the linear
measurement:
Formula 3: (L2)3 =(kd3 X (L1)3
These relationships are well established and are foundational in the study of geometric
similarity and can be summarized as:
if Projected are~ a (length)2 and Volume a (length)3, then
Formula 4: Projected area a (volume)2J3
Formula 4 provides a power function to describe the relationship between the projected area
and volume of two isometric objects (113), which is of particular importance in the case of
normalization of aBMD for bone size. The surfaces of any two isometric objects are related to their
volumes by a power of 0.67. As a consequence of this equation, a smaller object will have a larger
surface area relative to its volume than a larger one. Extrapolating these observations to the
measurement of aBMD it can be observed that this power function between area (projected area)
and mass has vast implications on the assumptions made by DXA in its estimation of bone
density. DXA assumes bone density to be a ratio of bone mass divided by projected area, and it
incorrectly assumes projected area and volume change linearly. A smaller bone will have a
correspondingly projected area and a larger bone a larger area. However, when taken as a ratio of
their volume, the smaller bone will have a greater projected area as compared to its volume. This
will result in a corresponding lower aBMD value for the smaller individual and a larger aBMD value
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for the larger person, even with identical true volumetric densities. These observations are based
solely upon the laws of geometric similarity.
2.3.1.2 Allometric Scaling
It is rare that organisms are isometric. Instead, certain proportions change in a non-isometric
regular fashion (length, mass, height, etc.). Non-isometric scaling is referred to as allometric
scaling (113). In biology numerous physiologic and morphological variables are scaled, relative to
body size, according to allometric equations in the form:
y =a~ or log y =log a + b log x.
When two variables (y and x) are plotted on logarithmic coordinates, the result is a straight
line with the slope b. Isometric structures have a slope of one (b=1). If structures are not isometric
they exhibit slopes other than one, with the slope dependent upon how much one variable
changes out of proportion with respect to the other (67).
In animals, as body mass increases the mass of the bones increase disproportionately faster,
resulting in a positive slope greater than one. Conversely, if the dependent variable increases at a
slower rate than would be estimated by proportionality, the regression line would have a slope less
than one. Variables that do not increase with body size have a slope of zero (Le. brain) and
functions that decrease with body size have a negative slope (Le. heart rate) (113).
2.3.1.3 Scaling the bones of animals
The extremities of animals support body mass, in both stationary and dynamic activity.
Logically, as the mass of the structure increases and the strains engendered upon it increase so
must the strength of the support.
Based on isometric scaling:
Formula 5: CSA q (length)2 and length a (volume)1J3, and strength q (volume)O.67.
Given proportional increases in bone mass with body mass, bone CSA would only increase at
two-thirds the rate of body mass, leading to structural failure. Therefore, in terrestrial vertebrates
there is disproportionate scaling between body mass and bone mass. The relative size of the
bones must be scaled out of proportion in order to supply the required strength to support
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increasing body mass. Because of this, large bone is disproportionately thicker than small bone
(113).
2.3.1.4 Scaling mammalian bones
Terrestrial mammals are scaled with mass increasing to the cube of the linear measure. The
material properties of bone are relatively homogeneous across terrestrial mammal sizes, thus
increases in body mass, and the additional compressive force it creates, must be resisted by an
increasingly large supportive structure. To increase the strength of a bone in proportion to the
load, the bone GSA must increase in proportion to that load, since the supportive strength of a
columnar structure is directly dependent upon its GSA (113).
Assigning the load (mass) as being Mb, the length of the supporting column increases in
proportion to a characteristic linear dimension (Le. in proportion to Mb0.33; inverse cube of body
mass). As GSA must increase proportionally to mass, the volume, or mass, of the supporting
column will then be a product of the GSA (Mb1.0) and its length (Mbo.33). Therefore, the mass of the
bone must scale proportionally to Mb1.33. In other words, if the height of the column is scaled in
proportion to the linear dimensions of the load, the volume or mass of the supporting column
should be scaled as the load raised to the power of 1.33. Unfortunately, scaling animal bones is
not this simplistic as they experience extreme ranges of dynamic strain, which changes the loading
environment; empirical evidence has shown that the supportive bones do not scale according to
this function. Static stresses are not the primary factor in the scaling of mammalian skeletons
since dynamic loading can invoke stresses on the bone a full magnitude higher than while
stationary. If bones were scaled for static support, they would fail (113). Bones must scale in
relation to the dynamic strains placed upon them, or be susceptible to failure.
2.3.1.5 Scaling the bones of real mammals
Selker & Gater (114) observed that as animals get larger, their bone lengths get proportionally
shorter. Increasing the stoutness of the bones with increased mass reduces the magnitude of the
bending and torsional moments created as bone is loaded. Empirical data shows that the volume
of supporting bone in a vast range of animal sizes scales to the volume of the body by 1.08
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(±0.04), which is far from the theoretical slope of 1.33 derived from the consideration of static loads
and the slope of 1.0 subscribed to by proportionality (115).
Based on empirical evidence modeling mammalian bone in proportion to body mass based
on static loads is not valid as the mammalian skeleton is not scaled primarily to support stationary
gravitational loads. Alexander et al. (116) and Biewener (117) measured the forces encountered
during active locomotion across a number of mammalian groups (25,000-fold size range). They
concluded that the estimated bone stresses, regardless of body mass, were all within a small
window (50-150 MN/m2). The maximum stresses from this group of animals in the most vigorous
forms of locomotion approach the calculated yield strength for bone in both tension and
compression (118).
Scaling bones to support body mass through geometric similarity will lead to fracture failure
with locomotion because the compressive strength of the supporting column (Le. legs) increases
only with the square of the diameter (the CSA, which is a measure of surface area; surface area a
volume2l3), whereas the load increases with the third power of the diameter (the diameter being a
linear measure; volume a length3). Bones of heavier animals would most certainly fail during
active locomotion if they were scaled according to this assumption. Selker & Carter (114)
observed that in real animals the strength of the bone was proportional to massO.82, rather than the
expected proportion of massO.57.
McMahon (119) concluded that if a structure is too slender for its respective load, any small
lateral displacement of force will cause the structure to fail past the elastic region (on the stress-
strain curve), and fracture would result. The critical variables in the strength of a column are the
length and the diameter (assuming that the elastic modulus remains constant). Accordingly, the
length of a bone should scale one-quarter the body mass and that the diameter should scale with
three-eighths the body mass. In an investigation of a wide range of ungulates, McMahon (120)
later concluded that bone length should scale with the bone diameter to the power of 0.67.
Formula 6: I a M 1/4 and daM 3/8
• b • b
To test his hypothesis McMahon (120) measured the limb bones of a number of adult
ungulates and found that the length of their limb bones differed by a factor of seven. When
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investigating the difference in body masses, he found that the difference was close to the accepted
range to support his elastic load hypothesis. In McMahon's model, limb bone length should scale
with bone diameter by a factor of 0.67, and body mass by a factor of 0.25.
Alexander et al. (116) concluded after measuring the bones of mammals ranging from shrews
to elephants that limb bone lengths tend to be proportional to (body mass)O.35 and diameters to
(body mass)O.36. Interestingly, for the animals that were in the family Bovidae, the exponents for
length were much closer to the 0.25 predicted by McMahon (120). Alexander suggested that this
may be reflective of the stiff-legged stance of the bovids, which is much like a column that was
used as the model for this procedure. Other animals rarely have straight, vertical legs.
When looking at the results of Alexander's study (116) the volume of the bones (length
multiplied by diameter squared) is proportional to body mass by the power 1.07, similar to the
prediction of Prange et al. (115).
Observing the following equation:
Formula 7: Volume a l_d2 =MbO.35_Mbo.3602 = M b1.07
The exponent 1.07 for the bone volume is exactly that for skeletal mass in mammals
described earlier, which suggests there must be similar principles in scaling leg bones and the
entire skeleton. The findings of Alexander et al. (116) have been supported in that measurements
across several magnitudes of animal mass in adult mammals have indicated that bones scale
more closely to geometric similarity than to static strain similarity. Recently, it has been shown that
scaling characteristics may not be a result of intrinsic genetic factors, but rather the consequence
of highly conserved, extrinsic biophysical processes where bone strain is the primary modulator of
skeletal morphogenesis (121). In fact, the supposition that bone width is primarily determined by
the engendered strains makes sense when one looks at the variation even in human humeri (122).
Tennis athletes' dramatically hypertrophied playing-arm humeri is evidence of the variation that
can occur naturally from different loading patterns (122). Rubin & Lanyon (123) similarly
concluded that the safety factors in bone were maintained by the allometric scaling the magnitude
of the peak forces applied to them during vigorous locomotion, instead of by scaling by bone
dimensions. Therefore, bones in weight-bearing areas are scaled in proportion to dynamic strains
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encountered with active locomotion. It can be seen that none of the theories (geometric similarity,
static, elastic) can explain how to adequately scale bone volume for changes in body volume in
mammals. Further investigation needs to be performed in order to elucidate the stresses involved
in determining the scaling factors in this group.
Larger animals, particularly those with columnar-type legs structure (Le. elephants), are very
careful about the way they locomote; for example, an elephant will not full gallop. There appears
to be some deeper evolutionary safeguard that helps ensure that the safety levels of certain bones
are not exceeded, to ensure safety and longevity in the wild (124).
2.4 Specific techniques used in attempting to adjust for bone size in humans
Despite the well-acknowledged limitations of aBMD measurement when comparing
individuals of different size or for following an individual through a period of rapid growth and
change in bone size (56;68;69;93;97;101-103), aBMD has been widely used in both the pediatric
and adult literature. However, in light of the problems associated with the estimation of aBMD and
the radiation concerns with aCT, a number of investigators have tried to utilize the information
gathered from the DXA, along with basic anthropometric measures, to further correct for bone size.
There have been two main streams in the attempt to control for bone size: 1.) Those that use
a model of scaling to estimate the third unmeasured dimension (geometric correction) or; 2.) Those
that use sophisticated statistical techniques (statistical correction) to control for the effects of bone
size. Each of these methods has strengths and weaknesses and valid applications.
2.4.1 Geometric normalization procedures
Geometric normalization procedures are rooted in the principles of geometric scaling. In
these procedures size and volume are assumed to have well defined relationships that can be
utilized to estimate the third dimension (depth). Estimation of the third dimension allows for BMC
to be corrected for an estimated volume.
27
2.4.1.1 Bone mineral apparent density (BMAD)
Katzman et al. (69) was the first group to publish the pitfalls of measuring aBMD in subjects of
differing sizes. To overcome the problem with bone size they proposed a number of equations for
calculating the volume of the LS, FN and TB based on basic anthropometric information and DXA
output. They proposed an "apparent" volume by assuming a constant relationship between PA
and other skeletal measurements to volume. This apparent volume was then used in the
calculation of a volumetric bone density (BMC/apparent volume), which they termed bone mineral
apparent density (BMAD) in grams per cm cubed (g/cm3). It was believed that since the calculated
reference volume (apparent volume) was approximately proportional to the actual volume, BMAD
could more accurately reflect changes in volumetric bone density than aBMD (69). Indeed, in the
investigation by Katzman et al. (69) BMAD was shown to be less dependent on size measures
than aBMD as assessed by correlation.
Katzman et al. (69) used a log-log linear regression model to examine the interaction of whole
body area and body height. In this equation PA increased disproportionately faster than height.
Another log-log linear regression with average skeletal width (whole body BA/height) and height
found that height and average width did not change proportionately either. For the whole body, the
volume was therefore estimated to be proportional to both the PA and the height of the individual
being examined, with an emphasis on PA (in proportion to bone depth) over that of height:
Formula 8: TB BMAD =BMC/(BA2/height)
In the estimate of LS BMAD the lumbar spine was assumed to be a perfect cube. The area of
the front surface of the cube was estimated by the DXA and the depth was assumed proportional
to the square root of the area. Therefore, BMAD at the LS was assumed to be:
Formula 9: LS BMAD =BMC/BA1.5
The estimation of volumetric BMD with the BMAD formula is likely an overestimate as in the
scanning of the vertebrae the posterior processes of the spine are invariably included in the
quantification of LS BMC.
The femoral neck was assumed to be a cylinder. Since the DXA software imposes a 1.5 cm
limit to the length of the femoral neck scanning region:
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Formula 10: FN BMAO =BMC/(BA2/1.5)
While BMAD removes some of the dependence of bone density on bone projected area, it
has a number of flaws, primarily because of its stringent geometric assumptions. The authors
stressed "this reference volume is only an approximation of the true bone volume, and that it can
be estimated only by employing certain assumptions about the geometric proportionality or lack
thereof for different bones." (69). Unfortunately, rarely do bones scale in exact geometry with one
another; errors results in the estimation of true volumetric density if bones deviate from perfect
geometry. Additionally, by forcing the data to fit a predefined relationship the removal of some of
the deleterious effects of bone size on the density measure is attained, but it is impossible to
estimate exactly how much variability has been accounted for (67). While BMAD adjustment will
decrease dependence on size, it is impossible to ascertain how much error is corrected.
2.4.1.2 BMOvol
Kroger et al. (68) similarly proposed normalization procedures for aBMD based on geometric
assumptions of skeletal isometry, stating that the normalization of BMD values for the size of
bones is necessary when the aBMD changes of an individual child are followed; otherwise, bone
growth, and therefore bone size, affects the results.
Unlike the equation of LS BMAD by Katzman et al. (69) the vertebra was assumed to be
cylindrical, like the femoral neck. Accordingly, the BMDvol of the spine is calculated as a cylinder
of a known length and height:
Formula 11: LS BMOvol =BMC/[pi * (width/2)2 * (BA/width)].
Similar to Katzman et al. (69) the femoral neck is assumed to be cylindrical:
Formula 12: FN BMOvol =BMC/[pi * (BA2/(4 * height»].
Kroger et al. (125) utilized MRI and DXA to test whether their equation of BMDvol for the LS
was valid. They recruited 16 pairs of monozygotic twins (24 men, 8 women) aged 25-69. MRI
based volume was positively correlated with age (r=O.56), height (r=O.73) and mass (r=O.68).
aBMD and BMC were also correlated with height (r=0.47,O.76) and mass (r=O.65,O.76). After
correction for the size of the vertebral body as assessed by MRI, the correlations between aBMD
and size measures diminished or disappeared, illustrating the dependence of aBMD on size.
29
Interestingly, BMDvol and BMDmri decreased with age, while no such trend was observed with
aBMD. Based on these findings the investigators concluded that volume-corrected aBMD
measurements removed part, but not all, of the dependence of aBMD on body or bone size.
2.4.1.3 Others
In newer models of DXA, lateral scanning of the LS is possible. With the information
garnered from both the PA scan (height and width) and the lateral scan (depth) it is possible to
make an estimate of volumetric density; unfortunately, the lateral scan is associated with large
degrees of error which make its use limited (93). Decreased utility of the lateral exam is a
consequence of poor LS access, thick tissue masses to pass through (necessitating increased
radiation), and poor software design.
Static procedures that attempt to control for bone size have conclusively demonstrated that
they decrease some of the variability in density measures that can be attributed to bone size alone.
However, static procedures force data to fit predefined relationships; consequently, it is not
possible to judge whether any residual effects of bone and body size remain once the correction
has been applied.
2.4.2 Dynamic normalization procedures
2.4.2.1 Linear regression analyses
Dynamic correction of bone mass for bone volume makes no assumptions of the underlying
bone geometry and thus is not influenced to any great extent to variations in bone shape as is
static approaches. Prentice et al. (67) was the first group to formally control for differences in bone
size through a dynamic correction technique using linear regression as the basis. In recognizing
the problems with uncorrected aBMD measures they proposed that aBMD provides a simple and
crude adjustment for bone size, and strongly urged that its use in population-based research be
abandoned (67).
In the Prentice et al. approach, the PA and BMC are first converted into their natural
logarithms for two reasons. First, the transformation is performed to strengthen the linear
relationship between the variables, a necessary tenet when utilizing linearregression analyses (in
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the untransformed state the variables of PA and BMC typically share a slightly curvilinear
relationship). Secondly, the regression coefficient value supplied from the linear regression
analysis allows for direct quantification of the relationship of the variables as percentages of one
another. For instance, a regression coefficient of 1.5 suggests that for a 1% change in one of the
variables there would be a corresponding 1.5% change in the other (67). The primary assumption
of aBMD is that for every 1% increase in BMC there will be a corresponding 1% increase in BA. If
this assumption were true then in the linear regression of the natural logs of PA on BMC the
resulting regression coefficient should not be significantly different from unity (1). However, if there
is a significant difference between unity and the regression coefficient then the DXA aBMD is likely
erroneous.
After the regression coefficient (lambda) has been determined, a new equation for
dynamically-adjusted BMD (sBMD) based on the relationship between PA and BMC can be
generated. The equation takes the form:
Formula 13: sBMD =BMC/BAlambda
2.4.2.1.1 Use in population-based studies
Dynamic BMD normalization is useful in population-based investigations because it creates
equations specific to the population and the measurement site and is not confounded by errors in
the assumptions of geometry. Further, since factors such as calcium intake, grip strength, and
energy expenditure are all dependent on both body size, only after control of body size can the
relationship between these variables and BMD be ascertained (67). Prentice et al. (67) concluded
that the simplest way to avoid the possibility of size-related artifacts in the analysis of bone mineral
data is to use BMC as the dependent variable and to include PA, weight, and height as
independent variables in all multiple regression models.
One of the inherent problems with the dynamic correction of bone mass is its dependence on
sample size. Since it is a statistically driven technique, there is a need to collect a relatively large
population for the formulation of the regression equations and subsequent sBMD. With small
samples, increasing probability of error is introduced due to lack of power. Thus, this technique
cannot be used on an individual basis until standardized equations are made available for specific
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populations. The static equations, which are based on geometric similarity, can be used on an
individual basis without prior establishment of normative values.
2.4.2.1.2 Use in clinical-based studies
Bone mineral content is dependent on both the absolute size and the density of the bone
(126); therefore, differences in BMC may be due to either differences in size, tissue density, or
both. In children with diseases that affect normal growth and maturation of the skeletal tissue it is
often difficult for the clinician to determine the cause of the low bone mass. Confounding this is the
vastly different sizes of children and their often rapid rates of growth. Since DXA has been shown
to be highly size-dependent in its assessment of aBMD it is essential to control further for the effect
of size. A low BMC may be due to low stature, narrow bones (low PA for height), or low size-
adjusted BMC (corrected for PA and height) (126).
The investigation of the linear relationship between BMC and PA is clinically applicable for
individuals who are afflicted with bone growth or mineralization disorders. Recently, a number of
investigations have utilized a version of the Prentice et al. (67) technique to estimate the amount of
bone mass patients should have for their PA, height, weight and age or pubertal status (126-130).
These investigations endeavored to create specific regression equations that can be utilized to
establish normative BMC values based on given anthropometric and age values. This BMC
estimate is then compared to the actual value of BMC to acquire a percentage value of normal
compartment density. Unfortunately, many subjects are needed to decrease the error associated
with the generation of these equations. Most recently, Warner et al (128) published norms for
children based on sample sizes that were likely inadequate.
The use of size-adjusted normative density measures promise to provide a substantial tool for
the assessment of growth-delayed children in clinical practice but more research with larger
sample sizes in specific populations needs completion.
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2.5 Changes in bone with growth and maturation
2.5.1 Changes in bone size with growth and maturation
Since bone size is infrequently reported in the literature in its raw form, but rather as a
component of density, it is difficult to establish how it changes with growth and maturation.
Bone size increases both longitudinally and laterally during the growing years, with bone
apposition occurring at both the endosteal and periosteal surfaces (131). Once linear growth has
ceased with skeletal maturity, many bones continue to increase their total cross-sectional area until
death through periosteal apposition at the expense of endosteal resorption (79). This increase of
total cross-sectional area, as witnessed frequently in the vertebrae, is thought to be an attempt of
the body to maintain skeletal integrity during a time of absolute bone losses; by increasing cross-
sectional area the cross-sectional moment of inertia increases, perhaps partially compensating for
the absolute losses in mass (104).
2.5.1.1 Stature: A gross measure of changes in bone size
While there are few direct measures of bone size in the literature, there are many reports on
changes of stature with growth and maturation. Stature can be used as a general, but imperfect,
surrogate of bone size since height is closely associated with bone size in healthy individuals
(129), however there are gender and race differences in bone lengths after correcting for stature.
Yearly gains in stature are typically observed to decelerate from the one year of age and slow
until the adolescent growth spurt, when a dramatic acceleration in statural growth is observed
(132). In some instances, there is a smaller magnitude, transient growth spurt around the age of
6.5-8.5 years, termed the mid-growth spurt (65). The adolescent growth spurt begins at about 10-
12 years in females and 12-14 years in males, on average. A recent Canadian longitudinal
investigation, with a primarily Caucasian cohort, concluded that the age of peak linear growth was
at 13.5 years for males and 11.6 years for the females (59). These maximal rates of growth
velocity can be surmised to comprise the time of maximal bone envelope expansion. At PHV
males had attained 90% and females 92% of their respective adult statures (59). After the peak of
the adolescent growth spurt, longitudinal growth decelerates into adulthood and with the closure of
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the epiphyseal growth plates increases in stature halt. It seems that by early in the life span the
majority of linear bone growth has occurred and that further observed increases in bone mass
must be either a consequence of periosteal expansion, endosteal contraction, and/or increased
material density.
Accordingly, before puberty the association between bone mass and stature is strong
(53;133), but loses strength as adolescents experience puberty, and is weakest in adults (133).
2.5.1.2 Changes in bone projected area
2.5.1.2.1 Bone projected area and chronological age
Bone projected area (PA) increases with chronological age, with dramatic acceleration around
the adolescent growth spurt, followed by deceleration to adult values. Molgaard et al. (129)
investigated 201 girls and 142 boys (6 to 19 yrs. of age) and concluded that TB PA was similar
between sexes from 6 to 11 yrs. TB PA between sexes was identical until 15 yrs. of age after
which gains in females plateaued and the males continued gaining PA, slowing at 17 yrs. PA was
more highly related to height than age in both sexes (129). Bonjour et al. (133) reported that LS
PA increased with chronological age from 9-18 yrs. in both males and females, with a dramatic
acceleration in LS PA in females from 12 through 15 yrs. and in males from 13 to 17 yrs.
Therefore, changes in PA most closely approximate the changes in statural growth, at least until
the arrest of linear growth with the fusion of the epiphyseal growth plates.
A study by Gilsanz et al. (108) utilizing aCT to measure the cross sectional areas of both the
femur and vertebrae concluded males had an 11 % larger vertebral body cross-sectional area,
while there was no gender difference for femoral cross-sectional area. Both gender and body
mass were significant predictors of vertebral CSA. When chronological age, skeletal age, height,
muscle and fat masses were entered into a linear regression model along with total body mass,
none of the other variables significantly accounted for variance in the femoral measures. They
concluded that in children, regardless of gender, body mass was the primary determinant of
vertebral cross-sectional area and the area of cortical bone in the midshaft of the femur. Similarly,
an investigation by Moro et al. (134) concluded that body mass was the primary determinant of
femoral mid-diaphyseal bone mass and structure in adolescents.
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2.5.1.2.2 Bone projected area and pubertal stage
Data concerning the relationship between bone projected area and pubertal status is sparse.
Goulding et al. (135) investigated 200 girls aged 3-16 yrs. to examine changes in femoral neck
geometry with aging and to establish at what age adult hip geometry was achieved. At 12.5 yrs.
(average age of menarche) the girls had attained 91 % of their femoral axis length (FAL), 92% of
femoral neck width (FW), and 93% of femoral aBMD, but only 72% of adult BMC. By 15 yrs. of
age the girls had adult dimensions of hip geometry and 85% of their total BMC (135). FAL was
highly dependent on height and pubertal stage. Both FAL and FW were significantly associated
with TB BMC and FN aBMD, height and weight. However, adjustment for both age and height
eliminated all significant relationships between bone mineral accrual and femoral geometry. In a
similar investigation of hip geometry in adolescent females, it was concluded that full adult hip
geometry is achieved by age 15 yrs. (136). In females, it appears that the majority of growth in the
bone envelope occurs largely by the time of peak height velocity, slowing thereafter. Bass et al.
(137) reported that in a large cohort of girls 70% of the predicted adult peak in femoral cortical
width was achieved prepubertally. Through puberty, periosteal diameter increased with little
change in endocortical diameter, resulting in an increased cortical width, particularly after the
endocortical diameter contracted folloWing menarche. There is a paucity of data concerning the
expansion of the bone envelope in males with respect to puberty.
2.5.1.2.3 Bone projected area and gender differences
In a recent cross-sectional investigation no gender difference was observed in TB PA
between the ages of 6 and 15 yrs. (129). While there was a general increase in TB PA with age,
with a slight acceleration with the onset of puberty, gains plateaued in females by 15 yrs. of age
and in males by 17 yrs. of age. In both sexes TB PA was highly related to height. The same
trends were observed at the LS with no apparent sex difference until 14 yrs. when the females
ceased significant growth in size whereas the LS PA in the males continued to expand until 18 yrs.
of age. As a consequence of this discrepancy in growth duration males possessed significantly
greater LS PA as compared to females from 17 yrs. onward (129). In another investigation, it was
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concluded that when males and females were aligned on pubertal status, males consistently
displayed greater LS PA (133).
Seemingly, the differences between males and females in terms of bone projected area
largely are a consequence of a longer period of bone expansion in males as compared to females
during the adolescent growth spurt and the years immediately thereafter.
2.5.2 Changes in bone mass with growth and maturation
Bone mass, or bone mineral content (BMC), increases throughout childhood and
adolescence, peaking sometime shortly after the peak height velocity (61; 138). A recent
longitudinal analysis of calcium accretion from the cohort used in this investigation suggested that
the age of peak BMC accrual for the TB occurred at approximately 14.0 yrs. in males and 12.5 yrs.
in females, after PHV (138). The rapid change in bone mass with growth and maturation in males
and females is illustrated by the approximate tripling of BMC that occurs between the ages of 8
and 17 yrs. (61). Depending on the skeletal site, at least 90% of the adult BMC is deposited by the
end of adolescence (48;53;55;57;60; 139).
2.5.2.1 BMC and Stature
BMC is intimately associated with height in children up until the point of linear growth
cessation (53;133;140), after which there is dissociation of BMC with height as the bones continue
to consolidate and accrue bone mineral (59;141-143). In a recent longitudinal investigation both
girls and boys accrued approximately 90% of their final adult height by peak height velocity (PHV),
but had only achieved about 57% of their adult total body BMC values, illustrating the dissociation
of these two measures following prepubescence (59). Additionally, peak velocity in BMC occurred
approximately a year later than PHV in both girls and boys at the TB, LS and FN (40;59). Matkovic
et al. (144) reported that in girls skeletal height reached a maximum 1 to 7 years earlier than
maximum values in BMC and aBMD (depending on site) further demonstrating the dissociation
between BMC accrual and linear growth after linear growth has ceased. In females, after
longitudinal bone growth ceases and the epiphyses fuse, skeletal consolidation continues as the
shoulders and hips broaden to their mature state (145). Clearly, stature and BMC are closely
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related so long as there is moderate-rate longitudinal bone growth occurring at the epiphyseal
growth plates, but once the adolescent growth spurt is realized, longitudinal growth may simply
outpace the body's ability to supply adequate calcium supplies, leading to dissociation between
stature and BMC (138;146). After the epiphyseal growth plates become fused, growth of bone
length is arrested while BMC consolidation continues leading to further dissociation.
2.5.2.2 BMC and Chronological Age
Numerous investigations have reported a significant association between chronological age
and BMC, particularly before puberty. While growth occurs somewhat steadily throughout
childhood there is an acceleration around the years of puberty with the peak gains in BMC at the
lumbar spine, femoral neck and total body occurring at approximately age 13.0 for girls and 14.5
yrs. for boys, approximately 1 year after PHV (56;141;147-150).
Hannan et al. (151) measured LS and TB BMC in 216 females between the ages of 11 and
17.9 yrs. and concluded that chronological age was a significant predictor of LS and TB BMC.
Another cross-sectional evaluation determined that chronological age was significantly (p<0.001)
associated with BMC for the TB and all it's subregions (152). In another investigation by Faulkner
et al. (61) a significant association was found at all sites between BMC and age in both males and
females. A rece~t cross-sectional study displayed that by 12.5 years of age females had attained
72% of adult TB BMC and by 15 years of age 85% of their total BMC had been accrued (135).
Sugimoto et al. (87) investigated radial BMC with SPA in 229 prepubertal Japanese children
from the ages of 3 days to 11 yrs. to establish normative curves. BMC of the radius increased
from birth until age 12 (end of study group), whereas the bone width (BW) rapidly increased until
age two after which there was a slower increase. Consequently, BMD did not change significantly
until age two after which there was a significant increase throughout childhood. Therefore, after
two years of age the bone formation accelerated as compared to the bony expansion processes.
Radial BMC, BW and BMD were all highly correlated with chronological age (r = 0.955, 0.783,
0.937, respectively), stature (r =0.957, 0.871, 0.907, respectively) and body mass (r =0.966,
0.832, 0.916, respectively).
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2.5.2.3 BMC and pubertal stage
Comparison of adolescent bone accrual rates with reference to chronological age is
misleading as individual timing and tempo of growth and development is variable at similar
chronological ages; thus, comparison based on maturational benchmarks, such as pubertal stage
or time of peak height velocity (PHV), are necessary to determine true accrual rates. Following
childhood, gains in BMC are more a function of pubertal stage than chronological age (68;153-
155), as is supported by biochemical bone marker studies (156;157).
Children accrue tremendous amounts of bone tissue during childhood and early adolescence,
with a maximum rate, the peak bone mineral accrual velocity (PBMAV), occurring approximately
one year after PHV (59;138;146). Before puberty, there is a direct relation between chronological
age and BMC, as described in detail above. Numerous investigations have reported a progressive
increase in bone mineral mass through childhood (53; 152;158;159) with an acceleration of BMC
accrual during pUberty (53;133;150;160;161). During puberty, the strong prepubertal relationship
between BMC and chronological age is typically observed to diminish as the influence and different
timing of puberty comes into play. Postpubertally, the association between BMC and age is
diminished further as skeletal maturity is realized and rapid rates of accrual are ceased. De
Schepper et al. (162) reported BMC to be relatively stable over Tanner stages 2 and 3, with a rapid
accrual between stages 3 and 4, with a subsequent stabilization into stage 5.
The results from a recent longitudinal investigation concluded that in males peak TB bone
mineral accrual occurred approximately 0.6 yrs. after PHV (TB PBMAV= 14.0 yrs. and PHV = 13.4
yrs.) in males (138). In an earlier investigation with the same cohort analyzed in a cross-
sectionally, by PHV males attained approximately 59% of adult TB BMC and in the four years
surrounding PHV, 36% of the adult TB BMC was laid down, demonstrating the importance of this
time for bone mineral accrual (59). Similarly, females peak TB bone mineral accrual occurred
approximately 0.7 yrs. after PHV (TB PBMAV = 12.5 yrs. and PHV = 11.8 yrs.) (138). At PHV 60%
total adult value of the females TB BMC had already been laid down and in the four years
surrounding PHV 36% of the adult TB BMC was accrued (59). Cadogan et al. (143) estimated,
from a short-term longitudinal study, that in females during the transition from Tanner stage II to
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Tanner stage IV, the annual increase in TB BMC was 15.5 ±4.0%. They further concluded that
height velocity peaked more than 2 years prior to menarche and at the time of menarche the
greatest accrual of bone mass was observed.
In the study by Bailey et al. (59) males LS PBMAV was at 14.6 yrs. and by the time of PHV
58% of the total adult LS BMC had been laid down. Astoundingly, in the four years surrounding
PHV 39% of the total male adult LS BMC had been accrued. In females LS PBMAV was a
13.1yrs. and at PHV 60% of the total adult LS BMC had been laid down. Similar to the males, in
the four years surrounding PHV 35% of adult LS BMC was accrued. At the FN, the PBMAV
occurred at 14.4 yrs. in the males and by the time of PHV 71% of the FN BMC had been accrued.
Further, 28% of the total male adult FN BMC was laid down in the four years surrounding PHV. In
the females FN PBMAV occurred at 12.4 yrs. and 72% of the total adult value of FN BMC was
present at PHV (59). In the four years surrounding the PHV the females accrued 27% of their total
adult FN BMC. Similarly, in another investigation it was concluded that 27% of the female total
adult FN BMC was laid down in four years surrounding PHV (163).
In females, the onset of menarche is closely related to the accrual of bone mass. In an
investigation by Bonjour et al. (133) in the two years following menarche a substantial increase in
LS BMC in females was observed and after four to eight years postmenarche there were general
losses in LS BMC with maintenance of bone projected area, displaying the importance of adequate
calcium intake, eumenorrhea and physical activity in the years immediately following menarche.
Bass et al. (137) reported between 7-11 years of age (prepuberty), 11-14 years of age (puberty)
and 14-17 years of age (postpuberty) the increases in spine BMC in healthy females was 38, 72,
and 46 g, respectively. The corresponding increases in leg BMC were 240, 241 and 149 g,
respectively. While appendicular accrual is relatively constant prepubertally and pubertally, there
is a dramatic increase in accrual at the spine pubertally as compared to prepubertally. In a
longitudinal sample, McKay et al. (164) concluded that menarche and the peak rate of BMC
accrual occurred at approximately the same time, with PHV occurring about 1 year before these
events, similar to the findings of Cadogan et al. (143). Further, earlier maturing girls were found to
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possess greater peak BMC velocity and PHV as compared with later maturing girls in the McKay
et al. study (164).
In summary, bone accrual occurs in step with increases in statural growth or chronological
age until the adolescent growth spurt. However, after and during the growth spurt this association
disappears with tremendous accrual occurring at all sites, particularly during a period of four years
surrounding PHV. After the closure of the epiphyseal plates there is little association between
BMC and stature. At the onset of menarche in females there typically is a maximal rate of BMC
accrual, suggesting an effect of elevated sex hormone on bone accrual.
2.5.2.4 Gender Differences in BMC
Before puberty, there is little gender difference in BMC. There were no significant differences
between genders for TB BMC in a large cohort (n=773) children who were examined once in third
grade (mean age 8.9 yrs.) and later in fourth grade (mean age = 9.9 yrs.) (165). During this stage
of life the variance in BMC found was a factor of age and mass, not gender (165). Numerous
other investigations have concluded almost unequivocally that there are no gender differences in
BMC prepubertally at either axial or appendicular sites (40;57;129;140;150;154;166-169). In
contrast, a cross-sectional investigation of males and females (n=27 and 43, respectively) aged
5.3 to 14.4 yrs. concluded that before puberty females had significantly lower BMC at the radius,
LS and hip (170). The preponderance of evidence, however, suggests a relative equality of BMC
between the genders before puberty.
Since females typically experience puberty earlier than males, they exhibit initially higher
levels of BMC in early adolescence, but this relationship is reversed as skeletal maturity
approaches. Chronologically, females have slightly greater BMC at all sites from approximately
11-14 years of age when compared to males; however after this period males typically exhibit
higher levels of BMC as seen in adults (53;57;87;133;141;142;154;166;168;171). However, when
aligned on PHV, males tend to have only slightly greater BMC following the onset of puberty (59).
In a mixed-longitudinal investigation of BMC during adolescence, males had consistently greater
BMC at all sites, due to their larger skeletal size, but when taken from the standpoint of percent of
adult values there was little gender difference (59).
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In a group of 234 children between the ages of 8 and 16 yrs., there were no differences in TB
BMC at any chronological age (152). In a later investigation of the same cohort with further data,
males were seen to have greater TB BMC than the females after 14 yrs. of age (61). Molgaard et
al. (129) observed TB BMC in a cohort of males and females (n=142 and 201, respectively) aged 6
to 18 yrs. and concluded that between the ages of 6 through 11 yrs. there were no gender
differences in TB BMC. They further reported that from 11 through 15 yrs. females possessed
slightly higher TB BMC than the males. At 15 yrs. of age BMC gains arrested in the females and
continued in the males until 18 yrs. Consequently, after the age of 16 yrs. males possessed higher
T8 BMC than the females. Similarly, results from the most comprehensive mixed-longitudinal
database to date demonstrated that TB BMC is similar between the genders until about age 13
yrs. after which BMC gains are greater in males (59). These data are consistent with others that
have reported no differences in TB BMC values in prepubertal boys and girls, but report boys to
have a more pronounced increase in BMC during puberty and at skeletal maturity possess greater
bone mass than their female counterparts (57;140;154;166-169).
There are inconsistencies in the data comparing gender BMC differences at the LS. Although
some studies report small or no gender differences in BMC during childhood or adolescence
(147;153;155;170), others report greater values in females (56;158), while still others have
reported greater values in females until about age 15-18 yrs. when males surpass the female
values (53;140;161;166;169). In a recent longitudinal investigation LS BMC was found to be equal
for males and females until the age of 12 and 13 yrs. after which females had significantly higher
BMC until 17 yrs. of age when the males had significantly higher LS BMC (61). In a study by
Bonjour et al. (133) LS BMC was equal between genders until 12 yrs. of age after which females
had greater LS BMC until the age of 15 yrs. In this investigation, the males continued to accrue
bone until 16 yrs. after which their gains plateaued similar to what was seen with the females at 14
yrs. (133). The varying results using DXA between investigations may be a consequence of
inadequate controls for maturity and the inclusion of numerous cross-sectional investigations. For
example, when males and females are aligned on pubertal status, males consistently display
greater LS BMC than their female counterparts at all time points (133; 150).
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Several studies have reported greater BMC values in males at the FN at some stage in
childhood and certainly by late adolescence (56;68;133;150;158;169). Others, although reporting
no statistically significant gender differences in FN BMC, have found a trend toward greater values
in males (153;170;172). Mixed-longitudinal data suggest that boys have greater FN BMC at all
ages, but the differences are clearly accentuated after age 13 yrs. (40). In another investigation of
the same mixed-longitudinal dataset, there were no gender difference in FN BMC before the age
of 14 yrs., but after this there was significantly higher FN BMC in the males (61).
Lastly, at the radius, there were no significant differences observed between a large group of
prepubertal «12 yrs.) males and females for radial BMC (87), supporting the concept of relative
equality before puberty.
In general, at skeletal maturation males have greater BMC than females, theoretically due to
their larger skeletal size. Women generally have a smaller skeleton than men, accounting for
much of the gender differences in BMC (173). Additionally, the postpubertal gender difference at
skeletal sites containing relatively greater amounts of cortical bone may be a result of the greater
skeletal size and greater cortical shell mass in males (158; 166;174). There are smaller gender
differences at sites containing relatively more cancellous bone (148;166;175). Supporting the
theories that gender differences may be a consequence of size, a group using aCT demonstrated
that the greater lumbar spine BMC found postpubertally in males is primarily a function of their
larger vertebral bodies (160).
2.5.3 Changes in bone mineral density with growth and maturation
Studies have demonstrated that aBMD increases are gradual throughout childhood
(53;160;176) and accelerate during adolescence until skeletal consolidation is attained
(53;61;160). After this consolidation. decreasing sex-steroid levels and almost imperceptible
losses due to bone turnover imbalance are hypothesized to be responsible for the gradual bone
loss witnessed until death.
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2.5.3.1 Changes in areal bone mineral density
The relative importance of chronological age, stature and body mass on aBMD was
demonstrated in a cross-sectional investigation of 216 girls between 11 and 17.9 yrs. (151) where
a considerable proportion of the variation in LS aBMD was attributable to stature. Surprisingly,
when linear regression analyses were completed, the inclusion of Tanner stage did not significantly
contribute to the regression equation after age, mass and stature were entered. In the regression
equation a second degree polynomial (age squared) always led to the best fit while stature, body
mass and shoulder width consistently entered significantly into the equations (151). Similarly, LS
aBMD was analyzed by DPA in a multiracial group of 184 (n=101 boys) children aged 5 to 11.99
years of age and it was concluded that LS aBMD had significant correlations with body mass
(r=0.746), lean body mass (r=0.725), stature (r=0.693) and chronological age (r=0.580) (159). The
relationship of lean body mass (LBM) on bone density was further demonstrated by Faulkner et al.
(152) with a significant association between TB aBMD and LBM in males (~=0.75) and females
(~=0.80) (152). These results demonstrate the significant relationship between aBMD and
anthropometric measures such as stature and body mass.
2.5.3.1.1 Areal bone mineral density and chronological age
aBMD increases with age in children, with a peak or plateau typically occurring some time in
the third decade of life (69;141;147;150;158); however, increases in height and body mass are
thought to account for most of the age-dependent increase in aBMD (158). In one mixed-
longitudinal and one cross-sectional investigation of changes of bone density with growth and
maturation, Faulkner et al. (61;152) observed a significant effect of chronological age on aBMD at
all sites in both males and females. However, after the age of 17 yrs. aBMD in females stablized,
suggesting PBM may have been attained (152). Further, there were no significant differences
between either aBMD or BMC for any site between groups of 17 and 21 yrs. females, indicating a
relative attainment of PBM (61).
In a group of 205 males and 295 females aged 4-20 yrs. of age it was shown that TB aBMD
increased significantly with chronological age (177). There was an accelerated increase in bone
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density after 13 yrs. of age in males and 11 yrs. in females, with age-dependent increases
continuing to 20 yrs. Stature was significantly associated with TB aBMD throughout the age span.
Theintz et al. (150) conducted a longitudinal investigation of changes in LS aBMD for
approximately a year in a cohort of adolescents (n=198; 100 boys). LS aBMD increased rapidly
through 11-14 yrs. in females, decelerating to 16 yrs. with the gains becoming insignificant by 17-
20 yrs. A pubertal-associated rapid accumulation in LS aBMD in females from 11-12 to 13-14 yrs.
was observed, as was a rapid accumulation in LS aBMD in males from 13-14 to 16-17 yrs. Male
LS aBMD and BMC continued to increase significantly through 17-20 yrs. (150). In a cohort of
207 boys and girls aged 9-18 yrs. LS aBMD was found to be highly dependent on age throughout
the entire age range (133). Boot et al. (177) confirmed a positive relationship between LS aBMD
and chronological age in a group of 205 males and 295 females aged 4-20 yrs. of age. There was
an accelerated increase in bone density after 13 yrs. of age in the males and 11 yrs. in the females
and the age-dependent increase continued to 20 yrs. (end of trial). Stature accounted for most of
the variance in LS aBMD, again displaying the relative dependency of aBMD on size measures.
Additionally, body mass was significantly associated with LS aBMD measures after adjustment for
age (177).
Rubin et al. (178) assessed 299 children (163 girls and 136 boys) between 6 and 18 yrs. for
changes in distal radial aBMD and LS aBMD. Gains in LS aBMD were generally low in the
prepubertal years for both sexes. Females had greater LS aBMD from 11-15 yrs. as compared to
the males. In general, there was a rapid increase in girls from 10 to 15 yrs. and in males from 13
to 17 yrs., with most rapid increase during 15-16 yrs. in the males. In both sexes the increments
for bone size growth slowed before significant increments in BMC and BMD were observed.
Theintz et al. (150) reported that FN aBMD increased rapidly through 11-14 yrs. in females,
decelerating to 16 yrs. with the gains becoming insignificant by the 17-20 yrs. period. There was a
rapid accumulation of FN aBMD in females from 11-12 to 13-14 yrs. An important and significant
gain in FN aBMD was observed in the two years postmenarche, displaying the importance of
estrogen on bone consolidation. In general, there was rapid accrual in FN aBMD for males from
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13-17 yrs. with a decline in aBMD velocity with further age (150). In a similar investigation, FN
aBMD was highly dependent on chronological age throughout the entire age range (133).
Moreira et al. (179) investigated changes in radial density with growth and maturation in 121
children (52 girls, 69 boys) aged 3-18 yrs. Three radial measures were acquired: the one-third
distal radius, middle distal radius and ultra-distal radius. Radial aBMD increased slowly, but
significantly, with age in both genders and the only gender difference observed was in the 10-11
yrs. group in which the boys had denser radii than the girls (179).
In summary, aBMD seems to increase at all sites until approximately 17 yrs. in females, and
up to 19 yrs. of age in males. The dramatic acceleration of bone mass accumulation during the
pubertal years as well as the distinct age-patterning in maximal gain between males and females
clearly underline the influence of sex steroids on bone mass.
2.5.3.1.2 Areal bone mineral density and pubertal stage
In a cross-sectional investigation of 500 children (177), Tanner stage was a significant
predictor of TB aBMD in both boys and girls. After adjustment for age, Tanner stage was still
significantly correlated with TB aBMD only in the females (177). Body mass was also significantly
associated with TB aBMD after adjustment for age in both genders. Variance of aBMD increased
during puberty for all sites displaying the sensitivity of bone during this period to interventions or
perturbations as compared to prepubertal values (177). In a cross-sectional investigation of 216
girls between 11 and 17.9 yrs. (mean =13.4 yrs.) it was concluded that a considerable proportion
of the variation in TB aBMD was attributable to body stature, but in contrast to the above study,
inclusion of Tanner stage did not significantly contribute to the regression equation. (151).
In the investigation by Boot et al. (177), Tanner stage was a significant predictor of LS aBMD
in both genders and after adjustment for age, Tanner stage was still significantly correlated with LS
aBMD. An increase in LS aBMD with age occurred until puberty after which there was
acceleration in aBMD gains and bone mass became more associated with pubertal status than
age. From Tanner stage II to Tanner stage IV, the annual increase in LS aBMD was 5.5 ±1.8%.
Similarly, Ferrari et al. (24) studied a cohort of prepubertal girls (37% beginning Tanner stage 2 at
trial termination) for 1 to 2 years and reported a 3.8% increase after 1 year in LS aBMD, and a
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4.7% increase after 2 years. Southard et al. (155) investigated 218 children (134 girls) aged 1-19
yrs. of mixed racial origin (28 black females and 28 black males) and found that higher LS aBMD
was significantly associated with increased body mass, chronological age and pubertal status.
There were no significant differences in LS aBMD between blacks or whites or between genders
for any age group. The largest gains in LS aBMD occurred between 1-4 and 12-17 yrs.; these
results were suggested to correspond with the early childhood and pubertal growth spurts,
respectively. A significant increase in LS aBMD occurred with each successive pubertal stage;
however, after controlling for body mass, there was no difference between subjects at Tanner
stages I and II. In multiple regression analyses, chronological age and body mass separately
accounted for (-=0.77 and Tanner stage alone (-=0.76. Body mass and Tanner stage together
provided the best prediction of LS aBMD (~=0.85) (155). Moreira et al. (179) conducted a study
with 121 children (52 girls, 69 boys) aged 3-18 yrs. There was a significant effect of puberty with
an increase of 40% in the LS from the time of T1 through T4. Inspection of the data suggested
that the increases in LS aBMD ceased earlier in girls than in boys. Similar to other investigations,
Tanner stage and body mass were the best predictors of LS aBMD (179).
Slemenda et al. (55) completed a three-year prospective trial of calcium supplementation in
90 children (32 female and 13 male pairs of monozygotic twins) divided into postpubertal,
peripubertal and postpubertal groups. The more sexually mature children had greater LS aBMD at
baseline, suggesting a positive affect of sex steroids on bone mass. During the three years all
three of the groups had significant gains in aBMD at all sites investigated; however the peripubertal
children had the largest gains in aBMD over the three-year period. When aBMD gains in the
peripubertal group were compared to the prepubertal group there were significant gains at the LS,
but not at the radius. Increases in height and mass were positively associated with aBMD at all
sites and changes in height were more closely associated with radial aBMD and changes in mass
more closely associated with LS aBMD. The authors postulated that the increase in trabecular
bone density was linked to estrogen exposure in the females.
Ferrari et al. (24) longitudinally studied a cohort of prepubertal girls (37% beginning Tanner
stage 2 at trial termination) for 1 to 2 years and reported a 2.6% increase after 1 year in FN aBMD,
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and a 4.7% increase after 2 years, clearly demonstrating the increases bone mineral accrual that
occurs with the onset of puberty. Further, Ferrari et al. (24) reported a 6.0% increase after 1 year
in femoral shaft (FS) aBMD, and a 7.0% increase after 2 years.
Rubin et al. (178) assessed 299 children (163 girls and 136 boys) between 6 and 18 yrs. for
changes in distal radial aBMD. After puberty, there was an accelerated increase of aBMD in both
sexes. Simple regressions showed radial aBMD to be significantly correlated with age, height,
mass and Tanner stage. Multiple linear regression showed that peripheral aBMD had significant
associations with height, mass, pubertal stage and age (76%).
The effect of estrogen on bone mass is well described through its association with menarche.
Boot et al. (177) reported that girls who experienced menarche had higher density than those who
were premenarcheal, regardless of age, and earlier age of menarche was significantly associated
with higher aBMD at all sites. In another investigation during the initial 2 yrs. following menarche
there was a substantial increase in FN and FS aBMD (133). There was a small increase between
the second and fourth year postmenarche, followed by a decrease in aBMD after the fourth year
up to the eighth (133). In yet another investigation a significant gain in aBMD was observed in the
two years postmenarche in aBMD at the TB, FN and LS (150).
In summary, the largest gains in aBMD occur during the pubertal growth spurt, after which
gains slow into adulthood. In females, there are significant gains in aBMD following the onset of
menarche which are likely a result of an increase in circulating sex hormone (estrogen).
2.5.3.1.3 Gender differences in aBMD
Prepubertally, there is little difference in aBMD between genders; the differences observed
following the prepubertal period are the result of earlier initiation of puberty in females, and the
longer and greater magnitude of adolescent bone growth typically observed in males (59).
Nelson et al. (165) found no significant gender differences in TB aBMD in a cohort (n=773) of
third grade children (mean age 8.9 yrs.) and later when they were in fourth grade (mean age = 9.9
yrs.). Log body mass was found to be the major correlate for TB aBMD. Similarly, there were no
significant differences in TB aBMD between genders in a group of 234 individuals between 8 and
16 yrs. (152) and in another large cross-sectional investigation of males and females aged 4
47
though 20 yrs. there was no difference between genders for TB aBMD at any age (177). In
contrast, Faulkner et al. (61) found that males exhibited significantly greater TB aBMD than the
females after age 16 yrs.
Miller et al. (170) investigated aBMD in girls and boys (average age =9.47 yrs. with 27 male
and 43 female pairs of identical twins). In this sample 67% of the girls and 90% boys were Tanner
stage 1. There were no gender differences at the radius, but the girls possessed greater LS aBMD
at all ages (170). This investigation may have been biased in that the females would have been
more sexually mature than the males at the end of the trial. However, in a number of
investigations females have significantly greater LS aBMD when compared to males of the same
age or pubertal stage (61;170;177). Different from the above investigations, in a cohort of 9-18
yrs. males and females (n=207), between the ages of 12 and 15 yrs. the females had slightly
higher LS aBMD compared to the males, but not significantly so. When males and females where
compared at equal pubertal stages there was still no significant differences in LS aBMD (133).
In contrast to the LS, males typically possess higher densities than females in other, more
cortical, sites such as the TB, FN and FS. In a Canadian study females had significantly lower FN
aBMD at all ages, which was suggested to be a factor of greater physical activity (61) In a similar
investigation, at 17-18 yrs. males tended to have higher aBMD at the FN and FS, but not the LS
and for any given pubertal stage the males tended to have greater aBMD than the females at the
FS and FN, but not the LS (133).
Gunnes et al. (58) investigated changes in SPA-derived BMD accrual with growth at two
regions of the ulna and radius - one being of primarily trabecular constitution and the other
cortical. They recruited 494 children (247 of either sex) between the ages of 8-17 yrs. and
determined distal (65% cortical) and ultra distal BMD measures (65% trabecular). In the
prepubertal children (those <11 yrs. mean = 9.6yrs.), mean BMDd (distal radial BMD) was 6.8%
(p<0.0001) higher in boys compared to girls, while BMDud (ultra-distal radial BMD) was similar
between the genders. BMDd prior to puberty did not correlate significantly with anthropometric
variables in either sex, while BMDud was positively correlated with both height and body mass in
both sexes. Surprisingly, age was not a significant predictor in either measure prepubertally.
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When both mass and height were entered into multiple linear regression analyses it was
concluded that height was significantly associated with BMDud in the females as was mass in the
males. In adolescents (mean age=13.4 yrs.) mean BMDud was 8.2% (p<0.0001) higher in boys
than girls while BMDd was similar in both sexes. Age, height and mass were all significantly
correlated with both measures in both sexes. In multiple linear regressions, female BMDd
correlated positively with age and mass but negatively with height, and BMDud was positively
correlated with age and weight. In the boys, both densities correlated well with age and mass.
BMDd increased dramatically from age 11 in the females and 13 in the males until age 17 yrs.
(study end). During this period, the average increase rate was 10% higher in the females. The
only difference in the adolescent group was in the BMDd where females had greater values in the
15-16 yrs. age group. BMDud increased from age 10 in boys and 11 yrs. in girls. After 11 yrs. of
age, all boys groups had greater BMDud (not significant in 15-16 yrs. group). In the females, both
the increases in BMDd and BMDud were highest in the two years following menarche. BMDd
continued to increase after the third year following menarche, but BMDud did not. By the age of 17
yrs. girls had adult values in BMD. Trabecular aBMD was at a mature state in the girls by 14 yrs.
The authors concluded that female cortical and trabecular aBMD are regulated by different factors;
from 11 through 16 yrs. of age, 33% and 22% of the cortical and trabecular density, respectively,
were accumulated.
In summary, it appears that prepubertally there is little difference between genders for aBMD
and that following puberty males tend to have greater aBMD at more cortical sites (FN, TB, FS)
and equal or slightly less aBMD at the more trabecular-dominated LS when compared to females.
However, since males typically possess greater bone size as compared to females it is impossible
to determine whether the differences described between the genders are a true or whether the
differences are primarily a result of DXA not adequately accounting for size differences.
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2.5.4 Changes in volumetric bone mineral density
2.5.4.1 Volumetric BMD and chronological age
Several investigations that have examined the true volumetric density of growing bones have
concluded that the observed increase in aBMD with age is unfounded (103;180). Trotter (181)
compared ash density in the radius, humerus, tibia and femur in 143 cadavers, who at death
ranged from birth to adulthood (22 yrs.). All density calculations were done by ash density where
the volume of the bone was established by displacement and the mass by ash weighing. She
observed an early and rapid increase in density from birth through 5 yrs. after which there was a
gradual leveling off of increases in bone density, which seemed to be continued into the early
twenties, at which time losses began. Most importantly, there was no discernable increase in
bone density accumulation during puberty as suggested by aBMD investigations (181;182).
Schonau et al. (103) determined distal radial BMD by paCT in eight healthy children (4.8 -
8.3 yrs.) and concluded that density remained stable throughout growth and that the density
measurements were similar to those found in adults. The authors surmised that bone likely
adapted with changes in bone biomechanics and structural characteristics rather than density
during growth. Unfortunately, this investigation was intended to be a pilot study and there is an
extremely small sample size (103). Similarly, Zamberlan et al. (183) x-rayed the non-dominant
wrist in 167 females and 158 males and estimated that the volumetric BMD of the radius remained
stable from 3 through 21 yrs. They concluded that skeletal growth is mainly related to bone
enlargement and relative diminution of the medullary cavity in the appendicular skeleton, whereas
vOlumetric bone density is identical in males and females and increases after puberty as a result of
diminished bone turnover (183). In another cohort of girls aged 4-15 yrs. of age radial cortical
BMD as assessed by OCT was reported to remain unchanged over the entire growth period (184).
2.5.4.2 Volumetric BMD and pubertal stage
In a aCT study by Gilsanz et al. (175) pubertal children had significantly greater trabecular
and cortical LS BMD compared to prepobertal children. There was a gradual maintenance of LS
BMD during childhood with a rapid gain during puberty (-20-25%) after which it plateaued.
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However, the methodology in this investigation was questionable as there were not many
postpubertal subjects, so a true plateau cannot be supported (160). In another aCT investigation,
adolescent girls (mean = 15.9 yrs.) had significantly higher trabecular BMD as assessed by aCT
when compared to young, adult women (mean age = 30.3 yr; 196.2 vs. 180.3 mg/cc K2HP04).
Further, multiple regression analyses failed to find a significant relationship between trabecular LS
BMD and height, weight, surface area or BMI (r = 0.09-0.30). The authors concluded that
trabecular vertebral density reached its peak in females around the time of cessation of
longitudinal growth and epiphyseal closure, not the end of the third decade as suggested by others
(175).
Mora et al. (180) cross-sectionally conducted a aCT investigation with 96 Caucasian girls (4-
20 yrs.) to differentiate LS BMD in both the trabecular and cortical bone compartments. Both
compartments of bone generally increased with age. Cortical bone increased gradually with each
successive stage of puberty; however, cancellous bone was generally stable through Tanner
stages 1-3 but increased from 3 to 4 and then plateaued. Interestingly, small decreases of
cancellous bone in early puberty occurred, resulting in the values for girls in early puberty being
slightly less than prepuberty. Significant correlations occurred with age, height, weight, BMI, BSA
and cortical BMD, but there were no significant correlations between these variables and
cancellous bone in the entire age group (180).
A separate analysis of only the prepubertal girls (n=38; 4-12 yrs.) showed a trend of
increasing cortical bone with age, but decreasing cancellous BMD. Additionally, as the volume
and the height of the vertebrae increased there was increased cortical density but decreased
cancellous density. The cortical bone was positively associated with anthropometric variables
whereas the cancellous bone was negatively associated in this prepubertal sUbsample. The
results of this study suggest that there are differing patterns of cortical and cancellous vertebral
density throughout growth (180). The authors concluded that DXA investigations, which show a
gradual increase of aBMD with age, are influenced by the amount of cortical bone and/or the size
of the vertebrae and that cortical bone is most responsive to loading. Cancellous bone may be
less impacted by loading during puberty, but is more dependent upon endocrine status in the first
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two decades (180). However, due to the high degree of error associated with the measurement of
cortical bone at the LS with aCT (a result of the extremely thin cortical shell and errors in the
pixilation of it), caution must be used in interpreting.these results.
2.5.4.3 Gender Differences in Volumetric BMD
In an investigation by Gilsanz et al. (160), true volumetric bone density, as assessed by aCT,
did not differ between boys and girls (n=101; 2-18 yr. of age) as long as maturity was controlled
for. One of the flaws of this investigation, however, was the classification of pubertal status based
on age. Basically, the authors categorized children as prepubertal, pubertal or postpubertal
entirely based on chronological age. Multiple regression analyses failed to find a significant
relationship between trabecular LS BMD and height, weight, surface area or BMI (r = 0.1-0.29),
similar to Mora et al. (180), differing from almost all investigations that have assessed LS aBMD
with DXA. Further, Gilsanz et al. (108) concluded in an investigation of primarily prepubertal
children that males and females have identical LS trabecular and cortical BMD and that the
apparent gender differences in bone mass in children are simply a reflection of bone size.
2.5.5 Summary
As individuals grow and mature, their bones grow in both size and increase in BMC and
aBMD as assessed by DXA. These increases are typically rapid during early childhood (0-2 yrs.),
slowly increasing through childhood, and once again accelerate for the period surrounding the
pubertal growth spurt. The earlier punctuation in bone mass and density in females during puberty
reflects the fact that females typically experience puberty two years earlier than their male
counterparts. Following the pubertal growth spurt, bone mass gains in females slow or cease,
whereas males tend to continue a slow increase into their third decade. Unfortunately, most of the
information gathered regarding bone mass and density and growth has been garnered from cross-
sectional investigations. Dependence on cross-sectional investigations can lead to errors in the
interpretation of growth-related data as it often tends to distort the normal growth curves that would
be observed longitudinally. To date, only one longitudinal cohort has been of sufficient sample
size to adequately describe the changes in bone mass during adolescence (59). Compounding
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the degree of error in pediatric bone research is the fact that the DXA calculates an areal bone
mineral density as compared to a true volumetric density. This areal density is highly dependent
on bone size and any fluctuation in this parameter can lead to gross errors in the assessment of
bone change over time. The paucity of investigation that has been carried out with aCT has
suggested that the dramatic increases observed in aBMD over puberty are most likely erroneous.
Lastly, very few investigations have attempted to control for pubertal status, almost certainly
introducing error in to the BMD patterns described.
2.6 Changes in geometrically corrected areal bone mineral density
Numerous investigators have attempted to correct aBMD for bone size in adults. Reid et al.
(185) reported that after adjusting for height the differences observed between TB aBMD men and
women were eliminated. They further postulated that any linear measure of body size would
provide an adequate size correction, as the skeleton tends to scale proportionately. In contrast,
Faulkner et al. (186) observed that after adjusting for height there was still a difference in aBMD
between elderly men and women. The elderly males were heavier and taller than the elderly
females and possessed significantly greater aBMD values than the females at the LS, FN and TB.
However, after adjusting for bone projected area (based on the Kroger equation) there were no
significant differences in estimated volumetric BMD between the genders (186).
2.6.1.1 Geometric corrected aBMD and chronological age
Kroger et al. (68) compared aBMD and statically corrected volumetric BMD (voIBMD) at the
LS and FN in 84 Finnish children and adolescents (44 females and 40 males) aged 6-19 yrs.
There was a significant increase in LS aBMD with age and BMC and aBMD were significantly
correlated with mass, height and BMI at the LS. When LS aBMD was adjusted for bone size,
density only increased minimally, far less than what had been presented based on the evidence
from aBMD investigations (68). Kroger et al. (56) performed another investigation with 65 Finnish
children (37 females and 28 males) aged 7-20 yrs. to determine changes in BMD with growth and
maturation. Male LS aBMD significantly increased with age (r=0.89) and there was significant
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linear trend between age and LS volBMD (r=0.70). In the females there were similar correlations
between age and LS aBMD and volBMD (r=0.77 and 0.54, respectively). In females the most
marked increase in LS aBMD occurred between 11 and 13 yrs. (13% per year.). Long bone
growth in females decreased markedly following menarche. LS BMC gain before menarche was
primarily dependent upon expansion of the vertebral envelope, whereas after it was ascribed to an
increase in voIBMD. In males, the maximum increase in LS aBMD was between 13 and 17yrs.
(11 % per year). The maximum increases in LS volBMD occurred at the same time, but with muted
gains (5-6% per year). In a similar study, Boot et al. (177) reported that LS BMAD increased with
age and after adjusting for age, height had no significant association with BMAD in either sex.
When VOlumetric corrections were made to FN aBMD, correlations between volBMD and size
measures were no longer significant (68). Surprisingly, in this cohort there was no significant
correlation of age to FN volBMD suggesting that the observed increases in FN aBMD with aging
were an artifact of bone size. Unfortunately, this investigation was confounded by lack of control
for pubertal stage (68). Similar to other investigations, Kroger et al. (56), found a significant
increase in FN aBMD with increased age. The males in their study had a significant increase in
FN aBMD with age (r=0.68), but follOWing adjustment for apparent volume, no significant
relationship was found between age and FN volBMD, as was found in their previous investigation.
The boys had significantly higher FN aBMD in the 6-7 and 18-19 yrs. age groups as compared to
the girls, whereas the FN volBMD was significantly higher in the males for the 18-19 yrs. group
only (56). For the adjusted values the FN volBMD remained constant over childhood and
adolescence for both sexes. The authors suggested that before puberty the increase in bone size
is a more important constituent of bone mass accumulation than increases in material density.
Bone mass accumulation was more rapid and longer lasting in the males with the onset of puberty,
especially at the FN and expansion of the bone envelope was especially pronounced in the males.
In the females, accumulation of BMC, bone expansion and height gain slowed soon after the
menarche (56).
In a mixed-longitudinal study, when FN aBMD was adjusted as with Kroger et al. there was no
apparent change with age or a sex difference among males and females aged 6-18y. for FN
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volBMD (61). Despite the dramatic change in aBMD observed in the Ferrari et al. (24) longitudinal
trial there were little, if any, changes in BMAD at the LS, FN or FS during puberty/prepuberty.
Finally, Lu et al. (187) investigated changes in LS, FN (Kroger technique) and FS volBMD in
209 subjects (109 males) aged 5-27y. The mid-femur was estimated by
Formula 14: pi x length of femur section x (diameter/2)2 (diameter =area/height).
The femoral neck was assumed to be cylindrical as well, therefore
Formula 15: pi x height x (diameter/2)2 .
Lu et al. observed a significant age-dependent increase in LS aBMD in both genders with
increases that plateaued at 17.4 yrs. of age for males and 15.7 yrs. of age for females. LS aBMD
was height and mass dependent even after controlling for age. LS volBMD was significantly
associated with size variables but after controlling for age, height lost its significant interaction with
LS voIBMD. FN aBMD was significantly associated with age, height and weight (age-controlled as
well), whereas FN volBMD had no association with age or weight in either sex, similar to other
investigations. FN volBMD was related to height in females but not males and there was no
significant sex difference. Femoral shaft (FS) aBMD increased with age in both sexes until 17.2
yrs. in the boys and 13.5 yrs. in the girls. Again, height and weight were significantly correlated
with aBMD even after controlling for age. Conversely, FS volBMD measures had no significant
association with height or age as volBMD stayed consistent across the age ranges. When
corrected for volume, males had significantly higher FS volBMD than the females (187). The
authors concluded that the volBMD of the FN and shaft were independent of age through
childhood and early adulthood (187), similar to what is seen with OCT studies (103;148).
It is possible that the true density of the LS increases with age because of an increase in the
number of trabeculae during the growth period. Anatomically, the lumbar spine vertebral body is
neither a cylinder nor a cube, which invariably adds error to the estimation of true density in the
static or geometric-based equations. To further add error, the posterior aspects of the transverse
processes are inevitably included in the quantification of BMC, but not in the bone projected area.
A combination of posterior-anterior and lateral DXA scans may provide a more realistic
assessment of the bone dimensions of the LS, however the technology is currently limited by the
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large error in the lateral scan assessment of bone projected area. It appears that in the more
cortical regions (FN and FS) that after correction for volume there is minimal association between
age and volBMD, as supported by OCT and cadaveric investigations.
2.6.1.2 Geometrically corrected aBMD and pubertal stage
In a mixed pubertal sample (9-21 yrs) with few subjects in each pubertal stage (3 prepubertal,
8 in early puberty, 15 in midpuberty, and 19 in late puberety), acceleration in BMC and aBMD was
most rapid in the early teens and tapered off at approximately 16 yrs. of age (69). Contrasting to
this, BMAD increased with age at the spine and midradius, but there were no significant changes
associated with age at the whole body or femoral neck. When BMC, aBMD and BMAD were
correlated with measures of weight, height and Tanner score, the highest correlations were seen
with BMC, followed by weaker correlations with aBMD and the weakest with BMAD. All of the
predictors of bone mass were found to be highly intercorrelated (r = 0.78-0.89). The results
demonstrated that the increase in height and weight associated with pubertal growth in this group
of girls was largely completed by the age of 16 yrs. and that the greatest increases in bone mineral
occurred in the younger girls and from those who had recently begun to menstruate. The authors
suggested that 50% of the change in lumbar spine BMC is accounted for by expansion in vertebral
dimensions alone. Similarly, they suggested that 96% of the changes in femoral neck mineral,
55% of the midradial shaft, and 99% of the adolescent increase in TB. BMC was due to bone
expansion, rather than increased mineralization, implying that the expansion of cortical area
accounts for the BMC changes. The two most important determinants of bone mass acquisition
were found to be pubertal stage and body size (69).
Plotkin et al. (188) measured LS bone density in 433 Argentinean girls between the ages of 2
and 20 yrs. They corrected LS aBMD for body height according to the formula:
Formula 16: LS volBMD =BMC/(BA x height).
aBMD was also measured by lateral DXA, and a volumetric estimate was made. Between
Tanner stages 1, 2 and 3 there were significant differences in LS aBMD for both PA and lateral
scans, but no significant differences between Tanner stages 3 to 5. The most rapid growth in LS
aBMD occurred from 11-15 yrs. of age. LS volBMD values showed significant differences between
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Tanner stages 1-3 and no differences between 3-5. Interestingly, there were no differences
observed for lateral LS volBMD for any stage. The authors concluded that the rapid gain in aBMD
observed from 11-15 yrs. was not realized when corrected for volume (188).
Uusi-Rasi et al. (163) investigated 176 eight to 20 yr. old females to determine growth
patterns of the LS. LS BMAD was assumed to describe the bone composition and trabecular
architecture as a lumped, size-independent parameter of average porosity. Mass and height were
significantly associated (0.62-0.90) with LS BMC and LS aBMD with the strongest correlations with
LS BMC, as expected. Only body mass was significantly correlated with spinal BMAD of the pre
and post-pubertal subjects, with no significant correlations in the peripubertal group. BMC, aBMD
and BMAD at the spine increased with age at all measurement sites and both age and Tanner
stage had high correlations with the bone variables (0.41-0.86). Radial BMAD had no relations
with age or Tanner stage. In regression analyses Tanner stage was a better predictor than age in
both radial and LS bone measures, demonstrating the importance of sex steroids during puberty.
2.6.1.3 Gender differences in geometrically corrected aBMD
In the investigation by Boot et aI., girls had higher LS BMAD than males at all ages (177).
Similarly, in Kroger et aI., before the age of 12 yrs. there were no significant differences in LS
volBMD between genders, but in the 12-13 yrs., group and the 16-17 yrs. group, the females had
significantly higher LS volBMD (68).
When FN aBMD was adjusted as with Kroger et al. there was no significant change with age
or a sex difference in a large Canadian cohort (40). In contrast, the mean adjusted FN volBMD
was significantly higher in the males as compared to the females in a Finnish cohort (68).
2.7 Changes in statistically corrected bone mineral density
2.7.1.1 Statistically corrected aBMD and chronological age
Warner et al. (128) utilized the dynamic correction methods of Prentice et al. to generate
predictive formulae for BMC based on PA, age, height, weight, pubertal stage and gender. A mean
regression line of BMC was created that could be used to monitor healthy children or to examine
those with a deficiency of normal bone metabolism. All aBMD measures were significantly
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(P<O.001) related to PA, elucidating the size dependence of aBMD. They concluded that a more
appropriate model for aBMD would be BMC/BAlambda, where lambda was the power coefficient
from the regression equation of BMC on BA. The power coefficients after regressing BMC on PA
were: whole body (1.39), LS (1.66), total hip (1.44), femoral neck (1.63), trochanteric region (1.26)
and intertrochanteric region (1.42); all of the regression coefficients were significantly different from
unity (p<O.01). After sBMD was calculated using this method the correlation of PA to BMC
became insignificant at all sites (r=O.02-0.03). Lastly, after correction for pubertal stage and body
size there were no differences between genders. Unfortunately, the very small sample size utilized
was likely insufficient to be setting guidelines for norms (58 subjects over 5 pubertal stages and
two genders). Further, their research was cross-sectional in nature and susceptible to the bias
associated with the establishment of norms based on that form of data analysis (128).
It is evident that there is a need for scaling or some type of correction to be performed in order
for a clear picture to emerge of what is actually happening during growth and development in terms
of true volumetric density. Until the time when bone size can be controlled for it will be impossible
to accurately longitudinally assess the changes that are occurring in bone mass during
adolescence and childhood.
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2.8 Increased incidence of fracture during the adolescent growth spurt
Increased incidences of distal forearm fracture during adolescence, particularly around
the period of the growth spurt, are a frequent observation in an abundance of epidemiological
investigations (189-195). In fact, the peak fracture incidence in both sexes corresponded
approximately with the time of PHV (194). After this period of apparent skeletal fragility, fracture
rates decrease into adulthood and remain low in men but again increase substantially in women
after the age of 50, coincident with the occurrence of menopause (1).
2.8.1 Increased physical activity or increased body mass as a cause for greater
fracture rate
Frequently, the increase in fracture incidence associated with the growth spurt has been
attributed to increased levels of physical activity, and thus a higher probability of incurring a
traumatic accident of some sort (44). While this theory does seem to have merit, on closer
inspection of physical activity patterns in children and adolescents, this period is actually when
there is decreased physical activity as compared to years previous (194). It is also unrealistic to
assume that there is an increase in physical activity for the years during the growth spurt, and for
significantly lower levels just before and after this period. Distal forearm fracture incidence seems
to be climbing when activity is falling, leading to the conclusion that they are not causally related.
During the growth spurt, a concomitant significant increase in body mass is witnessed in
both males and females (65). It is a fundamental dictum in bone biology that bone mass and
architecture are intimately related to load bearing. However, in a time of rapid linear growth, it may
be the case that all exogenous calcium (and almost certainly some endogenous from trabecular
sources) is shunted to those areas of rapid growth of the long bones, as consolidation can and
does occur afterward (44;146). During the growth spurt, trabecular mass may be relatively
unchanged from prepubescence, but now must support the mass of an individual 15-20 kg heavier
than when that structure and mass of trabecular bone was appropriate to withstand dynamic
loading of this magnitude. At this time should a traumatic stress related to body mass be
encountered at the distal forearm, it would have significantly more inertia than the trabeculae were
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designed to resist and theoretically be more prone to fracture. Other factors may be at playas well
to worsen the situation. Since the bone is sensitive to the loads placed upon it (34;123), it is
probable that at some time the trabeculae of the distal forearm would be structurally inadequate for
the stresses placed upon them. Bone adapts to increased stress by either altering its material
properties or changing its architecture to better suit its loading environment. During the growth
spurt it has been postulated that the calcium is shunted to the areas of longitudinal bone growth,
therefore the building blocks for accruing more mass are not available (44). In light of the inability
to accrue mass at this time, the trabeculae may attempt to remodel to some extent to better be
suited to the loads commonly encountered. However, the inherent weak link in the chain is the
chronology of the remodelling cycle in bone. While it only takes a few days to excavate the bone
for remodelling, it can take up to as long as 4 months for replacement and full mineralization to
occur afterwards (109). Thus, the remodelling space increases in the trabecular bone, causing
both less mineral mass and decreased biomechanical competence, both of which decrease the
strength of the structure and make it susceptible to fracture under lower loads.
A further theory is that the epiphyseal cartilage of the growth plate may act as an
"attenuator" of force before it is mineralized for the distal forearm. Since a large proportion of the
plate is of cartilage, and cartilage in terms of a material is relatively malleable, it can be seen as
a "crash pad" for the distal forearm in that any stresses coming through the distal forearm will be
passed directiy to the cartilage. As the cartilage becomes more completely mineralized near the
end of the growth spurt, it will attenuate less of the forces placing the trabecular portion of the
distal forearm in a position where it many be crushed by the stress of the load on one side and
by the greater mechanically stiff cortical bone on the other. This would put the site in the
greatest mechanical disadvantage experienced to that time. Later, consolidation would allow
more proper mineralization of the trabeculae and corticies, allowing for this type of fracture to
occur less easily. However, there is a time of fragility for the distal forearm when it has lost the
structure to maintain its strength, has lost some mass, and has now lost its "shock absorber".
Therefore, the question remains as to why there is an increased fracture incidence in the
distal forearm during the growth spurt. While there has been exceedingly little direct research
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performed to address this question, there have been a number of investigations that have
addressed it indirectly.
2.8.2 Bone turnover during adolescence and menopause
During bone turnover osteoclastic resorption forms pits on and in the bone that
subsequently are filled with osteoid from osteoblasts. These pits alone can lead to
biomechanically weaker bone. After the osteoid is laid down from the osteoblasts it typically
takes about two weeks before any mineralization occurs and it slowly becomes further
mineralized over the next six months. Since it takes nearly half a year for bone to become fully
mineralized, recently deposited matrix has a lower material density than does that of relatively
older bone matrix (84). Therefore, the material density of a given bone is inversely related to the
rate of bone turnover as with higher turnovers there will be relatively more undermineralized
bone than in situations with lower rates of turnover (84; 196).
Bone turnover and remodeling are dramatically increased during growth, as evidenced by
bone resorption markers; for example, urinary excretion of hydroxylysyl and Iysyl-pyridinoline peak
during adolescence and decline with the cessation of growth and skeletal maturity (197). Bone
turnover markers peak in boys and girls at approximately 12 and 14 yrs. of age, respectively,
approximately the same time as PHV , and peak fracture incidence (53; 197). Unfortunately,
remodeling carries with it the burden of a small amount of bone lost per BMU, but more importantly
it always leaves a remodeling space as a result of the inability of the osteoblasts to immediately fill
in the areas excavated by the osteoclasts (198). The remodeling space normally represents about
2-5% of the total volume of a given bone, but is increased as the turnover of a bone increases.
Therefore, an increase in the porosity of the bone is witnessed in high turnover conditions (38).
This increased porosity would lead to decreased mechanical strength.
At times of high turnover, cancellous bone, such as that seen in the vertebrae after
menopause in women, can become biomechanically weakened and fail under smaller loads
(38; 198). In the femur, cortical bone during times of elevated turnover become mechanically
impaired due to increased porosity (29), which is alarming since the cortical shell at the distal
radius is thinner and thus a given resorption cavity would take up a greater proportion of its
61
thickness, further compromising its strength (109). Further, Cadogan et al. (143) concluded that
peak bone turnover rates occurred 1-2 years in advance of peak bone mineral accretion.
Therefore, remodeling is occurring at its most rapid rate, thereby increasing the remodeling space
and decreasing biomechanical integrity, well before peak mineral accretion.
The only other time in the lifespan when there is a dramatic increase in the fracture rate
is postmenopausally in women. One of the characteristic responses to the loss of estrogen is an
increased turnover of bone during the years immediately following menopause. There are many
negative effects of increasing turnover; since there is a slight loss of bone in each BMU, an
increased turn-over would mean that there would be increased losses of bone (there is evidence
that there is even more bone lost per BMU in postmenopausally) and a dramatic increase in the
remodeling space which can represent up to 10% of the skeletal volume. With high levels of
bone turnover, increased rates for fracture especially in those areas with high components of
trabecular bone such as the radius, the vertebrae, and the femoral neck invariably result.
2.8.3 Calcium requirement and adolescence: inadequate supply?
The adolescent growth spurt is punctuated with dramatic increases in total body bone
mass and is one of the only periods during life that there is concomitant deposition of bone on both
the periosteal and endosteal surfaces (131). During this time of peak growth in bone the
requirements for calcium are excessive, even to the extent that optimum intake and absorption
may be insufficient to meet the demands for calcium (145;146;199). In order to meet the demands
of rapid growth in the long bones, it is essential for adequate calcium to be available. Rarely do
children meet the RNI for calcium in a given day, further compounding the insufficiency of
exogenous calcium (146). If exogenous sources are unable to supply the needed calcium for
growth, then it must come from endogenous sources of sites not undergoing rapid growth. The
most readily available supply of endogenous calcium is from trabecular bone owing to its high
metabolic activity (5-10 times higher than cortical bone) (109). Calcium for longitudinal bone
growth has also been suggested to originate from the cortical shell (40). Therefore, bone must be
taken from regions where there is little growth occurring to be used for foundational building at
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areas that are undergoing extensive collagenous matrix formation, and thus need the calcium in
order to mineralize this tissue, if even incompletely.
Interestingly, Bonjour et al. (200) concluded that calcium supplementation in pubertal
aged girls showed a preferential effect on the appendicular skeleton, demonstrating perhaps a
persistent deficiency in this area during growth, furthering the hypothesis that this region may be
somewhat calcium deficient as a whole during rapid growth.
2.8.4 Mechanical changes in bone with adolescent growth
The ultra-distal portions of both the radius and the ulna are comprised of predominantly
trabecular bone, encapsulated by an exceedingly thin (-200 IJm thick) shell of cortical bone (38).
The trabeculae at this site provide the majority of strength needed for support during dynamic
loading (201). A greater proportion of rigid cortical bone is found moving proximally into the
diaphysis of each bone. Since the majority of functional strength is recognized as originating from
the trabecular bone at the distal radius, it is interesting that no studies have yet addressed the
affects of this compartment of bone at the distal forearm as related to fracture risk during
adolescence.
Bone strength is most highly correlated with bone density at all times during the lifespan,
accounting for between 70-80% of the material strength of the structure (38). However,
architecture also plays a large role in strength, and it has been observed that with rapid growth
there is an increase in the porosity of the cortical shell (44). Unfortunately, there have not been
any investigations that have questioned the effects of rapid growth on the trabecular bone in this
region, but one would suspect that the losses here would be more acute that those witnessed at
the cortical region, since trabecular bone is more sensitive to hormonal fluxes than is cortical
bone (109). Cortical bone porosity may be a conservative marker for what may be occurring
underneath the thin cortical shell. It is well established that trabecular structure, in terms of
connectivity and the actual width of the trabecular struts, account for much of the mechanical
strength (38). Further evidence by Turner et al. has demonstrated that trabecular architecture
mimics the external and internal forces engendered upon it to better withstand typical loading
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environments (81). Accordingly, any loss of trabeculae mass in the distal forearm could lead to
diminished biomechanical strength in the region.
Differences in the matrix and mineral, the modulus of elasticity, bending strength and
tensile strength of cortical bone are all lower in children as compared to adults (202), but are no
lower during adolescence than at any other time during childhood, so probably do not
independently account for the increase in distal fracture rate observed. However, during rapid
growth imperfect alignment of collagen fibers with the principle directions of loading has been
reported (203), which leads to a decrease in the mechanical properties of the tissue, most
specifically tensile strength, which would lead to increased fragility. The modulus of elasticity and
the breaking strength of bone are directly proportional and attributed to the orientation and quantity
of collagen fibers, as the direction and organization of fibers will have a large influence on the
patterns of mineral deposition (203) There has not been a study completed that has utilized
technology that would be appropriate to detect the microarchitectural changes that could b~
occurring, or the variations in density of the trabecular bone during this time of seeming fragility.
Hagino et al. (190) measured metaphyseal and diaphyseal BMD at the distal radius in
children at all stages of growth. They observed that BMD of the metaphysis increased slowly
before puberty, whereas the diaphysis increased linearly throughout the period of skeletal growth.
Accordingly, the metaphyseal/diaphyseal ratio was lowest at the age when the peak incidence of
distal radial fractures occurred. It has been previously described by aCT that cortical bone
increases linearly through childhood and adolescence, whereas trabecular bone stays relatively
steady throughout adolescence, but gains rapidly after linear growth had arrested in late
adolescence (180). In other words, there is an arrest of accretion to the trabecular bone at this
time (maintenance of status quo), with all the efforts of the system being expended into growth of
the metaphyses.
As a testament to the rapidity of trabecular bone lost in the distal part of the radius as
compared to the diaphyses, an investigation of children who fractured their arm had their BMD
assessed before and after casting, to stUdy the amount and patterns of bone loss. An
immobilization period of between three to six weeks resulted in a reduction of the bone density of
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up to 44% (mean 16%) in the distal part of the radius, whereas no significant change could be
seen in the diaphyseal part of the same bone (204); the most rapid site of loss being that of the
highest proportion of trabeculae.
A crude semi-quantitative measure of radial cortical porosity, the striation index, indicates
high porosity in childhood that peaks at adolescence, but then falls dramatically into adulthood
(205). This increased porosity has been suggested to be one of the causes of the increased
fracture rates (198). After the cessation of linear growth, there is a slowing of intracortical
remodelling and a decrease in cortical porosity, which leads to bone mass gain and is termed
consolidation. Bailey et al. (206) also suggested that there is a temporary increase in the porosity
of bones during the most rapid period of linear growth. Thus a pattern of both extensive trabecular
and cortical loss appears during the adolescent growth spurt. Loss of any amount of bone in an
area such as the distal radius, which is particularly susceptible to traumatic fracture owing to its
anatomical location, could theoretically be the cause of the increased fracture incidence witnessed.
Skaggs et al. (184) recently reported that in a group of young girls (4-15 yrs. of age) the
primary cause of radial fracture was a decreased relative cross-sectional (8% smaller) area as
compared to controls and an increased body mass. Interestingly, BMD, as assessed by aCT, was
not different between the fracture and nonfracture groups.
Parfitt (44) postulates that one of the causes of a weaker bone during the adolescent
growth spurt may be due to the inability of newly laid down periosteal bone to achieve full
mineralization before it is subsequently absorbed on the endocortical surface of the bone.
2.8.5 Dissociation between bone expansion and bone mineralization
Bone mineral accrual continues after the cessation of linear growth, as the bone becomes
consolidated (142;207). Peak bone mineral content velocity occur approximately 1.2-1.6 yrs.
after PHV in boys and girls, respectively (146), elucidating a dissociation between volumetric
growth of bone and its subsequent mineralization. Interestingly, in a large cohort of girls
followed longitudinally it was concluded that the age of onset, peak growth velocity, and
completion of growth of a regions external dimensions preceded the mineral accrued within the
periosteal envelope (137). Further, they demonstrated that the deceleration in bone mineral
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accrual occurred 1 year later than the deceleration in bone length at both the vertebral body and
the femoral diaphysis, demonstrating dissociation between bone mineral accrual and bone
expansion.
Clearly there is physiological rationale behind the increased prevalence of fracture
surrounding PHV and it is most likely attributable to dissociation between expansion of the bone
envelope and its subsequent mineralization.
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2.9 Statement ofproblem
Numerous investigations have sought to describe the changes that occur with bone mineral
density during growth and maturation and the majority have concluded that BMO generally
increases throughout childhood, accelerates through puberty, and slows and finally plateaus in
early adulthood. This generally supported conclusion has its foundations in a large number of
investigations that described the changes in OXA-derived aBMO over the pediatric years, with the
preponderance of these studies cross-sectional in nature and with chronologically-based
groupings.
Cross-sectional investigations provide inaccurate and often misleading data for the
development of growth standards. Further, since the timing of puberty is variable and because it
has such a large impact on both bone size and bone accrual, it is imperative to have some form of
control for maturation in order to control for this variability and accurately describe growth; very few
investigations have attempted to categorize children with respect to their pubertal status and of
those that have, few have been methodologically sound. Unfortunately, aBMO is confounded by
bone size in its representation of true density. A paucity of cross-sectional investigations have
utilized techniques to partially control for the effect of bone size during growth and maturation on
the measurement of aBMO by DXA, with none controlling for maturity.
Therefore, the true volumetric BMO patterns during adolescence are largely unreported
and/or inaccurate due to a strong dependence on cross-sectional studies, a lack of proper
grouping of individuals based on maturational development, and the reporting of only size-
dependent aBMO.
This investigation is unique because:
1. No previous investigation has had the serial data available to longitudinally compare
different measures of bone density over the growth period or to describe the
patterning and tempo of bone density changes precisely through velocity analyses;
velocity analyses are a unique strength of longitudinal data as they allow for the rate
of accrual to be determined. Further, longitudinal analyses allow for the retention of
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individual growth curve characteristics, which is essential in the production of normal
curves.
2. No previous investigation has investigated these bone density variables grouped by
an objective, definitive maturational benchmark such as PHV.
3. No other investigation has compared aBMD, BMAD and sBMD in an adolescent
population to try and accurately describe the size-independent bone density
patterns that occur with growth and maturation, which were, up to this point, largely
unknown.
The purpose of this investigation was to longitudinally describe changes in BMD patterns
across childhood and adolescence in a cohort that was maturationally aligned to minimize
variability associated with differential timing of puberty. Further, patterns in aBMD over the
investigated growth period were compared with two measures of BMD that attempted to correct for
the size-mediated errors in DXA assessment of aBMD.
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2.10 Hypotheses
This investigation tested the following hypotheses:
H1: aBMD is significantly influenced by body height, body mass and the bone
projected area of the respective site.
H1 1: Body height, body mass and bone projected area will be significantly
positively correlated with areal BM0 at all sites.
H1 2: All regression coefficients of PA regressed upon BMC will be significantly
different than unity at all measurement sites.
H2: aBMD corrected for bone size will not be significantly influenced by body height,
body mass and the bone projected area of the respective site.
H21: Body height, body mass and bone projected area will not be significantly
correlated with bone mineral apparent density (BMAD) at any site.
H22: Body height, body mass and bone projected area will not be significantly
correlated with statistically corrected BMD at any site.
H3: The age-related increase in aBMD in both genders is eliminated when corrected
for bone size.
H31: aBMD will increase significantly throughout the growth period at all sites in
both genders.
H32: BMAD will not change significantly throughout the growth period at all sites
in both genders.
H33 : sBMD will not change significantly throughout the growth period at all sites
in both genders.
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H4: The gender difference observed in aBMD will be eliminated when corrected for
bone size and maturation.
H41: Males will possess significantly greater aBMD at all sites as compared to
females, when corrected for maturation.
H42: No statistical difference will exist between genders for BMAD at all sites
when corrected for maturation.
H5: The age-related acceleration in aBMD velocity during the pubertal years is
eliminated when corrected for bone size.
H51: aBMD velocity will remain positive throughout the growth period at all sites
in both genders.
H52: BMAD velocity will be negative or zero through the growth period at all sites
in both genders.
H53: sBMD velocity will be negative or zero through the growth period at all sites
in both genders.
H6: There will be a significant lag period between the age at peak PA velocity and
age at peak BMC velocity.
Throughout the thesis sections pertaining to a specific hypothesis will be preceded by a
designation of the hypothesis number and subhypothesis denotation, when appropriate (ie. for
hypothesis 4 sub 2 =H42).
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2.11 Limitations
As the distance curves generated in this investigation are of a mixed-longitudinal design
and not a true longitudinal design, the conclusions that come from the distance curves may be
subject to bias and should be viewed as such. Growth curves generated from cross-sectional data
tend to be smoothed and can mask the wide range of individual variation inherent in any age group
of children (62).
Although the non-parametric smoothing spline (in this investigation, the cubic spline)
technique preserves the major features of the velocity curves of growth it has some drawbacks;
most notably, the spline may significantly underestimate the value of peak velocity of growth during
the adolescent spurt. This phenomenon is the result of serial velocity measures put together in a
piecewise fashion, which may not adequately reflect changes in velocity, and are often truncated
(208).
Since DXA does not provide separate cortical and trabecular measures, it is only possible
to provide an integrated estimate of aBMD.
The conclusions made here should be limited to primarily Caucasian populations, .as
approximately 98% of the cohort was of that race.
In the mixed-longitudinal data (distance data) a general linear multilevel ANOVA was
utilized to determine significant age and gender effects. Since the data was not independent in
each age group (there was a degree of serial correlation as there was longitudinal and cross-
sectional data combined) the assumption of independence for ANOVA analyses was broken.
However, this was the most appropriate method of analysis based on the study design.
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3 Methods and Procedures
3.1 Subjects
Participants were males and females from the Saskatchewan Pediatric Bone Mineral Accrual
Study (SPBMAS). The SPBMAS is a mixed-longitudinal investigation of seven years in duration
(1991-1997) that's primary objective was to describe the effects of growth and maturation on bone
mass through adolescence. At study initiation, 375 children (8-14 yrs.) from two Saskatoon
(Saskatchewan, Canada) elementary schools were invited to participate, of which 228 (115
females and 113 males) accepted and obtained parental written consent. Over 98% of the sample
was Caucasian, with Aboriginal, Asian, and African individuals accounting for the remaining 2%.
During the seven years of study, numerous individuals were added to the sample, while some
individuals chose to discontinue or were lost to follow-up. Consequently, the sample size
fluctuated from year to year. Mixed longitudinal (or multiple longitudinal) designs have the
advantage of being able to isolate main effects, such as age effect, from interfering effects such as
time of measurement and cohort (64). Additionally, measures of dietary intake and physical
activity habits were collected throughout the investigation to assess the impact of these variables
on bone mineral accrual; these variables were not addressed in the current investigation. The
SPBMAS was given approval by the University of Saskatchewan Advisory Committee on Ethics in
Human Experimentation (Appendix A) and all subjects, and their legal guardians, gave signed,
informed consent prior to participation.
After seven years of data collection, a sub-sample of the SPBMAS (longitudinal database)
was established that consisted of 70 males and 67 females that possessed enough growth data to
allow for the accurate determination of their peak height velocity (PHV) through cubic spline linear
regression. This longitudinal dataset was used for all of the analyses in this investigation as it
allowed for the quantification of pubertal status based on PHV to correct for differences in
maturational status of study participants.
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Age at PHV was used as a maturational benchmark in this investigation. Maturational
differences in the cohort were controlled by grouping individuals based on their respective age of
PHV; all subjects were aligned on their respective age of PHV and were assigned maturational
age values in relation to PHV. For example, a child at 2 years before his/her calculated PHV
would be termed -2 PHV whereas a child 1 year after would be labeled 1 PHV. This method to
control for differences in maturity is accepted in the pediatric literature as the gold standard (62),
but has not been previously used to compare individuals for density measures since this
information can only come from rare longitudinal investigations with serial density measures.
While bone measures at both chronological and PHV-based ages were determined in this
investigation, only the PHV-based age data is presented and discussed in the formal body of the
document as it is one of the unique strengths of this investigation; all chronological-based
measures can be found in the Appendices for comparison with previous trials.
For the generation of the distance curves, all of the subjects in the longitudinal database were
used. In this dataset, each individual was not necessarily represented in each data cell, therefore
creating a mixed-longitudinal dataset. In other words, while the investigation reports values from
11 through 18 yrs. of age (-4 to 4 yrs. PHV), a particular individual may only have measurements
for a smaller age span (ie. 12-16 yrs. or -3 to 2 yrs. PHV). Numerous individuals with different age
spans are combined to allow for the estimation of bone measures over the entire investigated age
span.
For the generation of the velocity curves, only a subset of the longitudinal data set was used;
only those subjects that possessed data spanning a predetermined age span (ie. -2 to 2 years
PHV or from 11 to 15 years of age). In this dataset, each individual was represented in each data
cell, therefore creating a pure longitudinal dataset.
3.2 Anthropometric and maturational assessment
Anthropometric assessments were completed every six months for all individuals in the
investigation (fall and spring measurements). At each visit, anthropometric measurements were
completed three times, with the average of the two closest values taken as the criterion measure.
Body mass was established by a digital scale (Toledo Scale, Canada; Model 2038), accurate to
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0.1 kg, with the subject dressed only in light shorts and shirt. Stature was established without
footwear by a fixed stadiometer accurate to 1 mm. During the assessment of stature, participants
were instructed to fUlly inhale and hold their inspiration while light traction was applied to the
occipital lobes of the cranium; since the intervertebral discs become compressed throughout the
ambulatory day as a result of weight bearing, traction was performed in an attempt to decompress
the vertebral discs to attain a true stature measurement. Skinfold and girth measurements were
also collected on these occasions, but are not utilized in this investigation. Decimal age was
assessed at each measurement point (years + (days/365.25)).
3.3 Determination of peak height velocity
Peak height velocity (PHV) is defined as the maximum rate (cm/y) of statural gain during
growth. The age of PHV is defined as the age at which the maximum rate of statural growth
occurs. Age at PHV has been found to be a useful landmark against which the tempo and timing
of other tissues development can be anchored (62). In females the attainment of PHV is highly
correlated with Tanner breast stage 2 and menarche, and in males moderately correlated with
genital and pubic hair Tanner stage 2, although there is some degree of variation in the timing of
the indicators of somatic and sexual maturation (62). Further, PHV is the most sensitive indicator
of skeletal growth as it essentially based on skeletal length. Therefore, by aligning growth on PHV,
individuals can be accurately compared maturationally. All individuals in this investigation were
assessed for stature twice yearly, as described above. To allow for the assessment of velocity, a
minimum of two time points are required to calculate the rate of change over that period. Height
velocity was calculated by calculating the staturaldifference between two time points (Stature time
2 - Stature time 1, in cm) and dividing this by the time between the points (Time 2 - Time 1, in y).
The product of this calculation leaves a velocity measure (in cm/y) and the calculated velocity
value is ascribed to the midpoint between the two time points.
It is well established that statural growth, as well as linear bone measures, display a seasonal
growth pattern of rapid growth during the summer months and slower growth during the winter
months (209). To smooth seasonal growth differences, a rolling average technique was utilized
which paired adjacent fall-fall measures and spring-spring measures and established their
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velocities at the midpoint, thus avoiding the deleterious effects of seasonal growth on the velocity
curves produced.
For each subject growth velocities and corresponding ages were plotted and analyzed by
cubic spline regression with the use of a software analysis package (GraphPad Prism, San Diego,
CA, USA). The cubic spline analysis provides a smoothed curve that allows the maximum velocity
to be determined over the growth period. The cubic spline technique has been commonly used
with growth data as it accurately models normal growth processes (138;164;210-215). Each peak
velocity, as well as the corresponding age at which it occurred, was recorded as the PHV and age
of PHV, respectively.
3.4 Bone mass assessment
Bone mass measurements were completed each fall during the investigation (October
through November) by dual-energy x-ray absorptiometry (DXA), using a Hologic quantitative digital
radiographic (QDR) 2000 bone densitometer (Hologic, Waltham, MA, USA) in the Department of
Nuclear Medicine at the Royal University Hospital, Saskatoon, SK.
Bone mineral content (BMC) and bone projected area (BA) were measured yearly for the total
body (TB), AP lumbar spine (LS; L1-L4), and the femoral neck (FN)1 with the exception of the initial
year when no LS measurements were completed. All scans were made in the array mode utilizing
enhanced global software version 7.10. TB scans were analyzed using software version 5.68A
and the LS and FN scans utilized software version 4.42:1. Following analyses, all bone
densitometry results were forwarded to a Nuclear Medicine physician for clinical assessment.
DXA assumes the bone mass of a particular region to be proportional to the absorption of
ionizing radiation by the hard and soft tissues of the body. The QDR-2000 alternately pulses two
energies of x-rays (70 kVp and 140 kVp) from an x-ray generator that is mounted below the
subject during the assessment. These two voltages maximize differentiation between hard and
soft tissues. The DXA collects the x-ray photons not absorbed in the body via a collimator above
the anterior surface of the subject. The collimator compares the attenuation of the x-ray photons to
a reference standard and is able to assess the composition of that particular region or pixel based
on that reference. The QDR-2000 employs high-resolution images made possible by the fine (1.5
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mm) collimation aperture, allowing for better bone edge detection than with previous generations of
DXA. Additionally, shorter scanning times and lower doses of ionizing radiation are characteristic
of the QDR 2000.
SUbjects wore shorts and a light T-shirt during DXA scans and were free of all metal objects.
All participants had their body mass and stature measured prior to DXA bone mass assessment
and females were screened for pregnancy.
TB scans were made with tt:te subject lying supine in the longitudinal midpoint of the scan,
with the body composition phantom approximately 5 cm. lateral to the right foot. The body
composition phantom is necessary for body composition estimation (lean body mass and fat
mass). The subject's head was positioned so that the first scan line was air and not more than six
scan lines below the lateral demarcation on the superior aspect of the scanning mat. The chin was
raised and the shoulders depressed to prevent overlap of mandible and scapulae on the
densitometer image. For tall individuals, the feet were dorsi-flexed or the knees bent, depending
on the amount of tissue off the scan table. The arms were placed equidistant from the body, while
both remaining on scan mat and not touching the body, with the hands pronated. The feet were
rotated internally and masking tape was applied to join the great toes to immobilize the lower body
and to aid in repeat positioning. The TB scan required approximately 5 minutes and 20 seconds to
complete. In addition to BMC (g) and aBMD (g/cm2), the DXA TB scan also provided an estimate
of fat mass (g) and lean body mass (g) (LBM).
Anterior-posterior LS measurements were completed with the subject supine with the lower
legs raised on a padded box (38 cm by 32 cm by 45 cm) with the femora as vertical with respect to
the scan bed as was possible in order to decrease lumbar lordosis. The subject was positioned on
the midline of the scan bed with the lumbar region between the lateral upper and lower spine limit
lines. The hands were placed beneath the head maximally raising the rib cage out of the region of
interest. The laser guidance point was placed on the midline of the subject approximately 5 cm
below the level of the lateral aspect of the iliac crest. The scan ideally included L5 through T12
and took approximately 1.5 minutes, depending on the size of the subject.
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The left proximal femur scans were completed with the subject supine and the left leg
inwardly rotated (30 degrees) and fixed to a standardized positioning aid (Iucite positioning wedge,
Hologic) to both expose the head of the femur more completely and to standardize measurement.
The femoral head, lesser trochanter and greater trochanter are all included in the region of interest
analysis. To allow for proper analysis the lateral aspect of the greater trochanter was at least 5
lines (7.5 mm) from the outer edge of the ROI and the lesser trochanter was at least 10 lines (15
mm) away from the inferior aspect of the ROL The proximal femur scan takes approximately 3
minutes.
All scan analyses were completed as outlined in the HOLOGIC QDR Operator's Manual and
User's Guide, Hologic Inc., Waltham, MA., 1991. The compare function was used in all sequential
scans at all sites to allow for increased consistency in ROI placement between analyses.
All scans in the first six years were analyzed by the same individual, and scans in the last
year were analyzed by another. As an assessment of consistency, the last year's scans were
reviewed by the initial analyst for consistency of region of interest placement and landmarking
techniques.
Quality control of the DXA was performed by a Nuclear Medicine Department physicist and a
senior technologist with the use of the supplied quality control (QC) phantom and software installed
on the QDR 2000. QC lumbar spine phantom scans were performed daily and QC plots were
recorded daily for any evidence of systemic drift in the DXA.
3.5 Calculation of bone mineral density
Areal bone mineral density (g/cm2) was calculated by dividing DXA-determined BMC (g) by
the respective PA (cm2) for all sites.
Bone mineral apparent density (BMAD), an estimate of volumetric density, was established
for all sites by the formulae of Katzman et al. (69):
1.) TB BMAD =BMC/(BA2/height)
2.) LS BMAD =BMC/BA1.5
3.) FN BMAD =BMC/(BA2/1.5)
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Since Katzman et al. (69) used a Hologic QDR-1000, which set the ROI at the FN to be 1cm,
and the QDR-2000 used in this investigation set the ROI at 1.5cm, the FN equation was modified
to reflect this (corrected formula as shown above).
Statistically-adjusted BMD (sBMD) was calculated according to Prentice et al. (67). All sites
were calculated in the same manner. BMC and PA from the complete longitudinal sample were
first converted to their natural logarithms to obtain a more linear relationship between the variables,
following which univariate linear regression analyses of BMC on PA was completed. The resulting
regression coefficient (lambda) between the two variables is used as an adjustment of the aBMD
equation in the following manner:
4.) sBMD =BMC/BAlambda
According to Prentice et al. (67) this equation is sensitive to the site of investigation, the
population group investigated, and can account for all of the variance between the two variables.
For normal aBMD the allometric equation is aBMD =k x BA. For the statistically-corrected BMD
the allometric equation is sBMD =k X BAlambda. Gender-specific values for lambda for each site, as
generated from the SPBMAS data, are reported in Table 4.11. in the Results section.
3.6 Development of mixed-longitudinal distance curves
All variables (PA, BMC, BMD, BMAD, sBMD) for each individual, along with their respective
age (both chronological and PHV-aligned age) were entered into a program that performed a
cubic spline regression (GraphPad Prism 2.0, San Diego, CA, USA). The cubic spline program
provided exact decimal year values of each variable for the particular individual. All values for
each decimal year were averaged for each variable and distance growth curves were created for
time points --4 through 4 yrs. PHV (10 through 18 yrs. of age). Since this was a mixed-
longitudinal design, not all individuals were represented in each data cell.
3.7 Development of longitudinal velocity curves
A set of longitudinally developed normal curves was established for each of the following
variables for both chronological and PHV-aligned age: BMC, PA, aBMD. BMAD, and sBMD.
Each individual had their respective age and each of the bone variables entered into a program
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that performed a cubic spline regression (GraphPad Prism 2.0, San Diego, CA, USA). The cubic
spline program was programmed to provide exact decimal year values of each variable for the
particular individual. Each of these curves was developed from only those individuals who had all
bone mineral values from -2 to 2 yrs. (11 to 14 Yrs. in the females; 12 to 15 yrs. in the males), with
the exception of the LS where limited data only allowed for curves from -2 to 1 yrs. PHV in the
males and -1 to 2 yrs. PHV in the females. These time periods were selected as they represented
the points at which enough data was available for analyses.
3.7.1 Using normal velocity curves as predictive curves for estimating missing
velocity data
As this investigation involved mixed-longitudinal data, full growth information was .not
available for all SUbjects; as a consequence of this some subjects did not have their full spectrum
of growth represented in the dataset (individuals that did not have a value for -2 years PHV to 2
years PHV or for ages 11 or 15 yrs.; the longitudinal velocity analyses required subjects with at
least that span of growth data). For those subjects that were short a year of growth to satisfy the
analyses requirements, a normal growth curve, based on the results of the subjects with complete
growth data, was used to estimate their growth velocity for the missing data point. Those subjects
with greater than one year of missing data were excluded from further velocity analyses.
Predictions were calculated by simple algebraic solution in the following manner (BMC as an
example):
BMC (-1 PHV) =
BMC (-1 PHV normal curve)
X BMC (-2 PHV)
BMC (-2 PHV normal curve)
solving for X =BMC (-1 PHV) * BMC (-2 PHV normal curve)
BMC (-1 PHV normal curve)
This technique assumes that the missing value generated from the normal growth curve is not
significantly different from that which would have occurred should observation permitted; it
assumes that the missing value is typical of that observed in the cohort.
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3.8 Establishing size dependence of density measures
Two methods were utilized to determine the dependency of aBMD on size measures. First,
since aBMD has been found to be highly dependent on PA, the correlation between these two
variables is typically high, exemplifying the dependence of aBMD on bone size. As size-
independence is obtained, the resulting correlation between the density measure and the PA
should be insignificant. Correlation analyses was used to discern the relatedness of the aBMD
measures with PA, body mass- and body height and the relationship between the corrected
measures and PA, body mass and body height.
A further measure of the appropriateness of the aBMD measure can be established from the
sBMD procedure. The theoretical underpinnings of aBMD assume that BMC and PA remain in
direct proportion to one another throughout the size spectrum. If the resulting lamda from the
regression of BMC on PA was significantly different from unity, aBMD assumed an inaccurate
measure of true density at the particular site as BMC and PA change in different proportions from
one another, negating the assumption of direct proportionality. However, if lambda was not
significantly different from one, then aBMD was considered a valid measure of density at the
particular site.
3.9 Male and female comparisons of bone mineral
PA, BMC, aBMD, BMAD distance and velocity values were compared between males and
females at all sites for PHV-aligned age. Since sBMD was developed from different equations for
both the male and females, no gender comparisons were completed.
3.10 Statistical Procedures
For all statistical procedures alpha was set at p<0.05. Analyses were completed utilizing
SPSS for Windows Version 10.05. The statistical procedures used to answer each of the research
questions (where statistical analyses were appropriate) are delineated below.
Size dependence of aBMD, BMAD and sBMD was established at each site by performing
bivariate correlations (Pearson's Product Moment correlations - two-tailed) between each of the
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density variables and PA, stature and body mass. Higher correlations indicated a higher
dependence of the density measure on PA, stature or body mass. Statistical independence of
density from PA, stature or body mass was achieved when bivariate correlations were insignificant.
The appropriateness of aBMD as a measure of density was determined by the regression of
BMC on PA at each site. If the resulting regression coefficient was significantly different from one,
as established by the Wald's test, aBMD was considered an invalid predictor of true bone density
at that particular site.
A general linear multivariate model (gender x age) ANOVA was completed for all distance
variables. Differences between males and females for any measure were established by the
presence of a significant main effect for gender and associations with age determined by a
significant main effect for age. If a significant interaction (gender x age) was found, post hoc
comparisons were performed between males and females for each age group to delineate
where significant differences occurred.
Observations as to whether the velocity was negative or positive were performed without
any formal statistical procedures. In addition, a repeated-measures ANOVA (gender x age) was
performed for each variable at each site. A significant effect of age was determined through a
main effect for age, and a significant effect for gender was determined through a main effect for
gender. If a significant interaction (gender x age) was found, post hoc comparisons were
performed between males and females for each age group to delineate where significant
differences occurred.
No statistical analyses were made between genders for sBMD as different equations were
used for the estimate of sBMD.
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4 Results
Only PHV-aligned data are presented and discussed in the formal body of this investigation.
Chronological based data can be found in Appendix B (Tables 9.1-9.21 and Figures 9.1-9.9).
4.1 Subject Characteristics
4.1.1 Mixed-longitudinal sample: distance curves
Data from 70 males and 67 females were used to construct a series of mixed-longitudinal
growth curves, from which all distance measures were obtained. These subjects were selected
from the greater PBMAS study pool solely based on adequate statural data to determine PHV.
Due to the nature of mixed-longitudinal data all subjects were not represented at each age;
rather, subjects possessed datapoints that spanned a limited portion of the entire age ranges.
Chronological-based data was available from 10 through 18 years of age and PHV-based data
was available from -3 through 5 years relative to PHV. Table 4.1. provides the sample size for
each time point for the TB and FN (both chronological and phv-based).
Table 4.1. Mixed-Longitudinal/Distance Curve Sample Sizes at Each Investigated Age:
Total Body and Femoral Neck (Male and Female).
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Since LS data was not collected in the initial year of the SPBMAS there are consequently
fewer measurements available at the LS and therefore less data, as reflected in the sample size
(Table 4.2.).
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Table 4.2. Mixed-Longitudinal/Distance Curve Sample Sizes at Each Investigated Age:
Lumbar Spine (Male and Female).
Chronological A e
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4.1.2 Longitudinal sample: velocity curves
In the lon,gitudinal dataset, each individual was represented at each investigated age.
Table 4.3. presents the sample size at each age (both chronological and phv-based), for the TB
and FN.
Table 4.3. LongitudinalNelocity Curve Sample Sizes at Each Investigated Age: Total
Body and Femoral Neck (Male and Female).
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Since LS data was not collected in the initial year of the SPBMAS there are consequently
fewer measurements available at the LS and therefore less data, as reflected in the sample size
(Table 4.4.).
Table 4.4. LongitudinalNelocity Curve Sample Sizes at Each Investigated Age: Lumbar
Spine (Male and Female).
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4.2 Dependence ofaBMD on body height, body mass, and PA (H1)
4.2.1 aBMD correlations with body height, body mass and bone projected area
PHV-aligned bivariate Pearson product moment correlations between aBMD and body
height, body mass, and PA for males and females for all sites can be found in Tables 4.5-4.10.
Table 4.5. PHV-Aligned Correlations of Total Body BMD, BMAD and sBMD with Age,
Bone Projected Area, Body Mass, and Stature (Males).
Table 4.6. PHV-Aligned Correlations of Total Body BMD, BMAD and sBMD with Age,
Bone Projected Area, Body Mass, and Stature (Females).
Table 4.7. PHV-Aligned Correlations of Femoral Neck BMD, BMAD and sBMD with Age,
Bone Projected Area, Body Mass, and Stature (Males).
Table 4.8. PHV-Aligned Correlations of Femoral Neck BMD, BMAD and sBMD with Age,
Bone Projected Area, Body Mass, and Stature (Females).
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Table 4.9. PHV-Aligned Correlations of Lumbar Spine BMD, BMAD and sBMD with Age,
Bone Projected Area, Body Mass, and Stature (Males).
Table 4.10. PHV-Aligned Correlations of Lumbar Spine BMD, BMAD and sBMD with Age,
Bone Projected Area, Body Mass, and Stature (Females).
At all sites aBMD was significantly (p<0.001) associated with bone projected area, body
mass, and body height (Tables 4.5-4.10.). Further, PHV-aligned age was significantly (p<0.001)
associated with aBMD at all three sites.
4.2.2 Regression coefficients of PA regressed on BMC (H1 2)
Table 4.11. presents the linear regression coefficients from the regression of InBA on
InBMC. All of the regression coefficients were significantly different from unity.
Table 4.11. PHV-Aligned Linear Regression Coefficients (Lambda values) after the
Regression of InBA on InBMC at the TB, FN and LS (Male and Female).
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4.3 Independence of corrected bone mineral density measures (BMAD and sBMD)
from body height, body mass or bone projected area (H2)
4.3.1 BMAD correlations with body height, body mass and bone projected area
PHV-aligned bivariate Pearson product moment correlations and significance levels
between BMAD and body height, body mass, and PA for males and females for all sites can be
found in Tables 4.5-4.10.
At the TB and LS there were significant negative (p<0.001) correlations between BMAD and
age, PA, body height and body mass for both genders. At the FN the males had significant
correlations with BMAD in only PA and height, while the females had significant associations
between BMAD and all four measures.
4.3.2 sBMD correlations with body height, body mass and bone projected area
PHV-aligned bivariate Pearson product moment correlations and significance levels
between SBMD and body height, body mass, and PA for males and females for all sites can be
found in Tables 4.5-4.10.
At the TB only age in females was significantly (p<0.001) correlated with sBMD. At the FN
sBMD was significantly (p<0.001) correlated with all measures except PA in both genders.
Lastly, at the LS, sBMD was only significantly (p<0.001) correlated with age and body weight in
both genders.
.
4.4 Bone mineral density through adolescence (mixed-longitudinal growth curves -
distance) (H3 and H4)
PHV-based age group averages ± SEM for all PA, BMC, aBMD, BMAD and sBMD distance
curves are reported in Appendix C in Tables 10.1-10.6.
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4.4.1 PHV-aligned PA through adolescence
Growth curves for PA at the TB, FN and LS are found in Figure 4.1. As shown in Figure
4.1a., male TB PA increased with age, with acceleration in the year preceding and the two years
following PHV. PA for females increased linearly from -3 through 2 years PHV, with a slowing
thereafter. There was a significant (p<O.001) main effect for maturational age. While the PHV-
aligned pattern of PA change was similar between genders, males had significantly greater PA
at all ages as supported by the significant (p<O.001) main effect for gender.
As shown in Figure 4.1. b., FN PA increased in males from -3 through -1 years PHV, with
rapid expansion between -1 and 1 years PHV, and dramatic slowing of expansion from 1
through 4 years PHV. In females, PA increased from -4 through 2 years PHV, after which PA
decreased from 2 through 4 years PHV. There was a significant (p<O.001) main effect for
maturational age. At -3 yrs. PHV male and female PA was equal, however after this point males
had greater rates of expansion leading to significantly greater PA after -2 yrs. PHV, as
evidenced by the significant (p<O.001) main effect for gender and interaction between gender
and maturational age.
As seen in Figure 4.1c., males' LS PA followed a sigmoidal pattern with increases
throughout the age range and acceleration between -1 and 2 years PHV. In females, PA
increases were relatively linear from -3 through 3 years PHV, after which PA stabilized. There
was a significant (p<O.001) main effect for maturational age. LS PA was similar between the
genders, however males possessed a significantly higher PA at most ages investigated, with a
significant (p<O.001) main effect for gender.
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Figure 4.1. Male and female PHV-aligned growth curves for bone projected area
(mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
* denotes significant differences between genders at a specific maturational age in the
instance where a significant age x gender interaction is present.
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4.4.2 PHV-aligned BMC through adolescence
Results for BMC at the TB, FN and LS are found in Figure 4.2. As shown in Figure 4.2a.
TB BMC accrual in males mirrored the changes in BA. Female TB BMC accrual increased
throughout the age range, with acceleration between -1 and 2 years PHV. There was a
significant (p<O.001) main effect for age. BMC accrual was similar between genders, however
males had significantly greater BMC at all ages investigated; there was a significant (p<O.001)
main effect for gender.
FN BMC in males followed a sigmoidal pattern, as shown in Figure 4.2b., with increases
throughout the growth period and a period of acceleration between -1 and 1 year PHV. BMC
females increased from -3 through -1 years PHV, accelerating through -1 to 3 years PHV, then
stabilizing. There was a significant (p<O.001) main effect for maturational age. Bone mineral
was higher in males at all time points, as is evidenced by the significant (p<O.001) main effect for
gender.
As seen in Figure 4.2c., LS BMC accrual in males mirrored PA with increases throughout
the age range with acceleration between -1 and 2 years PHV. BMC increased in females
throughout the age range until 3 years PHV, with acceleration between 0 and 3 years PHV, after
which BMC plateaued. There was a significant (p<O.001) main effect for maturational age. The
pattern of accrual was similar between the genders, however, males possessed significantly
greater BMC at all ages, as evidenced from a significant (p<O.001) main effect for gender and an
insignificant interaction between gender and maturational age.
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Figure 4.2. Male and female PHV-aligned growth curves for bone mineral content
(mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
* denotes significant differences between genders at a specific maturational age in the
instance where a significant age x gender interaction is present.
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4.4.3 PHV-aligned aBMD through adolescence (H31 and H41)
Results for aBMD at TB, FN and LS are found in Figure 4.3. As shown in Figure 4.3a.,
male and female TB aBMD increased with age, with a period of rapid density increases from -1
through 2 years PHV. There was a significant (p<O.001) main effect for age. Males had
significantly greater aBMD values at all ages; a significant (p<O.001) main effect was found for
gender, with no significant interaction between gender and age.
In males and females, FN aBMD mirrored the gains made in BMC, as shown in Figure 4.3b.
A significant (p<O.001) main effect for maturational age was observed. Males possessed
significantly higher aBMD at all ages, as evidenced by the significant (p<O.001) main effect for
gender and no significant interaction between gender and maturational age.
As seen in Figure 4.3c. LS aBMD in males increased in a sigmoid fashion similar to both
PA and BMC. Female aBMD increased linearly from -3 through 0 years PHV, after which there
was an increase in aBMD between 0 and 2 years PHV, with slowing thereafter. There was a
significant (p<O.001) main effect for maturational age. LS aBMD was identical between genders
when aligned on PHV, as evidenced by a lack of significant main .effect for gender or interaction
between gender and maturational age.
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(mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
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4.4.4 PHV-aligned BMAD through adolescence (H32 and H42)
Results for BMAD at TB, FN and LS are found in Figure 4.4. As shown in Figure 4.4a., TB
BMAD in both males and females decreased from -3 through 0 years PHV, with a plateau
thereafter. There was a significant (p<O.001) main effect for maturational age. Females had
significantly greater TB BMAD at all ages as evidenced by a significant (p<O.001) main effect for
gender with no interaction between gender and maturational age.
As shown in Figure 4.4b., FN BMAD in males decreased until PHV and then rebounded
with increases until the end of the investigated age period. In females, FN BMAD was relatively
stable to PHV, after which there was a consistent increase. There was a significant (p<O.001)
main effect for maturational age. Male FN BMAD was significantly greater than female BMAD
from -3 years PHV until -1 years PHV after which it was equal; there was no significant main
effect for gender, but there was a significant (p<O.01) interaction between maturational age and
gender.
In males, LS BMAD was stable from -3 through -1 years PHV, after which it increased until
3 years PHV, and then slowed until the end of the investigated age range, as seen in Figure
4.4c. BMAD in females constantly increased with rapid acceleration from 0 to 2 years PHV.
There was a significant (p<O.001) main effect for maturational age. Female LS BMAD was
greater at all ages as evidenced by a significant (p<O.001) main effect for gender and no
significant interaction effect.
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Figure 4.4. Male and female PHV-aligned growth curves for bone mineral apparent
density (mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
* denotes significant differences between genders at a specific maturational age in' the
instance where a significant age x gender interaction is present.
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4.4.5 PHV-aligned sBMD through adolescence (H33 and H42)
Results for sBMD at TB, FN and LS can be found in Figure 4.5. Male and female TB sBMD
decreased from -3 through 0 years PHV, after which there was a deflection and an increase
thereafter, as seen in Figures 4.5a. and 4.5b., respectively. When aligned on PHV males and
females displayed identical patterns of sBMD over the age span. There was a definitive pattern
of diminishing bone until PHV, with a subsequent increase in sBMD.
As shown in Figure 4.5c. FN sBMD in males remained stable from -3 through 0 years PHV,
after which there was a linear increase in density until the end of the investigated age range.
Similarly, in females, sBMD increased minimally from -3 through -1 years, with a linear increase
in density thereafter, as shown in Figure 4.5d.
As shown in Figure 4.5e. LS sBMD in males decreased until PHV, increasing linearly
thereafter. In females, sBMD decreased slightly from -3 though 0 years PHV, and then
rebounded with rapid increases in sBMD thereafter, as seen in Figure 4.5f.
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Figure 4.5. PHV-aligned growth curves for statistically-corrected bone mineral density
(mean±SEM) of the a. Male total body; b. Female total body; c. Male femoral neck; and d.
Female femoral neck. Figure 4.5. continued on following page.
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4.5 Velocity of bone mineral density through adolescence (longitudinal growth curves
- ve/ocity)(H5)
PHV-based age group averages ± SEM for all PA, BMC, aBMD, BMAD and sBMD velocity
curves are reported in Appendix C in Tables 10.7-10.15.
4.5.1 PHV-aligned PA velocity through adolescence
All PA velocity measures for the TB, FN, and LS can be found in Figure 4.6. As shown in
Figure 4.6a., TB PA in males and females accelerated from -2 to 0 years PHV, followed by a
deceleration to 2 years PHV. There was a significant (p<O.001) main effect for maturational age.
When aligned on PHV, males and females had similar PA velocity curves, at nearly id~ntical
developmental ages, with the only difference being that the males had a significantly greater
magnitude velocity of expansion compared to the females at all ages. There was a significant
(p<0.01) main effect gender, with no significant interaction between gender and maturational
age (Figure 4.6a.).
As shown in Figure 4.6b, FN PA in males and females accelerated to PHV after which it
decelerated for the remainder of the time span. There was a significant (p<O.001) main effect
maturational age. When aligned on PHV, PA velocity was significantly greater in males at all
ages with the exception of 2 years PHV. There was a significant (p<O.001) main effect for
gender, as was a significant (p<O.001) interaction between gender and maturational age.
In males, LS PA accelerated to PHV, after which there was a deceleration, as seen in
Figure 10c. PA in females accelerated from -1 to 0 PHV after which there was a deceleration to
2 years PHV. There was a significant (p<0.001) main effect for maturational age. Males
possessed a significantly greater PA velocity only pt PHV. There was significant (p<O.001) main
effect for gender, and a significant (p<O.05) interaction between age and maturational age.
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Figure 4.6. Male and female PHV-aligned velocity curves for bone projected area
(mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
* denotes significant differences between genders at a specific maturational age in the
instance where a significant age x gender interaction is present.
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4.5.2 PHV-aligned BMC velocity through adolescence
All BMC velocity measures for the TB, FN, and LS are found in Figure 4.7. As shown in
Figure 4.7a., TB BMC in males and females accelerated from -2 to 1 year PHV, with a slowing
thereafter. There was a significant (p<O.001) main effect for maturational age. Males had
significantly greater BMC accrual velocities over the entire age range. There was a significant
(p<0.001) main effect for gender.
As shown in Figure 4.7b., in males and female FN BMC gains accelerated to PHV and
decelerated to 2 years PHV. There was a significant (p<0.001) main effect for maturational age.
The curves for BMC accrual at the FN were the same in shape for males and females, however
males possessed significantly greater BMC accrual velocities at all ages except for 2 years PHV.
There was a significant (p<0.001) main effect for gender, with a significant (p<O.001) interaction
between gender and maturational age.
As shown in Figure 4.7c., LS BMC in males accelerated from -2 to 0 years PHV and began
to slow thereafter. In females BMC accelerated from -1 to 1, after which it decelerated. There
was a significant (p<O.001) main effect for maturational age. BMC accrual velocity was
significantly greater at PHV and 1 year after PHV in the males. There was a significant
(p<0.001) main effect for gender, and a significant (p<0.01) interaction between gender and
maturational age.
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Figure 4.7. Male and female PHV-aligned velocity curves for bone mineral content
(mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
* denotes significant differences between genders at a specific maturational age in the
instance where a significant age x gender interaction is present.
101
4.5.3 PHV-aligned aBMD velocity through adolescence (H51)
All aBMD velocity measures for the TB, FN, and LS can be found in Figure 4.8. As shown
in Figure 4.8a., gains in male TB aBMD accelerated to 1 year PHV, with a deceleration
thereafter. For females, aBMD increased in the same manner as BMC. There was a significant
(p<0.001) main effect for maturational age. aBMD velocity curves were identical shape between
males and females, with the peaks occurring at identical developmental ages and with males
having significantly greater magnitude velocity at all ages; there was a significant (p<0.001) main
effect for gender, with no significant interaction between gender and maturational age.
As shown in Figure 4.8b., FN aBMD in males mirrored the gains made in BMC. Areal BMD
acceleration in females was steady between -2 and -1 year PHV, after which a rapid
acceleration occurred until 1 years PHV, and a deceleration thereafter. There was a significant
(p<0.001) main effect for maturational age. Areal BMD curves between the males and females
were of a similar shape and magnitude, however, the females possessed significantly greater
aBMD velocity at -2 years PHV, and the males significantly greater at PHV. There was no
significant main effect for gender, but a significant (p<0.01) interaction term for gender and
maturational age.
In males, LS aBMD increased from -1 to 0 years PHV, and a continued high rate of aBMD
increases thereafter, as shown in Figure 4.8c. LS aBMD velocity in females remained relatively
stable from -1 to 0 years PHV, with a dramatic acceleration to 1 year PHV, and a deceleration to
2 years PHV. There was a significant (p<0.001) main effect for maturational age. LS aBMD
velocity was practically identical at all time points for males and females, with males reaching
their peak slightly earlier than the females; there was no significant main effect for gender, nor
was there one for interaction between maturational age and gender.
102
a. Total Body
p<O.001
p<O.001
p=O.26
Main effect maturational age:
0.09 Main effect gender:
Interaction gender x
0.08 maturational age:
0.10
0.02
. Boys aBMD
0.01 ... Girls aBMD
0.00
-3 -2 -1 0 1 2 3
Years from Peak Height Velocity
c. Lumbar Spine
0.12 Main effect maturational age: p<O.OO1
Main effect gender: p=O.88
0.11 Interaction gender x
maturational age: p=O.36
0.10
~ 0.09
N E
-e, 0.08
>. 0.07:i:t
(J
0Q) 0.06
>
C 0.05::!iE
m
co
. Boys aBMD0.04
... Girls aBMD
0.03
0.02
0.01
-3 -2 -1 0 1 2 3
Years from Peak Height Velocity
N~ 0.07
(J
~ 0.06 f
.a-
'0 0.05 f.QQ)
> 0.04C
::!iE
m 0.03co
Figure 4.8. Male and female PHV-aligned velocity curves for areal bone mineral density
(mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
* denotes significant differences between genders at a specific maturational age in the
instance where a significant age x gender interaction is present.
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4.5.4 PHV-aligned BMAD velocity through adolescence (H52)
All BMAD velocity measures for the TB, FN, and LS can be found in Figure 4.9. As shown
in Figure 4.9a., TB BMAD in males was mostly negative, but accelerating from -2 years PHV to a
positive velocity at 1 year PHV, decelerating thereafter. TB BMAD velocity in females was
negative through the whole age range with the exception of the last year; however, a consistent
acceleration was observed throughout the age range. There was a significant main effect
(p<0.001) for maturational age. The males has significantly greater TB BMAD velocity as
compared to the females at all ages. There was a significant (p<0.01) main effect for gender,
but no significant interaction between gender and maturational age.
As shown in Figure 4.9b., FN BMAD in males constantly accelerated throughout the age
span, with positive velocity values being reached by 0 years PHV and thereafter. In females,
BMAD accelerated rapidly to 0 years PHV after which there was a stabilization of velocity until
the end of the investigated age span. There was a significant (p<0.05) main effect for
maturational age. Initially, BMAD velocity for females was negative, but by -1 year PHV
became a positive velocity. There was a insignificant trend for BMAD velocity to be greater in the
females from -1 PHV years onward. No significant main effect was observed for gender or
interactions between maturational age and gender.
As shown in Figure 4.9c., LS BMAD velocity in males was stable from -2 to -1, but rapidly
accelerated in the period from -1 to 0 years PHV, with a stabilization of the velocity thereafter.
In females BMAD accelerated linearly from -1 to 1 year PHV, after which there was
deceleration. There was a significant (p<O.001) main effect for maturational age. BMAD velocity
was identical for males and females at all time points. There was no significant main effect for
gender, nor was there a significant interaction between gender and maturational age.
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Figure 4.9. Male and female PHV-aligned velocity curves for bone mineral apparent
density (mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
* denotes significant differences between genders at a specific maturational age in the
instance where a significant age x gender interaction is present.
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4.5.5 PHV-aligned sBMD velocity through adolescence (H53 )
All sBMD velocity measures for the TB, FN, and LS can be found in Figure 4.10. As shown
in Figure 4.10a., male sBMD velocity was negative until PHV, with a consistent acceleration
throughout the age span. Females had a linear acceleration in TB sBMD from -2 to 1 year PHV,
with a stabilization thereafter, as shown in Figure 4.1 Ob.
As shown in Figure 4.1 Oc., FN sBMD in males was stable through -2 to -1 years PHV, with
a rapid acceleration to 0 years PH and minimal deceleration thereafter. In females, sBMD
decelerated from -2 to -1 years PHV, rebounded to PHV and remained stable until the end of
age range, as seen in Figure 4.1 Od.
As shown in Figure 4.1 Oe., LS sBMD velocity for males was relatively stable until -1 year
PHV after which rapid acceleration continued until 1 year PHV, the end of the measurement
period. In females sBMD was stable from -1 to 0 years PHV, with acceleration and deceleration
observed in the following two years, respectively, as seen in Figure 4.1 Of.
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Figure 4.10. PHV-aligned velocity curves for statistically-corrected bone mineral density
(mean±SEM) of the a. Male total body; b. Female total body; c. Male femoral neck; and d.
Female femoral neck regions. Figure 4.10. continued on following page.
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Figure 4.10. continued. PHV-aligned velocity curves for statistically-corrected bone mineral
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4.6 The dissociation between PA and BMC velocity curves (H6)
As shown in Figure 4.11 a., when males are aligned on PHV, TB PA velocity peaked at
0.22 years PHV with the peak BMC velocity occurring 0.49 years later at 0.71 years PHV. Peak
PA velocity occurred at 0.40 years PHV in the females, as shown in Figure 4.11 b., with the peak
BMC at 0.81 years, resulting in a dissociation of 0.41 years.
As shown in Figure 4.11 c., peak FN PA velocity occurred at 0.048 years in males while
the peak BMC velocity occurred at 0.258 years, a dissociation of 0.21 years. As shown in Figure
4.11d., the peak FN PA velocity in the females occurred at -0.32 years and the peak BMC
velocity at 0.29, a dissociation of 0.61 years.
In males, LS PA velocity peaked at 0.13 years PHV, as shown in Figure 4.11e., and BMC
peaked at 0.40 years PHV, a dissociation of 0.27 years. As shown in Figure 4.11f., the peak LS
PA velocity in the females occurred at 0.37 years PHV while the peak BMC velocity age was
0.86 years PHV, a dissociation of 0.49 years.
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Figure 4.11. PHV-aligned velocity curves displaying the dissociation between bone
projected area and bone mineral content (mean±SEM) for a. Male total body; b. Female
total body; c. Male femoral neck; d. Female femoral neck; e. Male lumbar spine; and f.
Female lumbar spine.
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5 Discussion
The discussion is organized around the hypotheses. For each hypothesis, each
respective sub-hypothesis is first addressed as it compares to the findings of prior investigations,
if applicable. After each subhypothesis has been addressed, disc~ssion of the overall
hypothesis with emphasis on underlying physiological mechanisms is offered, where
appropriate. At the conclusion of the hypotheses discussion, a brief summary of the findings is
presented.
5.1 General
During childhood and adolescence three irrefutable phenomena occur in regards to the
growth of bone in healthy children: 1.) There is an increase in the cortical thickness of the bones
through both periosteal expansion and endosteal apposition (131), 2.) There is an increase in
the length of the bone through growth at the epiphyseal growth plates until epiphyseal closure
(62), and 3.) As a consequence of the increased cortical thickness and length of the bones,
there is a cor.responding increase in bone mineral (BMC) (59;61; 152). While the BMC in a given
region of bone and for the entire skeleton can be accurately estimated by DXA (96), it is
infrequently reported in the literature owing to its dependence on bone size (67;97; 101). BMC or
bone size alone cannot adequately describe the qualitative changes in bone that occur with
growth. PA and BMC are both measures of bone quantity. The most commonly practiced
method of describing the qualitative characteristics of bone is bone mineral density, and typically
an areal density. Bone density measures attempt to use data from both bone mass and bone
size to estimate bone quality. The actual material density within bone, between bones within an
individual, and between individuals, varies at anyone time and over time (84). Areal density is
only an estimate of the average density of a defined region, and includes both osseus and
nonosseus materials.
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Little is known regarding the true pattern of bone density changes during growth. This
void in knowledge is due to a lack of longitudinal investigations that have corrected for
differences in maturity status, and partially to DXA-based misrepresentation of true vOlumetric
BMD changes. In the pediatric bone literature, aBMD is most frequently reported since it is
hypothesized to at least partially correct for volume differences. Although there is a partial
correction for size, the adequacy of size-correction with aBMD is hard to discern, and largely
inadequate (67-69;101). Thus, it is difficult to establish true BMD patterns during growth with
DXA-based aBMD measures as concomitant changes in bone size are observed throughout
growth cloUding the changes in true BMD.
As demonstrated in the literature review, several studies showed aBMD to be flawed in
that it is consistently significantly dependent on bone size (67-69), and the high correlation of
aBMD with PA, body height and body mass was further confirmed by the results in this
investigation. Based on these findings the use of DXA-based aBMD should be discontinued in
the pediatric population as it likely does not accurately reflect the true change in BMD occurring
within the growing child.
When corrected for bone size the rapid increases in aBMD typically observed in children
were either lost or at least attenuated, suggesting that the skeleton may not undergo a steady
increase in density during growth as has been suggested by a preponderance of investigations
that have utilized the size-dependent aBMD measures (55;61;133;150;152;155;178;216-218).
Conversely, in this investigation BMAD and sBMD results demonstrated that BMD does
not increase throughout growth, but rather that there are generally both periods of decreasing
density, as well as periods of increasing density, during growth. A frequent observation was that
of diminishing or stable BMAD or sBMD during rapid skeletal expansion, followed by a
subsequent increase in density of the bone as volume expansion slowed or arrested while bone
accrual persisted. The point at which there was a nadir (most frequently almost precisely at
PHV) in BMD could hypothetically represent the period of greatest skeletal fragility. This relative
fragility hypothesis is supported by epidemiologic investigations which report the highest fracture
rates during the period of PHV (189-195).
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5.2 aBMD is significantly influenced by the height of the subject, the mass of the
subject and the bone projected area of the respective site (H1)
5.2.1 Height, weight and bone projected area will be significantly positively
correlated with areal BMD at all sites (H1 1)
True measures of density are independent from the physical space in which the material is
found; much as the density of water at a constant temperature does not change whether it is in a
thimble or a 45-gallon drum. Ideally, in the measurement of BMD the measure should be
relatively independent from measures of BA; that is, when there is a significant association
between measures of density and size then a confounding relationship exists and the estimate
of density is flawed. Only when a size-independent measure of volumetric bone density can be
performed in vivo can accurate representations of the actual bone accrual patterns over the
lifespan be determined.
In this investigation aBMD measures at all sites were significantly (p<O.001) positively
associated with measures of PA, stature and body mass, confirming the subhypothesis that
height, weight and bone projected area are significantly positively correlated with aBMD at all
sites. This consistent significant association confirms the dependence of the DXA-derived
aBMD measures to size measures, particularly PA, which lends support to those techniques
such as BMAD and sBMD that attempt to minimize the relationship between aBMD and BA.
Numerous other investigations have similarly found significant associations between aBMD
and PA (67;127;128). In a mixed-gender sample of young children (mean = 12.9 yrs), Warner et
al. (128) found that aBMD was a poor expression of density as it failed to remove the significant
(p<O.001) association with PA (r=O.81 between LS aBMD and PA and r=O.91 at the TB).
Prentice et al. (67) also found significant (p<O.02 - p<O.001) correlations between aBMD and PA
in a cohort of healthy British men and women (TB, men r=O.56 and women r=O.22; LS, men
r=O.65 and women r=O.28).
The results of this significant association with size are that larger bones will appear to have
greater densities and smaller bones less, often regardless of their true densities. This finding is
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particularly problematic when applied to the pediatric population where rapid growth and
dramatic size differences between similarly aged children is common.
5.2.2 All regression coefficients of PA regressed upon BMC will be significantly
different than unity at all measurement sites (H1 2)
DXA-derived aBMD assumes that both PA (a surrogate of volume) and BMC increase
proportionally. If this relationship is valid then the regression of the natural logarithms of PA on
BMC should result in a regression coefficient not significantly different from unity. If, however,
the relationship is significantly different from unity then a better equation for the estimation of
density should be introduced with the PA adjusted to reflect the proportionality delineated by the
regression equation.
As at all sites regression coefficients were significantly different from unity; thus, the
assumption that PA and BMC increase proportionally and the subhypothesis that all regression
coefficients of PA regressed upon BMC would be significantly different than unity at all
measurement sites, was supported.
The only other non-clinical investigations to perform similar regressions found analogous
effects. In a study by Warner et al (128) power coefficients were similarly generated for a group
of children and adolescents from the age of 6 to 17 years and all were found to be significantly
different from 1 (p<O.01). The power coefficients were found to be 1.39 TB, 1.63 FN and 1.66
LS. These regression coefficients were similar to the coefficients found in my investigation:
male/female (TB 1.446/1.432, FN 1.591/1.866, and LS 1.807/1.953). Molgaard et al. (126)
regressed TB PA on BMC and found a regression coefficient of 1.43 for the females and 1.37 for
the males in a cohort aged 5 to 19 yrs. These coefficients also were similar to the regression
coefficients found in this investigation and further strengthen the argument to abandon the use of
aBMD in the pediatric population, where changes in PA over growth and between individuals of
similar chronological age are virtually inevitable.
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5.2.3 Hypothesis 1 Conclusion
In this investigation both of the subhypotheses that aBMD is significantly affected by size
measures were supported. These findings suggest the dependency of DXA-derived aBMD on
size measures, particularly PA, and implore that the use of DXA-derived aBMD be limited in
ped iatrics.
Based on these findings the preponderance of pediatric literature describing changes in
aBMD is most likely inaccurate due to aBMDs high dependency on bone size. Only when
individuals are matched for PA could aBMD be used as a comparator. However, matching
individuals prospectively by PA is impractical and exceedingly difficult.
The assumption that bone mineral density increases steadily with age through childhood
and adolescence is most likely an error of DXA measurement related to its dependency on bone
size. While there is a consistent increase in aBMD with growth, as observed in this
investigation, there is a concomitant increase in PA as well, making it impossible to determine
whether the increase in aBMD is due to a true increase in density, a size-related measurement
artifact, or a combination of both. The size-corrected measures give a better representation of
the actual density changes with growth.
5.3 aBMD corrected for bone size will not be significantly influenced by the height of
the subject, the mass of the subject and the bone projected area of the respective
site (H2)
5.3.1 Height, weight and bone projected area will not be significantly correlated
with BMAD at any site (H21)
When aBMD was estimated for bone volume by the use of static geometric equations
(BMAD), there was a significant decline in the variance accounted for by PA, body height and
body mass; however the associations did remain significant between the variables and BMAD.
BMAD removed some of the dependence of aBMD on bone size at the TB and LS (as compared
with the respective correlations of aBMD with size measures at a given site), however all the
size measures were still all significantly (p<O.001) correlated with BMAD. With the FN, the use
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of BMAD again decreased the dependence of aBMD on bone size; however BMAD was still
significantly correlated with PA and height in males, and mass and height in the females. At
both the TB and FN PA was, in most instances, significantly negatively associated with BMAD,
suggesting that as bone projected area increased, BMAD decreased. This may be interpreted
as the inability of the body to adequately supply adequate calcium for the rapid skeletal
expansion during adolescent growth (146). Perhaps as the bones increase in size the available
mineral is used simply for the minimum architectural needs with full mineralization occurring
sometime afterward when expansion has ceased and the body is able to supply the demands for
this increased density (44).
Interestingly, weight was significantly negatively correlated with TB BMAD in both
genders. This is the opposite to what would be expected based on the laws of mechanical
loading and bone mineralization in that greater loads lead to localized greater mineralization
(110;219-221). Possible explanations include that the TB site is 80% cortical in nature and not
as responsive to loading as the LS site, or that generally too much of the skeleton is unloaded
for vast proportions of the modern day to see a positive response of the whole skeleton to brief,
localized loading. Similarly, the association between weight and BMAD at the FN in males was
not significant. The FN is another more highly cortical region as compared to the LS. In the
investigation by Katzman et at. (69) similar findings were reported for the TB and FN sites with
correction by BMAD resulting in the loss of significant association between the BMAD and mass,
while the significant association between mass and BMAD was retained at the LS. These
observations suggest that this adjustment may not be appropriate for the TB in either gender or
the FN in males. However, there may also be an alternative hypothesis where the largely
cortical nature of the TB and FN sites are simply less responsive to loading from the total body
mass as compared to the more metabolically active, primarily trabecular, LS.
The associations between BMAD and bone size were negative at the TB and FN, implying
that smaller bones were denser. The epidemiological trials that hypothesize a period of
decreased density during rapid bone expansion support these findings in that the peak rates of
bone expansion and accrual differed by half a year on average. A smaller bone at the start of
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rapid expansion may be denser than a bone afterwards, as a lot of the mineral that was found in
the cortical shell may have been redistributed to allow for rapid expansion. It has been
hypothesized that there is a "borrowing" of calcium from the cortical shell to supply the rapid
growth regions with adequate calcium supplies (44). It has been postulated by Parfitt (44) that
the cortical shell exhibits increased porosity during the period of rapid growth which would both
decrease density as measured by DXA and lead to a decreased material strength within the
cortical shell. Since the FN and TB sites are primarily cortical and the LS primarily trabecular, it
is especially interesting to note that the only significant negative associations were observed in
the TB and the FN, not the LS, which supports the theory that there is a pattern of decreasing
cortical bone during growth with a relative maintenance of trabecular bone.
The results from this investigation were similar to the findings of Katzman et al. (69) in that
the strongest associations with PA, body mass and body height were with BMC, followed by
aBMD, and then BMAD. Similar to Kroger et al. (68) the results showed that when LS aBMD
was corrected for bone size, the strength of the association with size measures decreased, but
remained significant. Sir:nilarly, in the investigation by Lu et al. (187) after normalization for PA
the association between density and height and weight decreased, but remained significant at
the LS, but significant associations were lost at the FN with the exception for height in females.
Based on the mixed findings the subhypothesis that height, weight and bone projected
area would not be significantly correlated with BMAD at any site was not supported. The
correlations, however, were weaker than with aBMD in all instances suggesting that there was at
least a partial independence gained from size or mass measures.
5.3.2 Height, weight and bone projected area will not be significantly correlated
with statistically corrected BMD (sBMD) at any site (H22)
After correction of the data by the Prentice et al. procedure (67) the correlations between
PA and sBMD were non-significant at all sites (r=-O.008-0.061). These results support the
hypothesis that this equation was adequately accounting for PA in the assessment of density. At
the TB, the association between weight and sBMD was eliminated, while at the FN and LS it was
preserved (p<O.001). Numerous investigations have concluded that weight-bearing physical
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activity places mechanical stimuli on the loaded bones to increase their density and to organize
their trabecular infrastructure to accordingly resist the lines of strain to maintain mechanical
integrity (110;123;222;223). The total body may be too large an area to be sensitive to specific
mechanical loading. However, in the act of locomotion both the LS and the FN receive
significant osteogenic stimuli to regulate bone density, most likely independently of bone size.
One of the most consistent predictors of bone density is body mass, with higher masses leading
to higher stresses. Therefore, it may be logical to see the significant relationship remain intact
between weight and sBMD, even after the correction for bone size.
In the only other comparable investigation, Warner et al. (128) found that after statistical
correction sBMD was no longer significantly correlated with PA (r=0.02-0.03). Based on these
findings the sUbhypothesis that height, weight and bone projected area would not be significantly
correlated with sBMD at any site was supported in all instances except for body mass where LS
and FN sBMD were still significantly associated with mass. Theoretically, these corrected
measures of density can be hypothesized to be the most accurate estimate of the true patterns
of bone accrual during growth.
5.3.3 Hypothesis 2 Conclusion
In this investigation there was partial support for both subhypotheses. The use of BMAD
partially corrected for the effect of size; however, the relationships between BMAD and size and
mass measures remained significant in almost all instances, limiting its use in the pediatric
population. Further, the trend for negative relations between body mass and BMAD is puzzling
in light of the fundamental laws of mechanical adaptation in bone, apart from geometric or
architectural changes (Wolff's Law; Frost's Mechanostat). The use of sBMD consistently led to a
density measure that was independent from BA. This finding suggests that its use in correcting
for density in growing children may be very useful. There was a trend for the highest
correlations to be found with aBMD, then weaker with BMAD, and insignificant relations with
sBMD. Similar results were found with Katzman et al. (69) in their investigation, but with BMC,
aBMD, and BMAD.
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These findings further suggest that the previous research in growth and development that
has focused on aBMD as assessed by DXA is likely flawed in its dependence on bone size.
5.4 The age-related increase in aBMD in both genders is eliminated when corrected for
bone size (H3)
5.4.1 aBMD will increase significantly throughout the growth period at all sites in
both genders (H31)
This subhypothesis was supported in all of the sites investigated, in both males and
females, with aBMD displaying significant gains over age as evidenced by both a consistent
significant (p<O.001) main effect for maturational based age.
This investigation is unique in that maturation (through PHV) was controlled in the entire
cohort. The few previous investigations in bone growth that did report pubertal status attempted
to control for maturation by Tanner staging, which is more subjective and more imprecise than
maturation correction by PHV as used in this investigation. Tanner staging, while relatively valid,
is biased in both self- and investigator-based assessment and each one requires a degree of
subjectivity. Tanner staging is a qualitative assessment of a continuous process. The use of
self-assessment in Tanner staging is less accurate than investigator-assessed staging, however
it is less stressful to the child (224). Conversely, the use of Tanner staging by the investigator is
more accurate but is often stressful for adolescents at a time when their body image is
particularly sensitive. Further, a frequent finding in Tanner staging is that of differing Tanner
stages in a given individual, since generally an assessment of pubic hair development is
performed in both sexes, along with breast development in females and genital development in
males. Certainly, a child cannot be in two different stages of development during a precise
moment in time. While the use of Tanner staging is easier than determining PHV, it doesn't
easily allow for a comparison between genders and it only allows for very general categorization
of maturity status when compared to the precise estimates that can be deemed from the
estimation of PHV. Further, when assessing the maturity of the skeleton PHV would seem like a
logical choice to determine the tempo of growth in the skeleton since height is directly a product
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of skeletal growth. Tanner staging is a more appropriate measure of the endocrine status, which
does have an impact on skeletal growth, but probably is not as sensitive an indicator of skeletal
growth as height velocity (62). The use of PHV as a control for maturity has scarcely been used
as a consequence of the time needed to identify it; while Tanner staging can be done during a
single assessment, the determination of PHV can take years of diligent assessment during the
proper age span to ascertain, necessitating tremendous time and personnel commitments.
Tanner staging is most appropriate for cross-sectional investigations where the participant is
only observed once, and in longitudinal investigations Tanner staging can also be used, but PHV
would most likely be the preferred method as it is more precise and less subjective. A less used
method is that of radiographic bone age, but due to the necessity of x-ray exposure and the
labourious process of grading the many bones of the wrist region, it is infrequently used.
As is consistent from almost all investigations in the literature, aBMD increased with
maturation. Surprisingly, the patterns of mineral accrual between the genders were strikingly
similar when aligned on PHV, supporting the use of PHV-alignment for comparisons between
the genders when possible. The positive relationship between maturational level and bone
mineral accrual is logical since during puberty there is an increase in both growth hormone and
sex steroids, which have potent effects on bone mineral accrual in both males and females (the
specific affects of these hormones on bone discussed later (section 5.5.3).
The importance of sex steroids during puberty was demonstrated in an investigation by
Slemenda et al. (55) where they reported that prepubertal, peripubertal and postpubertal
children increased aBMD significantly at both the LS and FN over a three year period. They
concluded that children who were peripubertal exhibited the greatest gains in aBMD, and at the
LS the 3-year rate of increase was nearly threefold greater during puberty than before puberty
(p<0.001). Similar differences were seen at the femoral neck in terms of before and during
pubertal bone accrual, but to a lesser extent; this should be expected as the FN is more cortical
in constitution and thus less sensitive to endogenous estrogen. At the end of the investigation
the elder children (17 years of age) had attained peak bone mass values in the FN, but not the
spine. Further, Southard et al. (155) concluded that there was a significant effect of puberty on
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bone aBMD, with those more advanced possessing greater aBMD values in both genders.
Moreira-Andres et al. (179) reported that in 88 children aged 10 though 18 years of age aBMD
increased significantly with advancing states of puberty and Southard et al. (155) concluded that
there was a significant effect of puberty on aBMD, with those more advanced possessing greater
aBMD values. None of these previous investigations utilized the PHV-based maturity
assessment, but rather subjective Tanner staging and all were cross-sectional.
5.4.1.1 Total Body
When controlled for maturation, TB aBMD in the males increased throughout the age
span, with the most rapid mineral accrual occurring after PHV. The correlation between PHV-
age and aBMD at the TB was significant (r=O.823;p<O.001), displaying the dependence of aBMD
on pubertal age. Similarly, Boot et al. (177) reported significant increases in aBMD from Tanner
stages 2-5, compared with the previous stage. Rico et al. (154) similarly found a significant
increase in TB aBMD with higher Tanner stages in their cohort of adolescents.
After the females were aligned on PHV increases above that of the previous year were
observed yearly throughout the age span. The PHV-age was significantly correlated with TB
aBMD (r=O.805;p<O.001). Similar to the males, Boot et al. (177) reported that significant
increases in female TB aBMD were observed from Tanner stages 2 and 4 and 5, compared with
the previous stage.
5.4.1.2 Femoral Neck
Male FN aBMD was stable until PHV, then increased dramatically. The fact that PA had
the same growth pattern suggests the increase may simply be an artefact of the measurement.
PHV-age was significantly correlated with aBMD (r=O.678;p<O.001). Concurring with the
findings of this investigation, Ruiz et al. (225) observed significant gains in aBMD at the FN in
males in late puberty.
Similar to the males, girls had an increase in FN aBMD only after -1 year PHV. The
correlation between the PHV-age and aBMD at the FN was also significant (r=O.71 O;p<O.001).
The rapid increase in aBMD with a concomitant decrease in the years after puberty is supported
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by investigations by Bonjour et al. (133) and Theintz et al. (150). They observed rapid increases
in aBMD during puberty, and especially the years just after puberty. However, after 2 year
following menarche, aBMD decreased substantially to the point where no more mineral was
being laid down, suggesting that PBM had been attained at approximately 16 or 17 yrs. of age.
Ruiz et al. (225) similarly reported a steady increase in aBMD at the FN in girls, with accelerated
gains in mid and later pubertal stages.
5.4.1.3 Lumbar Spine
A dramatic increase in LS aBMD was found in the males after -2 years PHV, and the
PHV-age was significantly correlated with aBMD (r=0.809;p<0.001). The findings in this
investigation concur with previous studies. Boot et al. (177) reported that significant increases in
LS aBMD from Tanner stages 2-5, compared with the previous stage. In another investigation,
Ruiz et al. (225) reported that aBMD increased with pubertal maturation with the increases
being insignificant between prepuberty (Tanner 1) and early puberty (Tanner 2 and 3), but
vertebral density increased dramatically thereafter and measures from later puberty were
significantly (p<0.001) higher than those in prepubertal children. Ruiz et al. (225) reported a
significant and dramatic increase in LS aBMD in the final two stages of puberty (T4 and T5) in
males, with relative stability or minimal gains in the first three stages. Grimston et al. (153)
reported that there was little change in aBMD in Canadian children over the first three Tanner
stages in both sexes, with a dramatic increase in aBMD of the FN and LS between stages 3 and
4 (16% increase) and stages 4 and 5 (11% increase). De Schepper et al. (162) found similar
trends in the analysis of their Belgian database. Further, Rubin et al. (178) reported a
consistent, linear increases in aBMD with pubertal stage and a number of other investigations
have found significant increases in LS aBMD with higher Tanner stages (53;141 ;169).
Female LS aBMD increased dramatically from -1 years PHV onward until -3 PHV, with
a significant correlation between PHV-age and LS aBMD (r=0.798;p<0.001). The most rapid
periods of increasing aBMD were those observed around the pubertal years. Concurring with
the positive effect of estrogen on bone status during puberty, Boot et al. (177) reported that
significant increases in female LS aBMD were observed from Tanner stages 2-5, compared with
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Tanner stage 1. Ruiz et al. (225) reported that LS aBMD was not significantly different between
prepuberty (Tanner 1) and early puberty (Tanner 2 and 3), but vertebral density increased
dramatically thereafter and measures from later puberty were significantly (p<O.001) higher than
those in prepubertal females, similar as was seen in the males. Additionally, Rubin et al. (178)
reported consistent, linear increases in aBMD with pubertal stage. In contrast, Plotkin et al.
(188) reported significant increases in aBMD from Tanner stage 1 through 3, with insignificant
changes from stages 3 to 5. With the exception of the Plotkin et al. (188), all of the above
investigations support the findings of this study.
While it is not surprising that there would be an increase in BMC at all sites with
increasing maturational states, as was observed in both genders, and is expected with
increasing levels' of growth hormone and sex steroids, it is questionable as to whether the
increases in aBMD were real or an artefact of the rapidly expanding cortical shell.
5.4.2 BMAD will not change significantly throughout the growth period at all sites
in both genders (H32)
The subhypothesis that BMAD would not change significantly through the growth period
was not supported as there was a main effect for age observed at all sites. While there was
some evidence of stabilization in the TB, this was not seen in either the LS or FN. Since there
are very few previous investigations of this type to compare it to, the discussion will be primarily
limited to the theoretical physiological rationale of the trends witnessed.
An increase in true volumetric LS BMD may be associated with both age and growth,
with the increases theoretically attributed to increases in the quantity and thickness of individual
trabeculae, artefacts in the mathematical extrapolation of bone volume and the volume ratio
between the intravertebral disc and the vertebra (which influences the height of the ROI), or
methodological limitations such as the inclusion of highly cortical posterior and transverse
processes in the quantitation of BMC (but not of bone projected area) when the x-ray beam
comes from a posterior-anterior direction (226).
As with the aBMD curves, aligning data on PHVs generally results in similar shaped
curves between the genders, supporting its use for the comparison of genders.
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5.4.2.1 Total Body
Both males and females displayed a similar pattern for PHV-aligned TB BMAD curves.
TB BMAD decreased yearly from -4 to 0 years PHV and then remained steady for the duration
of the study period. The correlations between BMAD and PHV-age were both significantly
negative (males r= -0.493;p<0.001, females r= -O.372;p<0.001), suggesting a decrease in bone
BMAD with increasing age. Certainly, this decrease is observed from -4 to 0 years PHV, but not
for the period thereafter. This relative decrease and then stabilization suggests than as children
pass in to puberty there is actually a lower bone density in peripubertal children than in
prepubertal. There is evidence from investigations in adults that suggest that as the body loses
bone mineral it will compensate for the loss in material strength by increasing its architectural
strength through increasing its cross sectional area (104). Perhaps with an increased cross-
sectional area, less density is needed to resist the strains engendered upon it and then with the
stabilization of weight and PA expansion the body attains a state of homeostasis where the
strength matches the loading environment. As osteons mature their material density increase,
which may not occur to any great extent during growth as bone turnover is so rapid; only after
the relative arrest of skeletal expansion would bone turnover slow enough to allow for enhanced
mineralization of the osteons. Different from the findings in this investigation, Katzman et al. (69)
reported that BMAD did not change with age in a cohort of adolescent females (r=0.004;p NS).
The difference between this trials may be ascribed to the difference in sample size as Katzman
et al. (69) only had 45 subjects in her subject pool and they were measured cross-sectionally
using chronologically-based age.
It is interesting to note that many of the epidemiological trials where high fracture rates
are witnessed occur at the point of bone mineral stabilization in BMAD (189-195). Perhaps the
observed decrease in bone mineral density is a consequence of rapid bone envelope expansion,
with too little exogenous calcium being supplied, forcing the body to redistribute a relatively
equal bone mass over a greater volume, thus decreasing density, as was suggested by Parfitt
(44). Certainly the data from this study regarding the dissociation between TB PA and BMC
curves support this hypothesis. It is important to note that this observation is over a highly
124
cortical area. Parfitt (44) hypothesized that much of the calcium for rapid expansion is supplied
from the cortical shell, as evidenced by increased cortical porosity. This hypothesis is supported
in this investigation where during rapid skeletal expansion of the TB, a highly cortical region,
there was little, if any, increase in BMAD. Only following the slowing of skeletal expansion was
there stabilization or minimal increases in BMAD observed, hypothetically a result of a refilling of
the excavation sites burrowed by osteoclastic resorption during rapid growth and high bone
turnover.
5.4.2.2 Femoral Neck
In the males, PHV-aligned FN BMAD decrease each year from -4 through 0 years PHV
after which it increases each year to 4 years PHV. The correlation between age and BMAD was
not significant (r=0.083), suggesting that FN BMAD is independent of age. This rebound of bone
density at the FN may be explained by the dissociation of the PA and BMC curves, with BMC
accrual lagging behind PA expansion until BMC peaks while expansion decreases, allowing for
rapid consolidation to occur. This makes particular sense when PA literally arrests shortly after
PHV, while BMC continues to increase through the entire age range. Similar to this
investigation, Kroger et al. (56) reported no significant association between age and volBMD (r=-
0.08; NS) and Lu et al. (187) reported that after conversion to volBMD there was no longer any
significant association between density and age or weight. In another investigation, Kroger et al.
(68) concluded that there was no significant correlation of volBMD at the FN with age,
suggesting that the observed increases in aBMD were due simply to increases in the bone
envelope size.
In females BMAD was unchanged until year 1 PHV, after which it increased to the end
of the measurement period. There was a significant correlation between BMAD and PHV-age
(r=0.455;p<0.001), suggesting that BMAD is age-dependent at the FN in females.
Ferrari et al. (24) longitudinally studied a cohort of prepubertal girls (37% beginning Tanner
stage 2 at trial termination) for 1 to 2 years and reported a 2.2% increase after 1 year in FN BMAD,
and a 0.07% increase after 2 years. A smaller "rebound" can be seen in the female data, though
not as apparent as with the males. It is important to note that this observation is in a moderately
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cortical area. The phenomenon of a small rebound in early puberty is consistent with this
investigation. In contrast, Kroger et al. (56) reported no significant association between age and
volBMD (r=0.18; NS), Lu et al. (187) reported that after conversion to volBMD there was no longer
any significant association between density and age or weight and Katzman et al . (69) reported
that BMAD did not change with age. All of these other investigations were cross-sectional with
limited sample sizes, and did not control for maturity, which may explain the differences in the
findings.
5.4.2.3 Lumbar Spine
In males, when aligned on PHV, there was a maintenance of BMAD from -4 through -1
years PHV after which yearly gains were recorded; however a significant relationship was
observed between PHV-age and BMAD (r=0.593;p<0.001). Similar to these findings, Boot et al.
(177) described a curvilinear increase in LS BMAD across an age span of 5-18 y., Kroger et al.
(56) reported a linear association between age and volBMD (r=0.70; p<0.001) and Lu et al. (187)
reported that LS volBMD was significantly associated with age, height and weight. Both of the
investigations above utilized chronological age, so are likely biased.
A rapid rate of BMAD increeases was observed between -1 and 1 yr PHV. These
findings are similar to those of Boot et al. (177) who reported that significant increases in BMAD
were only observed from Tanner stages 4 and 5, compared with the previous stages. In earlier
stages of maturation, BMAD remained stable, suggesting that perhaps the dissociation between
PA and BMC in the LS is less than in other sites and after PA expansion slows, the greater
magnitude BMC gains account for augmented BMAD. Since the LS is primarily trabecular bone
in composition, it may be that during rapid skeletal growth less bone is removed from the
trabecular structure for growth, as it has been hypothesized that a large amount of endogenous
calcium is supplied from the cortical bone of the body (44). Further, trabecular bone, owing to its
high relative metabolic activity, can accrue bone at a much more rapid rate than cortical bone
(109). This enhanced accrual ability may be utilized when the bone is loaded and senses a
need for enhanced mineralization to withstand the stresses applied to it.
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Similar to the boys, the girls demonstrated only minimal gains in BMAD until PHV, after
which there was a dramatic increase in density from 0 to 2 yr PHV with slowing thereafter. The
relationship between PHV-age and BMAD was strong and significant at the LS for the females
(r=O.728;p<O.001), suggesting that BMAD is age dependent. Boot et al. (177) reported that
significant increases in BMAD were only observed from Tanner stages 4 and 5, compared with
the previous stage; in earlier stages BMAD remained stable. Ferrari et al. (24) longitudinally
studied a cohort of prepubertal girls (37% beginning Tanner stage 2 at trial termination) for 1 to 2
years and reported a 1.1 % increase after 1 year in LS BMAD, and a 1.4% increase after 2 years.
Similarly, changes in FS BMAD were 26% after 1 year and 2.9% after 2 years. These increases
were smaller in magnitude than the observed changes in aBMD at each site in this investigation
as they were at least partially controlled for bone size.
For chronologically-based age, similar to the findings in the females here, Kroger et al.
(56) reported a linear association between age and volBMD (r=O.54; p<O.001), Lu et al. (187)
reported that LS volBMD was significantly associated with age, height and weight and Katzman
et al. (69) reported that BMAD increased significantly with age. All the above investigations
concur with the findings presented here for LS BMAD. Kroger et al. (68) reported that only
minimal increases in LS volBMD were observed, far smaller than the increases suggested by
aBMD data.
Interestingly, the rebound effect was not too evident in this trabecular-dominated area of
the skeleton. However, there was a relative stability in bone mass until after PHV had been
attained and expansion had slowed so that bone accrual could subsequently increase BMAD,
with exceedingly rapid accrual for the 2 to 3 years immediately following PHV. These
observations support the hypothesis that skeletal expansion is occurring at a pace that is too
rapid for proper mineralization, whether it be a consequence of inadequate exogenous calcium
supplies, exogenous protein intake, or endogenous calcium supplies. Interestingly, in the Boot
et al. (177) investigation with adolescent females there was a trend for values to "rebound" for
LS BMAD.
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Looking over the three sites there was a trend for the largest rebound effect to be observed in
the most cortical region (TB), the intermediate region had an intermediate rebound (FN), and the
smallest rebound in the most trabecular region (LS). These findings support the hypothesis of
Parfitt (109) who suggested that the endogenous calcium suppfied for rapid skeletal growth is
primarily "borrowed" from the cortical shell as evidenced by increased cortical porosity.
5.4.3 sBMD will not change significantly throughout the growth period at all sites
in both genders (H33)
The hypothesis that sBMD would not change significantly with age was not supported in
this investigation. Because very limited studies are available for comparison most of the
discu.ssion is theoretical.
5.4.3.1 Total Body
When aligned on PHV males and females had the same pattern of sBMD change, with
the "rebound" effect prominent: TB sBMD decreased yearly from -4 to 0 years PHV after which
increases in sBMD were observed until the end of the age span. The associations between
sBMD and PHV-age were significant (males r=0.116;p<0.05, females r=0.257;p<0.001). The
prominent rebound effect observed in this region lends further support to the cortical borrowing
hypothesis of Parfitt (227). This rebounding of bone mineral may be a result of the dissociation
and different timing and tempo of PA and BMC over the growth period. It is possible that the
growth in envelope expansion may have been too rapid early in puberty for bone accrual to keep
pace with, but following PHV the lag was made up and consolidation began to become more
complete, leading to higher sBMD values with the slowing of PA expansion and the continuation
of BMC accrual.
5.4.3.2 Femoral Neck
Both males and female FN sBMD remained stable until PHV, then increased.
Significant associations were observed between sBMD and PHV-age (males r=0.369;p<0.001,
females r=0.509;p<0.001). This dramatic increase in density in both of the genders is likely a
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result of elevated growth hormone and sex steroid levels (affect of sex steroid and growth
hormone on bone discussed in section 5.5.3).
5.4.3.3 Lumbar Spine
Both males and females exhibited a "rebound" effect for LS sBMD and exhibited
significant relationships between age and sBMD (males r=0.200;p<0.001, females
r=0.271 ;p<0.001), implying a close relationship between age of maturation and sBMD.
5.4.4 Hypothesis 3 Conclusion
The hypothesis that, when corrected for bone size, there would be no increase in BMD
with age was not supported. However, interesting patterns did emerge from the data than are
different from what is currently presented in the literature. The results show that there is a
period of increasing BMD in later puberty, even early adulthood, but there is also a trend for
decreasing density during early puberty when the skeleton is undergoing rapid expansion. The
subhypothesis that BMAD and sBMD would not change significantly throughout the growth
period at all sites in both genders was not supported; however, an extremely interesting
physiological phenomenon was consistently found in the data. In almost every site, in both
genders there was a strong trend for the BMD values for the most size-independent measure,
sBMD, to decrease until approximately PHV, after which BMD was seen to increase until the end
of the investigated end period.
The rebound effect makes physiological sense when combined with the epidemiological
data of fracture rate during adolescence (189-195). Theoretically, the trough in the rebound
curve represents a point of increased skeletal fragility at a time of increasing body mass.
Numerous other investigations have shown evidence of a rebound effect in their data,
although it has rarely been highlighted. Gilsanz et al (160) performed a LS aCT investigation of
boys and girls aged 3-18 years of age. In this investigation maturational grouping was done
arbitrarily with prepubertal, indeterminate and pUbertal subjects being assigned to groups purely
on their age and not a measured maturity level. Certainly, the prepubertal group was valid (girls
and boys under 9 and 9.5 years, respectively), however the indeterminate (girls 9-13.4 and boys
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9.5-13.7 years, respectively), and the postpubertal (girls 13.4-18 and boys 13.7-18 years,
respectively) would have been inappropriate as the indeterminate would have certainly included
pubertal children and the pubertal would have certainly included postpubertal children.
Regardless of the methodological problems with this investigation, it did present interesting
volumetric data that lends strength to the findings of this study. For LS trabecular bone boys
had slightly higher BMD prepubertally than in the indeterminate stage, which was then followed
by dramatically higher BMD in the pubertal grouping. Similarly in the females trabecular bone
was steady through prepubertal and indeterminate stages, after which a dramatic increase was
observed in the pubertal grouping. This trend was similar to the LS findings of this investigation.
For cortical bone, in both males and females, a trend of slightly lower volumetric density for the
indeterminate subjects as compared to the prepubertal subjects followed by a dramatically
higher pubertal density supports the estimated volumetric data found at the TB and FN in this
investigation. In this aCT data, there was a similar trend of slight losses, or a minimal
maintenance of BMD, with a "rebound" in BMD after puberty.
Similarly, Mora et al (180) performed a aCT investigation in a cohort of girls categorized
by Tanner staging and found evidence of a "rebound" effect in trabecular bone mass in the LS;
cortical bone mass was observed to increase progressively throughout childhood and
adolescence whereas trabecular vertebral BMD changed little with age in the prepubertal girls,
decreased slightly in early puberty, and then increased in later puberty, after which it reached its
maximum value at sexual maturity. The authors concluded that hormonal or metabolic factors
played a more important role than mechanical factors in the regulation of trabecular bone mass
during the pediatric years.
In the BMAD data of Katzman et al. (69) there is some evidence of a rebound in the FN
and TB, but none in the LS, similar to some of the findings in this investigation. The extremely
small sample size of the is cohort, however, makes analysis far too subjective.
In a longitudinal study estimating vOlumetric BMD at the proximal radius Magarey et al.
(228) reported a trend for females to have stable bone mass from 11 to 13 years of age, after
which there was a dramatic increase in density. However, in the males, there was a decrease in
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estimated volumetric bone density from 11 to 13 years of age, after which there was a rebound
to higher values thereafter. When aligned on pubertal status, both males and females displayed
the "rebound" with a decrease in BMD from Tanner stage 1-3 and a subsequent increase. The
authors concluded that the decrease in BMD during midpuberty was a consequence of a lag
between bone mineralization and periosteal expansion.
Milinarsky et al. (229) assessed 571 (4-24 years of age) children and adolescents in
Chile with SXA at the distal (primarily cortical bone) and ultradistal (primarily trabecular bone)
forearm. D-BMD and U-BMD increased very slowly from 4 to 8 years of age in girls, and from 4
to 12 years of age in the boys. Dramatic increases from 8 and 19 years of age in the females
and 12 and 20 years in the males in both areas were observed. In terms of maturity, the boys
and girls both had significant increases in D-BMD between Tanner stages 3 and 4 and 4 and 5,
and in mean UD-BMD between Tanner stages 3 and 4. Significant increases in BMD after
menarche were observed in the females for 2 years for D-BMD, and for 1 year in UD-BMD. In
both of the genders height increases preceded increments in bone accrual. Interestingly, in this
investigation two "rebounds" were observed for both the cortical and trabecular site - one at
approximately the midgrowth spurt and one at the pubertal growth spurt.
The BMD volumetric data are consistent in showing a rebound effect during growth, with
the age of minimum density theoretically the period of maximum fragility.
As bone grows, cortical BMD increases as a result of the replacement of relatively low
density primary osteons with higher density secondary or tertiary osteons, along with secondary
calcification (230;231). The prevalence of osteoid seams may give some insight as to why older
bone may be denser; Frost et al (232) found 10% osteoid seams at age 5, 3% at age 15, 0.8%
a"t age 30, and 0.8% at age 70. Theoretically, a greater prevalence of uncalcified osteoid seams
would decrease the overall density of the cortical bone.
However, even after size-related controls have been made to correct for the
inadequacies of BMD assessment by DXA, the measurement itself rarely reflects the underlying
biological phenomenon. Changes in bone density with growth are commonly ascribed to
changes in mineralization, regardless of whether the changes are due to increases in the
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physical amount of bone within the envelope (as with increased trabecular thickness or a greater
cortical thickness) or due to true increases in mineralization in the form of an incorporation of
additional mineral into existing bone matrix (84).
5.5 The gender difference observed in aBMD will be eliminated when corrected for
bone size and maturation (H4)
5.5.1 Males will possess significantly greater aBMD at all sites as compared to
females, when corrected for maturation (H41)
The subhypothesis that males will possess significantly greater aBMD at all sites as
compared to females, when corrected for maturation was supported at the TB and FN, but not
the LS.
5.5.1.1 Total Body
The pattern of aBMD accrual was identical between the sexes, with males displaying
significantly higher values at all ages. Further, aBMD velocity curves were identical between
males and females, with the peaks occurring at identical developmental ages and with the males
only having a slightly larger magnitude velocity at peak (males =0.078 and females =0.064
g/cm2/y.). By aligning velocity curves on PHV and effective normalization for males and females
occurs, allowing for their direct comparison. The augmented BMD increase in the males may be
a consequence of DXA-mediated error in the measure of aBMD of subjects of differing sizes as
the males were physically larger than the females.
In chronological-based measures, Boot et al. (177) reported no significant differences
between the genders for TB aBMD at any age, whereas Maynard et al. (218) reported that TB
aBMD did not differ between the genders until age 15 after which aBMD was significantly greater
in the males, similar to what was found in this investigation.
5.5.1.2 Femoral Neck
In the males aBMD was consistently higher for all time points when compared to female
values. Similarly, Bonjour et al. (133) reported bone aBMD based on pUbertal stage and
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concluded that for all pubertal stages the males possessed greater aBMD (significantly so at T1
and T5) as compared to the females. Grimston et al. (153) found similar results in that the
males in their investigation, at each Tanner stage, had greater FN aBMD as compared to their
female counterparts. Differently from these results, Ruiz et al. (225) reported that only at Tanner
stage 1 did the males possess significantly higher FN aBMD as compared to the girls;
interestingly there was a trend for the females to have greater values at the other pubertal
stages.
BMD curves between the males and females were of a similar shape and magnitude
(males = 0.073, females 0.070 g/cm2/y) with the only difference being that of the timing of the
peak with the males attaining their peak approximately half a year before the females, just after
PHV.
By aligning velocity curves on PHV an effective normalization for males and females
occurs, allowing for their direct comparison and it was found that they were extremely similar in
regards to their patterns of BMD change, despite the size differences.
5.5.1.3 Lumbar Spine
aBMD was identical between the genders at the LS when aligned on PHV. Similarly,
Bonjour et al. (133) concluded that when aligned on pubertal status there was no difference
between males and females at the LS. Also, Rubin et al. (178) reported consistent, linear
increases in aBMD with pubertal stage, however at midpuberty the females briefly possessed a
greater LS aBMD. When adjusted for differences in body mass between the genders, the
females had significantly higher LS aBMD at all pubertal stages as compared to the males. Ruiz
et al. (225) reported that at no Tanner stage was there a significant difference between genders
for LS aBMD, although there were strong trends towards the females having greater densities,
particularly at the later stages of pubertal development. Southard et al. (155) reported no
difference between the genders for LS aBMD art any pubertal stage, but did report a collapsed-
group significant increase in LS aBMD with each succeeding pubertal stage.
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5.5.2 No statistical difference will exist between genders for BMAD at the TB, LS
and FN, when corrected for maturation (H42)
As there were no other trials in the literature to compare the data to no comparisons can
be made with previous investigations. The greater increases in BMAD rates with the females
might be attributed to the greater osteogenic potential of estrogen as compared to the
androgens (233). During puberty GH as well as sex steroid increase, which both have a positive
influence on bone accrual (234;235). The influence of puberty was more marked in females
than in males in a study by Boot et al. (177), as in a multiple regression analysis the Tanner
stage did not correlate significantly with aBMD in males whereas with the females it was a major
determinant. Animal investigations have shown the dominant effect of estrogen as compared to
androgens on the skeleton (233). Further, those girls that had an earlier menarche had higher
BMD, suggesting the importance of estrogen on mineralization (177).
5.5.2.1 Total body
BMAD between males and females showed the same pattern of initial loss concluding
with a plateau in density values from PHV onward; females had significantly higher TB BMAD
than the males at all time points as reflected by the significant main effect for gender and no
significant interaction effect for gender and age. When corrected for bone size it appears that
females contain slightly higher bone density than do males. These findings support the
contention that the differences observed between males and females in the aBMD literature are
skewed due to the larger bone size of the males.
5.5.2.2 Femoral neck
BMAD of the FN was higher in males from -4 years PHV until -1 years PHV after which
BMAD values were equal until 4 years PHV where females possessed greater BMAD as
compared to the males; however there was no significant main effect for gender, but a significant
interaction between age and gender.
These findings are similar to what have been reported in the chronological-based
literature. Lu et al. (187) reported no significant difference between the genders for volBMD at
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the FN. When aBMD was corrected for size, there was only a significant difference ion the 18-
19 y. group with the males having a greater volBMD (68)
There was a difference in the shape of the BMAD curves between the males and
females; the males exhibited a prominent rebound with the trough at PHV, but the females had a
rebound with a trough at -3 or -2 years PHV.
5.5.2.3 Lumbar Spine
. .
The females possessed higher BMAD at all ages past -2 years PHV when compared to
males as reflected by the significant main effect for gender and no significant interaction term. In
support of this trial, Boot et al (177) reported significantly greater LS BMAD at all ages (5-18 y) in
females as compared to males and Kroger et al. (68) reported that after the age of 16-17 girls
had significantly greater volBMD than the males.
Perhaps the effect of increasing estrogen elicits mineralization earlier or to a greater
degree in this highly trabecular region than is seen in the boys, resulting in higher true density in
trabecular-dominated regions.
5.5.3 Hypothesis 4 Conclusion
When aligned by maturation, only the FN displayed no differen~e between the genders,
so the hypothesis was only supported at the FN. Perhaps there is a real difference in
mineralization patterns between the genders at the TB and LS. For example, Zamberlan et al.
(183), after measuring cortical thickness and bone density of growing males and females at the
distal radius, concluded that most of the purported differences between males and females and
the changes that are associated with age are primarily an artifact of skeletal dimension rather
than changes in actual density. In fact, the estimated VOlumetric BMD of the radius remained
stable from 3-21 years in the investigation. The distal radius can be most compared with the TB
measure in this investigation as it is a highly cortical site.
In essence, differences between the genders in patterns of .bone mineralization have to
be at least partially attributed to differences in central, and perhaps local, hormonal action.
Trabecular bone has been suggested to be more responsive to estrogen and cortical more to
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testosterone; the preferential activity of these two gonadal hormones may provide some insight
as to the patterns observed in this trial.
The products of the GH-IGF-I system induce proliferation without marked maturation of
the epiphyseal growth plate and thus induce linear skeletal growth that lasts until sex-hormone
mediated epiphyseal closure (236). The sex hormones, estrogen and testosterone are present
in very ·Iow quantities during infancy and childhood and are produced in abundance during
puberty and afterward. These hormones promote both proliferation and maturation of the
epiphyseal growth plate. The direct actions of these hormones on the growth plate are difficult
to ascertain owing to the indirect actions it has through increasing the activity of the GH-IGF-I
axis and of insulin during puberty, and through the aromatization of testosterone to estrogens
(236).
Childhood growth is largely GH-dependent, with pubertal growth being dependent on a
combination of sex steroids and GH (237). During puberty there is a distinct rise in the release
of GH (238-240). Further, sex steroids have a direct anabolic action and a modulating effect on
GH secretion (237). During puberty the increase in sex steroids cause an increase in
endogenous pulsalite secretion of GH in boys and girls (241).
An adequate pubertal growth spurt cannot occur without sufficient quantities of GH
(242;243). However, the combined growth promoting effects of the gonadal axis and increased
GH secretion are required for growth at puberty (244). In an investigation by Rose et al. (245)
GH levels increased during puberty in both sexes, with the highest levels at midpuberty, with the
pulse amplitude, rather than the temporality, responsible for the increase. Children with GH
deficiency have dramatically lower bone mass as compared with their normal counterparts (246-
248). In adults with childhood onset GH deficiency, the lack of serial change in bone mass in
adulthood suggests that the reduced BMD observed may primarily be a consequence of reduced
bone mineral accretion as compared to advanced rates of bone loss (249).
It is well established that estrogen has potent osteogenic effects on bone. The
importance of estrogen in growing adolescent females is perhaps best observed in cases where
estrogen is absent - amenorrhea. In a recent investigation 21 of the 27 amenorrheic women
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investigated (mean age 27 yrs) showed pathological demineralization of the lumbar spine (250).
To illustrate the importance of estrogen on growing bone, the degree of undermineralization in
the investigation was higher in those subjects with primary as compared to secondary
amenorrhea; the authors concluded that the lower bone mass in the primary amenorrheics was
attributable to reduced bone formation in adolescence (250). In another investigation it was
estimated that amenorrehic women had a 15% reduction of BMD at the LS as compared to
normally menstruating women (251). Similarly, a aCT investigation concluded that LS
trabecular bone mass was 20-30% decreased in patients with amenorrhea as compared to
'eumenorrheic women (252). Obviously, there is unequivocal evidence that a lack of estrogen is
extremely deleterious to growing bone, particularly trabecular bone. However, estrogen is also
important for cortical bone accrual as shown in an investigation by Dhuper et al (207) where the
effect of estrogen on growing bone was demonstrated in that the girls with the lowest exposure
to estrogen during puberty had the lowest cortical and overall bone mass.
The presence of estrogen is also important for normal mineralization in males;
observations from males who lacked aromatase (253) or functional estrogen receptors (254)
displayed delayect. epiphyseal fusion, suggesting that even in male subjects estrogen plays a key
role in the maturation and eventual fusion of the epiphyseal plate.
Theoretically, estrogen could be a limiting factor to the adolescent growth spurt (236).
Blumsohn et al. (156) postulate that the effect of estrogen on growing bone in females is
biphasic in that during early puberty when circulating estrogen levels are low, estrogen
stimulates growth, while during later puberty, when estrogen levels are higher, it has a potent
inhibitory effect on longitudinal bone growth and accelerates growth plate closure.
Testosterone has an important influence on bone development as evidenced by the
concomitant increase in osteocalcin, a marker of bone formation, and serum testosterone during
puberty (255). In an investigation of adolescent male hypogonadism it was found that cortical
bone density was decreased in adolescent male patients with hypogonadism as comparison with
controls; gonadal sex steroid testosterone deficiency was attributed to this lower BMD (256).
Clearly, there was an effect of testosterone on cortical density.
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Testosterone may promote mineralization in bone through a number of pathways:
activation of the PTH-vitamin 0 axis, enhancement of GH secretion, which results in augmented
IGF-I action on bone, and most likely a direct effect on bone. The action of testosterone on bone
is thought to be direct even in the absence of systemic growth hormone and IGF-I (256),
however, the effect of testosterone on bone has been shown to be retarded without the
presence of GH (257).
It has been suggested that testosterone has a preferential effect on the axial skeleton
(primarily cortical bone). However, evidence from investigations with children afflicted with
primary hypopituitarism suggest thatthe growth of the lower body is primarily under the control
of GH, whereas the growth of the upper body segment is more under the control of testosterone
(258;259).
In a recent study of central precocious puberty and congenital adrenal hyperplasia it was
concluded that adrenal androgens appeared to have a smaller role in bone maturation than
estrogen despite the fact that both estrogen and adrenal androgen are involved in increasing
BMD (260). Adrenal androgens may act indirectly on bone cells by conversion to testosterone
and dihydrotestosterone (261). Androgens can also be aromatised into estradiol or estrone
(262).
Sex steroids influence circulating levels of GH and IGF-I, suggesting that an interaction
between these hormones may be important to the acquisition and maintenance of bone mass
(263). It is possible that the influence of GH deficiency on endogenous sex steroids may explain
the presence of reduced bone mass in GH deficient children (263). IGF-I has chrondrocyte
mitogenic effects, but is also anabolic to bone tissue through the stimulation of osteoblast
proliferation and differentiation, and matrix formation (264).
Based on these findings .it seems as though estrogen has a preferential effect on more
trabecular regions, whereas the androgens a preferential effect on the more cortical regions,
although there seems to be no clear answer in the literature as yet.
This preferential effect of estrogen on trabecular bone mass may partially explain the
higher BMAD found in the females in this investigation, and the higher aBMD found in a number
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of investigations, despite their smaller PA as compared to males of a similar age or
developmental stage.
5.6 The age-related acceleration in aBMD velocity during the pUbertal years is
eliminated when corrected for bone size (H5)
5.6.1 aBMD velocity will remain positive throughout the growth period at all sites
in both genders (H51)
aBM0 velocity remained positive in all sites for all genders, supporting the
subhypothesis. There are very few comparable studies with which to contrast the findings of this
investigation.
As with the distance data, when the velocity values were aligned on pubertal status
based on PHV the variance observed decreased and the velocity curves of the genders became
similar. If anything, this investigation gives credence to the methods used here; the conclusions
drawn from the maturity-aligned data have greater validity compared to the chronological data.
With the chronological data subjects were grouped according to a set chronological age, but
invariably are at differing points of maturation, since puberty can vary widely in terms of age. In
essence, by grouping the children based on chronological ages, there is a grouping of differing
maturity levels and thus differing growth tempos. The result of this erroneous grouping would be
to artificially attenuate those periods of rapid growth and enhance the lower levels - creating a
curve that is less reflective of individual growth. When aligned on PHV these problems are
eliminated and the true shape of the growth patterns can be determined and from that
mineralization patterns ascertained. The use of maturity based data is essential when
comparing or combining velocity curves.
)
5.6.1.1 Total Body
In the males all TB aBMD velocity measures remained positive, with the age at peak
aBMD velocity occurring at 0.89 years PHV. TB aBMD velocity remained positive over the entire
measurement period for the females, and the peak aBMD velocity was observed at 0.91 years
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PHV. There are no trials with which to compare this data. It is interesting to note that for both
the males and females the peak in BMC followed PHV by almost a year, giving support to the
theory that first the bone expands, and then becomes consolidated. It is possible that at the time
of rapid bone expansion the body simply cannot provide enough calcium to fully mineralize the
newly laid down osteoid, as supported by longitudinal research by Martin et al. (146).
5.6.1 ..2 Femoral Neck
When aligned on PHV the male peak aBMD velocity occurred at .021 years PHV and all
values were positive throughout the measurement period. All measures of FN aBMD velocity
were positive in the females throughout the measurement period with the peak occurring at 0.83
years PHV. The peak for the FN occurred earlier in the males than it did for the TB, showing
some form of temporal spacing. In the females there was a relative equality between the age at
peak in both the TB and FN.
5.6.1.3 Lumbar Spine
When aligned on PHV, male LS aBMD velocity remained positive at all time points, with
the peak velocity occurring at 0.52 years PHV. In females, all aBMD velocity values were
positive and the peak occurred at 0.81 years PHV. Again, the peak for the females was exactly
in the range of the other two sites, but the peak for the males was intermediate between the
sites.
5.6.2 BMAD velocity will be negative or zero through the growth period at all sites
in both genders (H52)
This subhypothesis was not supported in totality; however, there were notable portions of
the velocity curves that exhibi ed a negative velocity. The negative velocities observed are in
contrast to the findings of aB 0 investigations which show a constant increase in density with
growth (55;61;133;150;152;15 ;178;216-218). From this data it seems safe to claim that there
are periods of decreasing de sity during early puberty and periods of increasing density with
later puberty.
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5.6.2.1 Total Body
When aligned on PHV, male BMAD velocity peaked at 1.04 years PHV. Only at the
peak did BMAD velocity attain a positive velocity. At no time did the female BMAD reach a
positive velocity with the peak occurring at 2 years PHV. The -negative velocities described in
both the males and females in this investigation may be a result of dissociation between the
volume and the mineral content of the bone. As the curves are observed, they are accelerating
towards zero or positive values. This may be the result of bone volume slowing and BMC
accelerating, causing. bone which at first was expanding more quickly than it could be
mineralized, to become more and more mineralized as the lag between the two processes come
to a union before BMC accrual dominates. This highly cortical sample largely supports the
subhypothesis in both genders.
5.6.2.2 Femoral Neck
When the males were aligned on PHV, BMAD velocity was negative until 1 year PHV,
with the p~ak occurring at the end of the measurement period. In the females, the -2 year PHV
had a negative velocity associated with it, but a positive 'velocity was witnessed from -1 years
onward with the peak occurring at 1 year PHV. The male curve suggests that increases in BMD
are beginning to rapidly occur at the end of the measurement period - this may be the point at
which BMC gain overtakes bone envelope expansion. In the female curve, a stabilization and
the beginning of a downward deflection approximately 2 years after PHV support the findings of
Theintz et al. (150) and Bonjour'et al. (133), who both concluded that the most rapid time of
aBMD gain is in the two years directly after menarche. Once again, the intermediate cortical site
displays a pattern intermediate between the highly cortical and highly trabecular site.
5.6.2.3 Lumbar Spine
BMAD velocity in the males was consistently positive with a dramatic acceleration
occurring from -1 to 0 years PHV. The male peak BMAD velocity occurred at 0.68 years PHV.
BMAD velocity was not negative at any time point in the females and the peak occurred at 0.93
years PHV. In both the males and females, extremely rapid gains were made in bone density;
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the steepness of the velocity curves were much greater than that of the TB or FN, perhaps
reflecting the fact that trabecular bone is much more metabolically active as compared to cortical
bone (109) and that the sex hormones present during pUberty have a rapid effect on sites such
as this with large proportion of trabecular bone. It is interesting to note that the boys' peak value
was 0.0072 g/cm3/y and the females' 0.009 g/cm3/y., one of the rare instances where the
females had a greater peak, perhaps to the greater metabolic activity of estrogen in bone as
compared to the androgens (233).
Note that the most trabecular region was the only region with little or no negative
velocity values.
5.6.3 sBMD velocity will be negative or zero through the growth period at all sites
in both genders (H53)
5.6.3.1 Total Body
Male TB sBMD velocity remained negative until PHV after which positive velocities were
observed and peak occurred at 1.75 years PHV. Female TB sBMD velocity remained negative
until PHV after which positive velocities were observed, with the peak observed at 1.49 years.
These observations support the rebound hypothesis. Density is thought to decrease during
periods of rapid skeletal expansion and rebounds with increasing density after growth in skeletal
size has all but arrested allowing for increased mineralization and the filling of cortical porosity
(109).
5.6.3.2 Femoral Neck
Male FN sBMD data was positive at all time points with the peak occurring at 14.26
years. In the females, FN sBMD was positive at all time points with the peak velocity occurring
at the start of ,the measurement period. Although a positive velocity was observed at all time
points, there was a dramatic decrease in velocity in both the boys and girls that fit in with the
rebound hypothesis.
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5.6.3.3 Lumbar Spine
With PHV-aligned data, the males had a negative sBMD velocity at -2 and -1 years
PHV, after which they attained a positive velocity. The peak velocity was attained at the end of
the measurement period. The peak velocity in sBMD occurred in the females at 1.16 years at
the LS, with only some midpoint values between -1 and 0 PHV being negative velocities. A
definite trend for a rebound effect is observed in the data once again. Interestingly, the males
had a greater period of negative velocity as compared to the females, perhaps due to the greater
osteogenic response of trabecular bone to estrogen as compared to testosterone.
5.6.4 Hypothesis 5 Conclusion
In many of the circumstances, BMAD velocity was negative or close to zero. For BMAD
females only had negative values for TB, whereas the other two sites were primarily positive.
For the males, negative values were obtained for most of the TB measures, and from -2 to 0
years PHV at the LS. When aligned on PHV the hypothesis is supported at the TB, a highly
cortical site, partially supported at the FN, and intermediate site, and not supported at the LS, a
primarily trabecular site. Overall, however, these findings display a far different pattern of BMD
change as suggested by the linear increases of aBMD data at all sites.
There appears to be a preferential mineralization pattern during growth with trabecular
bone acutely more responsive to some factor for optimization of mineralization during puberty,
as compared to cortical bone. Certainly the higher metabolic activity of trabecular bone can be
one factor associated with this rapid growth as the LS would be the most responsive to central
hormone activity, such as the sex steroids. Further, the potent effect of endogenous estrogen at
this time in life in females could partially explain the significantly higher bone mass at the LS
during this period of life.
A consistent finding in this investigation is that after controlling for size there is evidence
of a period of decreased density, or a slowing of BMD acceleration, just prior to the PHV being
attained. This consistency suggests that bone is less dense at PHV that any other point during
growth and thus could be more susceptible to fracture. Interestingly, the most cortical regions
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seem to be the most effected, perhaps a consequence of the increased cortical porosity
espoused by Parfitt (44), or possible due to a difference in sex steroid or GH action on bone.
5.7 There will be a lag period between the age at peak PA velocity and age at peak
BMC velocity (H6)
At every site, for both genders there was a dissociation observed between the PA velocity
curve and the BMC velocity curve, with the PA curve always attaining peak values before that of
the BMC curve.
When aligned on PHV the data truly exhibits the dissociation that is occurring between
skeletal expansion and subsequent bone accrual. In both the males and females there is a
significant dissociation between TB PA and BMC velocity curves with males having a
dissociation of 0.71 years and females one of 0.41 years.' In both the males and females there
is a significant dissociation between FN PA and BMC velocity curves with males having a
dissociation of 0.21 years and females one of 0.61 years. In both the males and females there
is a significant dissociation between LS PA and BMC velocity curves with males having a
dissociation of 0.27 years and females one of 0.49 years.
These dissociations may be responsible for the transient osteopenia alluded to in
numerous investigations regarding higher fracture rates in adolescents during the period
surrounding PHV (189-195).
5.7.1 Hypothesis 6 Conclusion
A definitive dissociation between bone mineral size and bone mineral accrual occurred
in this population. In the females the FN was the first to expand and subsequently achieve its
peak bone mineral accrual, with the LS and TB following relatively equal to one another
temporally in terms of their peak PA expansion and BMC accrual. In the males, the FN similarly
achieves its peak first, followed by the LS and then the TB.
After investigating the relationship between the asynchrony of height gain and bone
mass accrual during puberty, Fournier et al. (216) concluded that during pubertal maturation
there is a time lag between bone mineral acquisition and statural growth, and that the lag was
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different for different sites depending on their constitution. They concluded that overall the
dissociation was generally larger in the males as compared to the females, particularly at the FN
and FS. The delay was found to be maximal at PHV. The findings of this investigation concur
with those of Fournier et al. (216).
These investigations, as well as this one, give support to the hypothesis that during
adolescence initially bone rapidly increases in size and then later undergoes consolidation. After
the period of maximal bone envelope expansion and before the period of rapid mineralization I
there hypothetically should be a period of heightened skeletal fragility.
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6 Summary and Conclusions
The use of a longitudinal database and the control of maturity by PHV is the unique
asset of this investigation. The design made the observations robust and meaningful as they
eliminated a tremendous amount of variability that would be present with cross-sectional data or
if comparisons were simply based on chronological age.
DXA-based aBMD is the most frequently reported measure of bone in paediatric growth
literature. Based on abundant aBMD evidence the pattern of BMD changes during growth has
been described to consistently increase with an accelerated rate of BMD increases during the
pubertal growth spurt, with BMD increases then slowing into adulthood coincident with the
attainment of PBM. These assumptions were supported in the data presented here. However,
the increase of aBMD with growth is at odds with epidemiological evidence (189-195) that
demonstrates a period of skeletal fragility precisely during the time when the most rapid skeletal
expansion is occurring.
DXA-derived aBMD was found in this investigation to be significantly dependent on bone
size, through both correlational and linear regression analyses. The result of the size
dependence of aBMD is that larger bones will have artificially inflated density values and smaller
bones artificially lower. During growth bone size changes dramatically and when a child is
measured serially over the growth period it is impossible to determine whether the changes
observed are due to a true increase in bone density or whether it is an artefact of the
measurement technology. Further, a comparison between individuals of different sizes cross-
sectionally with aBMD is flawed for the same reasons. Therefore, the pattern of BMD changes
with growth as described by aBMD is most likely not accurate as it is confounded by changes in
bone size.
When aBMD was corrected for bone size through either geometric (BMAD) or
statistically-based techniques (sBMD) the association between bone size and density was either
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diminished (BMAD) or eliminated altogether (sBMD) at all sites, as determined by correlational
analyses. Interestingly, BMD patterns with growth were determined based on the corrected
equations there was a definitive trend of decreasing BMD until PHV, with a subsequent
"rebound". This pattern is different from that typically described by aBMD investigations. This
phenomenon of decreasing BMD until PHV is supported by the epidemiologic investigations
(189-195) which suggest a maximum fragility of bone approximately the time of PHV. The
corrected measures of BMD more closely explain the epidemiological phenomena of maximal
fracture incidence during rapid growth than do the uncorrected values that suggest fractures are
occurring during periods of relatively maximal density. Interestingly, the region with the greatest
proportion of cortical bone (TB) displayed the most consistent and pronounced rebound
phenomenon, followed by the intermediately cortical FN, and least frequently and pronounced
with the highly trabecular LS. The different mineralization patterns with cortical and trabecular
bone may be a consequence of preferential resorption of cortical bone during rapid growth in
order to supply periosteal expansion.
BMAD may not be the most appropriate size-correction as it was shown to consistently
be significantly associated with PA and led to some patterns of BMD change that were difficult to
rationalize physiologically. The strict geometric assumptions used in the determination of BMAD
are probably not appropriate in this population. sBMD did attain independence from PA and led
to patterns of bone density that was physiologically plausible. The downfall of using sBMD is
that it must be developed for each specific population before it can be applied; however, it does
have promise for norm development if developed from a large sample.
When the growth curves of males and females were aligned on PHV-based maturation a
similarity in BMD patterns was consistently observed. While there were generally few
differences, there was a slight trend for females to have higher density measures at the more
trabecular LS site. It is likely that cortical and trabecular bone development are regulated by
different factors, whether they be environmental or endogenous, as supported by the work of
Gunnes et al. (265) in a large cohort of children. Slemenda et al. (55) concluded that the
different rates of change observed in sites with differing bone composition may be a
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consequence of preferential action of hormones on trabecular bone. However, after correction
for pubertal status and correction for bone size, density measures between the genders were
strikingly similar suggesting that a large part of the gender difference observed may simply be a
consequence of bone size.
When the velocity of BMD was determined, PA-dependent aBMD displayed consistent·
positive acceleration values at all time points and at all sites, suggesting that increases in aBMD
continues throughout growth with a period of particularly rapid aBMD increase during the
pubertal years. However, when density was corrected for bone size there was a pattern of
negative velocity in the years prior to PHV, with positive velocity after. This trend was most
evident and strongest in the TB, intermediate in the FN, and least obvious in the LS; the more
cortical sites displaying the greatest decreases in BMD prior to PHV. Parfitt (227) suggested
that during periods of rapid skeletal expansion the calcium requirements that cannot be met
completely by exogenous supplies are augmented by endogenous calcium removed from
cortical bone resulting in increased porosity of cortical bone during growth. Consequently, those
regions with the highest percentage of cortical bone (TB) should preferentially lose bone mass
before that of those regions with primarily trabecular bone (LS).
Lastly, when comparing velocity curves for PA and BMC a definitive and consistent lag
period was seen with the peak in bone projected area preceding the increases in bone mass
accrual anywhere from 0.21 years to 0.61 years. This dissociation between bone projected area
and bone mass suggests that bone first expands and then becomes further mineralized.
Theoretically, as supported by epidemiologic fracture investigations (189-195), the point of
maximal bone expansion, as seen in this investigation as the age at peak velocity of PA is the
point at which there is the greatest fragility as complete mineralization has not yet occurred. In
terms of the temporality of bone turnover this lag may make sense. In the basic multicellular unit
a packet of bone is removed relatively quickly (7-10 days). After bone has been removed by
osteoclasts there is a period of reversal where osteoblasts lay down osteoid and begin
preliminary ossification. However, after the osteoid has been laid down, it can take anywhere
from 3-6 months to see complete mineralization of the osteoid. During that period of increasing
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mineralization there would certainly be mechanically inferior bone and if enough regions were
undergoing this mineralization simultaneously, such as is seen with growth as evidenced by high
levels of biochemical markers for bone turnover, the bone as a whole would be more susceptible
to failure. Another theoretical rationale for the lag between expansion and mineralization may be
simply due to an outpacing of increases in size with the physical ability of the body to mineralize
that much osteoid; there simply is not enough calcium present from both endogenous and
exogenous sources to supply both the rapid expansion and mineralization needed to keep these
two parameters in balance.
The findings of this investigation suggest that aBMD as determined by DXA is not
appropriate for assessing changes in BMD in children during growth. Further investigations
need be completed to precisely determine volumetric BMD patterns during growth as it probably
has not been accurately described up until this point. The evidence from the corrected BMD in
this trial consistently suggests that there is a period of skeletal fragility during PHV that is a
consequence of an early pubertal decrease in density until PHV, with increasing thereafter.
While patterns of BMD change do explain some of the changes that occur in terms of
the mechanical integrity of the bone, a great deal of variability can most likely also be attributed
to changes in bone geometry and architecture over the growth period. In future investigations
there is a need to measure these mechanical parameters as well as measures of BMD to
completely understand the changes occurring. with growth as there is most certainly an interplay
between these factors.
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6.1 Hypotheses summary
H1: aBMD is significantly influenced by body height, body mass and the bone
projected area of the respective site.
SUPPORTED.
H11: Height, weight and bone projected area will be significantly positively
correlated with areal BMD at all sites.
SUPPORTED.
H1 2: All regression coefficients of PA regressed upon BMC will be significantly
different than unity at all measurement sites.
SUPPORTED.
H2: aBMD corrected for bone size will not be significantly influenced by height, body
mass and the bone projected area of the respective site.
H21: Height, weight and bone projected area will not be significantly correlated
with BMAD at any site.
NOT SUPPORTED.
H22: Height, weight and bone projected area will not be significantly correlated
with statistically corrected BMD (sBMD) at any site, demonstrating its
independence from size measures in the estimate of bone density.
SUPPORTED.
H3: The age-related increase in aBMD in both genders is eliminated when corrected
for bone size.
NOT SUPPORTED.
H31: aBMD will increase significantly throughout the growth period at all sites in
both genders.
SUPPORTED.
H32: BMAD will not change significantly throughout the growth period at all sites
in both genders.
NOT SUPPORTED.
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H33: sBMD will not change significantly throughout the growth period at all sites
in both genders.
NOT SUPPORTED.
H4: The gender difference observed in aBMD will be eliminated when corrected for
bone size and maturation.
NOT SUPPORTED.
H41: Males will possess significantly greater aBMD at all sites as compared to
females, when corrected for maturation.
SUPPORTED AT TB AND FN, not LS.
H42: No statistical difference will exist between genders for BMAD at the TB, LS
and FN, when corrected for maturation.
NOT SUPPORTED.
H5: The age-related acceleration in aBMD velocity during the pubertal years is
eliminated when corrected for bone size.
H51: aBMD velocity will remain positive throughout the growth period at all sites
in both genders.
SUPPORTED.
H52: BMAD velocity will be negative or zero through the growth period at all sites
in both genders.
NOT SUPPORTED.
H53 : sBMD velocity will be negative or zero through the growth period at all sites
in both genders.
NOT SUPPORTED.
H6: There will be a significant lag period between the age at peak PA velocity and
age at peak BMC velocity.
SUPPORTED.
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9.1 Chronological-based tabular data
Table 9.1. Chronological Correlations of TB BMD, BMAD and sBMD with Age and Size
Measures (Males).
Table 9.2. Chronological Correlations of TB BMD, BMAD and sBMD with Age and Size
Measures (Females).
Table 9.3. Chronological Correlations of FN BMD, BMAD and sBMD with Age and Size
Measures (Males).
Table 9.4. Chronological Correlations of FN BMD, BMAD and sBMD with Age and Size
Measures (Females).
Table 9.5. Chronological Correlations of LS BMD, BMAD and sBMD with Age and Size
Measures (Males).
Table 9.6. Chronological Correlations of LS BMD, BMAD and sBMD with Age and Size
Measures (Females).
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Table 9.7. Male Total Body Chronological Data.
Table 9.8. Female Total Body Chronological Data.
Table 9.9. Male Femoral Neck Chronological Data.
Table 9.10. Female Femoral Neck Chronological Data.
SEM 1
0.00317 1
0.00284 I
···6"~oo3-fr·1
_._--_.j
0.00328 1
0.00348 i
...Q:.9..~~~_~J
0.00563 I
0.00697 1
0.OQ?75J
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Table 9.11. Male Lumbar Spine Chronological Data.
Table 9.12. Female Lumbar Spine Chronological Data.
Table 9.13. Male Total Body Chronological Velocity Data.
Table 9.14. Female Total Body Chronological Velocity Data.
Table 9.15. Total Body Chronological Peak Data.
Age at Peak Velocity I Peak Velocity
i
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Table 9.16. Male Femoral Neck Chronological Velocity Data.
Table 9.17. Female Femoral Neck Chronological Velocity Data.
Table 9.18. Femoral Neck Chronological Peak Data.
Age at Peak Velocity I Peak Velocity-l
Table 9.19. Male Lumbar Spine Chronological Velocity Data.
Table 9.20. Female Lumbar Spine Chronological Velocity Data.
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Table 9.21. Lumbar Spine Chronological Peak Data.
Age·~ai·peak·veiociiYT·peak-veioCitY·""·-·····-·""·1
1 !
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9.2 Chronological-based figures
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Figure 9.1. Male and female chronological-based growth curves for bone projected area
(mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
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Figure 9.2. Male and female chronological-based growth curves for bone mineral content
(mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
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Figure 9.3. Male and female chronological-based growth curves for bone mineral density
(mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regions.
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Figure 9.4. Male and female chronological-based growth curves for bone mineral
apparent density (mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine
regions.
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Figure 9.5. Chronological-based growth curves for statistically-corrected bone mineral
density (mean±SEM) of the a. Male total body; b. Female total body; c. Male femoral neck;
and d. Female femoral neck. Figure 9.5. continued on following page.
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Figure 9.5. continued. PHV-aligned growth curves for statistically-corrected bone mineral
density (mean±SEM) of the e. Male lumbar spine; and f. Female lumbar spine
regions.
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Figure 9.6. Male and female chronological-based velocity curves for areal bone mineral
density (mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine regio~s.
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Figure 9.7. Male and female chronological-based velocity curves for bone mineral
apparent density (mean±SEM) of the a. Total body; b. Femoral neck; and c. Lumbar spine
regions.
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Figure 9.8. Male and female chronological-based velocity curves for statistically-
corrected bone mineral density (mean±SEM) of the a. Total body; b. Femoral neck; and c.
Lumbar spine regions.
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Figure 9.9. Chronological-based velocity curves displaying the dissociation between
bone projected area and bone mineral content (mean±SEM) for a. Male TB; b. Female TB;
c. Male FN; d. Female FN; e. Male L5; and f. Female LS.
187
188
10 Appendix C: Supplementary Peak Height Velocity-
Aligned Tabular Data
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10.1 PHV-aligned tabular data
Table 10.1. Male Total Body PHV-Aligned Data.
Table 10.2. Female Total Body PHV-Aligned Data.
Table 10.3. Male Femoral Neck PHV-Aligned Data.
Table 10.4. Female Femoral Neck PHV-Aligned Data.
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Table 10.5. Male Lumbar Spine PHV-Aligned Data.
Table 10.6. Female Lumbar Spine PHV-Aligned Data.
Table 10.7. Male Total Body PHV-Aligned Velocity Data.
Table 10.8. Female Total Body PHV-Aligned Velocity Data.
Table 10.9. Total Body PHV-Aligned Peak Data.
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Table 10.10. Male Femoral Neck PHV-Aligned Velocity Data.
Table 10.11. Female Femoral Neck PHV-Aligned Velocity Data.
Table 10.12. Femoral Neck PHV-Aligned Peak Data.
.....................--......................•.--.-.•••.···__···_·_·····r···-··_········__···············_··_········1
PHV-Age at Peak Velocity i Peak Velocity I
I
Table 10.13. Male Lumbar Spine PHV-Aligned Velocity Data.
Table 10.14. Female Lumbar Spine PHV-Aligned Velocity Data.
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Table 10.15. Lumbar Spine PHV-Aligned Peak Data.
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